UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q


(Mark One)
~~(Mark One)~~☒
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, ~~2018~~2019
OR
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to

Commission file number 001-33892

AMC ENTERTAINMENT HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation or organization)	26-0303916 (I.R.S. Employer Identification No.)
One AMC Way 11500 Ash Street, Leawood, KS (Address of principal executive offices)	66211 (Zip Code)

Registrant’s telephone number, including area code: ~~(913)~~ (913) 213-2000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large ~~accelerated filer~~ Accelerated Filer ☒

Accelerated filer ☐

~~Non‑accelerated~~Non-accelerated filer ☐

Smaller reporting company ☐

Emerging growth company ☐

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standard provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Class A common stock	AMC	New York Stock Exchange

Title of each class of common stock

Number of shares
outstanding as of ~~October 31, 2018~~November 1, 2019

Class A common stock
Class B common stock

~~51,744,412~~52,080,077

51,769,784

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements. (Unaudited)

AMC ENTERTAINMENT HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


	Three Months Ended				Nine Months Ended
(In millions, except share and per share amounts)	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
	(unaudited)				(unaudited)
Revenues
Admissions	$	797.3	$	751.4	$	2,424.3	$	2,522.7
Food and beverage		420.0		384.8		1,281.3		1,236.4
Other theatre		99.5		85.2		317.7		288.4
Total revenues		1,316.8		1,221.4		4,023.3		4,047.5
Operating costs and expenses
Film exhibition costs		416.8		378.8		1,264.6		1,276.7
Food and beverage costs		67.2		63.6		205.1		202.0
Operating expense, excluding depreciation and amortization below		419.0		400.5		1,259.2		1,236.9
Rent		238.7		203.7		726.6		593.1
General and administrative:
Merger, acquisition and other costs		4.7		18.1		11.2		27.1
Other, excluding depreciation and amortization below		37.5		48.4		126.9		135.6
Depreciation and amortization		112.1		130.2		337.1		398.4
Operating costs and expenses		1,296.0		1,243.3		3,930.7		3,869.8
Operating income (loss)		20.8		(21.9)		92.6		177.7
Other expense (income):
Other expense (income)		(1.3)		54.1		5.1		57.5
Interest expense:
Corporate borrowings		73.2		64.3		218.7		188.2
Capital and financing lease obligations		1.8		9.4		6.0		29.5
Non-cash NCM exhibitor services agreement		10.1		10.3		30.4		31.2
Equity in earnings of non-consolidated entities		(7.5)		(70.0)		(24.2)		(74.0)
Investment income		(0.5)		(0.7)		(18.7)		(7.4)
Total other expense		75.8		67.4		217.3		225.0
Loss before income taxes		(55.0)		(89.3)		(124.7)		(47.3)
Income tax provision (benefit)		(0.2)		11.1		10.9		13.2
Net loss	$	(54.8)	$	(100.4)	$	(135.6)	$	(60.5)
Loss per share:
Basic	$	(0.53)	$	(0.82)	$	(1.31)	$	(0.48)
Diluted	$	(0.53)	$	(0.82)	$	(1.31)	$	(0.48)
Average shares outstanding:
Basic (in thousands)		103,850		123,126		103,826		126,386
Diluted (in thousands)		103,850		123,126		103,826		126,386

Three Months Ended

Nine Months Ended
(in millions, except share and per share amounts)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017

(unaudited)

(unaudited)
Revenues

Admissions

$
751.4

$
753.5

$
2,522.7

$
2,332.4
Food and beverage

384.8

361.4

1,236.4

1,133.1
Other theatre

85.2

63.8

288.4

196.9
Total revenues

1,221.4

1,178.7

4,047.5

3,662.4
Operating costs and expenses

Film exhibition costs

378.8

364.8

1,276.7

1,164.2
Food and beverage costs

63.6

60.7

202.0

182.6
Operating expense, excluding depreciation and amortization below

400.5

383.2

1,236.9

1,128.8
Rent

203.7

200.7

593.1

590.9
General and administrative:

Merger, acquisition and transaction costs

18.1

5.6

27.1

57.2
Other, excluding depreciation and amortization below

48.4

32.6

135.6

113.0
Depreciation and amortization

130.2

135.2

398.4

393.9
Operating costs and expenses

1,243.3

1,182.8

3,869.8

3,630.6
Operating income (loss)

(21.9)

(4.1)

177.7

31.8
Other expense (income):

Other expense (income)

54.1

(0.4)

57.5

(1.9)
Interest expense:

Corporate borrowings

64.3

60.8

188.2

171.7
Capital and financing lease obligations

9.4

10.6

29.5

31.7
Non-cash NCM exhibitor services agreement

10.3

—

31.2

—
Equity in (earnings) loss of non-consolidated entities

(70.0)

1.8

(74.0)

199.1
Investment income

(0.7)

(16.6)

(7.4)

(21.6)
Total other expense

67.4

56.2

225.0

379.0
Loss before income taxes

(89.3)

(60.3)

(47.3)

(347.2)
Income tax provision (benefit)

11.1

(17.6)

13.2

(136.4)
Net loss

$
(100.4)

$
(42.7)

$
(60.5)

$
(210.8)
Loss per share:

Basic

$
(0.82)

$
(0.33)

$
(0.48)

$
(1.65)
Diluted

$
(0.82)

$
(0.33)

$
(0.48)

$
(1.65)
Average shares outstanding:

Basic (in thousands)

123,126

131,077

126,386

127,902
Diluted (in thousands)

123,126

131,077

126,386

127,902

See Notes to Condensed Consolidated Financial Statements.

AMC ENTERTAINMENT HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS


	Three Months Ended				Nine Months Ended
(In millions)	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
Net loss	$	(54.8)	$	(100.4)	$	(135.6)	$	(60.5)
Other comprehensive income (loss):
Unrealized foreign currency translation adjustment, net of tax		(68.2)		(5.7)		(102.9)		(101.6)
Realized loss on foreign currency transactions reclassified into other expense, net of tax		—		—		0.6		1.0
Pension and other benefit adjustments:
Net gain (loss) arising during the period, net of tax		0.1		0.1		0.2		(1.3)
Equity method investee's cash flow hedge:
Unrealized net holding gain (loss) arising during the period, net of tax	��	—		—		(0.1)		0.2
Realized net gain reclassified into equity in earnings of non-consolidated entities, net of tax		—		(1.9)		—		(2.2)
Other comprehensive loss		(68.1)		(7.5)		(102.2)		(103.9)
Total comprehensive loss	$	(122.9)	$	(107.9)	$	(237.8)	$	(164.4)

Three Months Ended

Nine Months Ended
(in millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
Net earnings (loss)

$
(100.4)

$
(42.7)

$
(60.5)

$
(210.8)
Other comprehensive income (loss)

Unrealized foreign currency translation adjustment, net of tax

(5.7)

34.4

(101.6)

109.3
Realized loss on foreign currency transactions, net of tax

—

—

1.0

—
Pension and other benefit adjustments:

Net gain (loss) arising during the period, net of tax

0.1

—

(1.3)

—
Amortization of net gain reclassified into general and administrative: other, net of tax

—

—

—

(0.5)
Marketable securities:

Unrealized net holding gain arising during the period, net of tax

—

0.2

—

0.5
Realized net gain reclassified into investment income, net of tax

—

—

—

(0.1)
Equity method investees' cash flow hedge:

Unrealized net holding gain arising during the period, net of tax

—

0.1

0.2

—
Realized net loss (gain) reclassified into equity in earnings of non-consolidated entities, net of tax

(1.9)

(1.0)

(2.2)

(0.9)
Other comprehensive income (loss)

(7.5)

33.7

(103.9)

108.3
Total comprehensive loss

$
(107.9)

$
(9.0)

$
(164.4)

$
(102.5)

See Notes to Condensed Consolidated Financial Statements.

AMC ENTERTAINMENT HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

~~(Unaudited)~~

(In millions, except share data)

September 30, 2018

December 31, 2017

ASSETS

Current assets:

Cash and cash equivalents

$
333.3

$
310.0

Restricted cash

11.0

8.3

Receivables, net

155.2

271.5

Assets held for sale

—

80.0

Other current assets

187.0

202.6

Total current assets

686.5

872.4

Property, net

3,028.6

3,116.5

Intangible assets, net

359.3

380.5

Goodwill

4,820.8

4,931.7

Deferred tax asset, net

29.5

28.9

Other long-term assets

438.3

475.9

Total assets

$
9,363.0

$
9,805.9

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$
395.1

$
569.6

Accrued expenses and other liabilities

387.1

351.1

Deferred revenues and income

293.2

401.0

Current maturities of corporate borrowings and capital and financing lease obligations

83.0

87.7

Total current liabilities

1,158.4

1,409.4

Corporate borrowings

4,840.3

4,220.1

Capital and financing lease obligations

516.7

578.9

Exhibitor services agreement

567.7

530.9

Deferred tax liability, net

44.3

49.6

Other long-term liabilities

980.7

903.8

Total liabilities

8,108.1

7,692.7

Commitments and contingencies

Class A common stock (temporary equity) ($.01 par value, 75,712 shares issued; 38,943 shares outstanding as of September 30, 2018 and 112,817 shares issued; 76,048 shares outstanding as of December 31, 2017)

0.4

0.8

Stockholders’ equity:

Class A common stock ($.01 par value, 524,173,073 shares authorized; 55,401,325 shares issued and 51,705,469 outstanding as of September 30, 2018; 55,010,160 shares issued and 51,814,304 outstanding as of December 31, 2017)

0.5

0.5

Class B common stock ($.01 par value, 75,826,927 shares authorized; 51,769,784 shares issued and outstanding as of September 30, 2018 and 75,826,927 shares authorized; 75,826,927 shares issued and outstanding as of December 31, 2017)

0.5

0.8

Additional paid-in capital

1,994.5

2,241.6

Treasury stock (3,732,625 shares as of September 30, 2018 and 3,232,625 shares as of December 31, 2017, at cost)

(56.4)

(48.2)

Accumulated other comprehensive income

26.0

125.6

Accumulated deficit

(710.6)

(207.9)

Total stockholders’ equity

1,254.5

2,112.4

Total liabilities and stockholders’ equity

$
9,363.0

$
9,805.9


(In millions, except share data)		September 30, 2019		December 31, 2018
ASSETS
Current assets:
Cash and cash equivalents		$	100.4	$	313.3
Restricted cash			10.2		10.7
Receivables, net			157.9		259.5
Other current assets			180.2		197.8
Total current assets			448.7		781.3
Property, net			2,581.4		3,039.6
Operating lease right-of-use assets, net			4,794.9		—
Intangible assets, net			193.9		352.1
Goodwill			4,693.8		4,788.7
Deferred tax asset, net			30.7		28.6
Other long-term assets			537.9		505.5
Total assets		$	13,281.3	$	9,495.8
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	361.6	$	452.6
Accrued expenses and other liabilities	��		338.6		378.5
Deferred revenues and income			347.5		414.8
Current maturities of corporate borrowings			21.4		15.2
Current maturities of finance lease liabilities			10.0		—
Current maturities of operating lease liabilities			568.1		—
Current maturities of capital and financing lease obligations			—		67.0
Total current liabilities			1,647.2		1,328.1
Corporate borrowings			4,710.1		4,707.8
Finance lease liabilities			89.5		493.2
Operating lease liabilities			4,857.6		—
Exhibitor services agreement			553.8		564.0
Deferred tax liability, net			49.8		41.6
Other long-term liabilities			190.0		963.1
Total liabilities			12,098.0		8,097.8
Commitments and contingencies
Class A common stock (temporary equity) ($.01 par value, 0 shares issued; 0 shares outstanding as of September 30, 2019 and 75,712 shares issued; 38,943 shares outstanding as of December 31, 2018)			—		0.4
Stockholders’ equity:
Class A common stock ($.01 par value, 524,173,073 shares authorized; 55,812,702 shares issued and 52,080,077 outstanding as of September 30, 2019; 55,401,325 shares issued and 51,705,469 outstanding as of December 31, 2018)			0.5		0.5
Class B common stock ($.01 par value, 75,826,927 shares authorized; 51,769,784 shares issued and outstanding as of September 30, 2019 and December 31, 2018)			0.5		0.5
Additional paid-in capital			2,008.9		1,998.4
Treasury stock (3,732,625 shares as of September 30, 2019 and December 31, 2018, at cost)			(56.4)		(56.4)
Accumulated other comprehensive income (loss)			(96.7)		5.5
Accumulated deficit			(673.5)		(550.9)
Total stockholders’ equity			1,183.3		1,397.6
Total liabilities and stockholders’ equity		$	13,281.3	$	9,495.8

See Notes to Condensed Consolidated Financial Statements.

AMC ENTERTAINMENT HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

~~(in millions)~~


	Nine Months Ended
(In millions)	September 30, 2019		September 30, 2018
Cash flows from operating activities:	(Unaudited)
Net loss	$	(135.6)	$	(60.5)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		337.1		398.4
Deferred income taxes		7.0		(3.5)
Amortization of net discount (premium) on corporate borrowings		8.1		(2.1)
Amortization of deferred charges to interest expense		11.8		11.5
Non-cash portion of stock-based compensation		11.5		10.9
Gain on dispositions		(16.0)		(2.9)
Gain on disposition of NCM		—		(30.0)
(Gain) loss on derivative asset and derivative liability		(15.4)		54.1
Loss on repayment of indebtedness		16.6		—
Equity in earnings from non-consolidated entities, net of distributions		(10.2)		(32.4)
NCM held-for-sale impairment loss		—		16.0
Landlord contributions		89.0		100.1
Non-cash rent - purchase accounting		19.5		—
Deferred rent		(45.3)		(81.3)
Net periodic benefit cost		1.3		0.5
Change in assets and liabilities, excluding acquisitions:
Receivables		93.8		117.1
Other assets		(3.2)		8.9
Accounts payable		(101.2)		(191.0)
Accrued expenses and other liabilities		(55.4)		(13.5)
Other, net		(3.2)		(1.5)
Net cash provided by operating activities		210.2		298.8
Cash flows from investing activities:
Capital expenditures		(348.2)		(374.9)
Proceeds from sale leaseback transactions		—		50.1
Proceeds from disposition of NCM		—		162.5
Proceeds from Screenvision merger		—		45.8
Acquisition of theatre assets		(11.8)		—
Proceeds from disposition of long-term assets		21.4		13.9
Investments in non-consolidated entities, net		(9.5)		(11.0)
Other, net		(0.3)		(0.7)
Net cash used in investing activities		(348.4)		(114.3)
Cash flows from financing activities:
Proceeds from issuance of Term Loan due 2026		1,990.0		—
Payment of principal Senior Secured Notes due 2023		(230.0)		—
Payment of principal Senior Subordinated Notes due 2022		(375.0)		—
Call premiums paid for Senior Secured Notes due 2023 and Senior Subordinated Notes due 2022		(15.9)		—
Principal payment of Term Loans due 2022 and 2023		(1,338.5)		—
Proceeds from issuance of Senior Unsecured Convertible Notes due 2024		—		600.0
Borrowings (repayments) under revolving credit facilities		(1.7)		6.6
Scheduled principal payments under Term Loans		(16.9)		(10.3)
Principal payments under capital and financing lease obligations		(8.5)		(53.5)
Cash used to pay for debt financing costs		(11.7)		(14.3)
Cash used to pay dividends		(63.4)		(237.4)
Taxes paid for restricted unit withholdings		(1.3)		(1.7)
Retirement of Class B common stock		—		(422.9)
Purchase of treasury stock		—		(21.8)

Nine Months Ended

September 30, 2018

September 30, 2017
Cash flows from operating activities:

(Unaudited)
Net loss

$
(60.5)

$
(210.8)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:

Depreciation and amortization

398.4

393.9
Loss on NCM charged to merger, acquisition and transaction costs

—

22.6
Loss on extinguishment of debt

—

0.5
Deferred income taxes

(3.5)

(137.9)
Amortization of net premium on corporate borrowings

(2.1)

(1.9)
Amortization of deferred charges to interest expense

11.5

9.2
Theatre and other closure expense

3.1

1.1
Non-cash portion of stock-based compensation

10.9

3.9
Gain on dispositions

(2.9)

(4.5)
(Gain) loss on disposition of NCM

(30.0)

22.2
Gain on sale of Open Road

—

(17.2)
Loss on derivative liability

54.1

—
Repayment of Nordic interest rate swaps

—

(2.7)
Equity in earnings from non-consolidated entities, net of distributions

(32.4)

(0.1)
NCM held-for-sale impairment loss

16.0

204.5
Landlord contributions

100.1

76.4
Deferred rent

(81.3)

(35.2)
Net periodic benefit cost

0.5

0.6
Change in assets and liabilities, excluding acquisitions:

Receivables

117.1

104.5
Other assets

8.9

(3.1)
Accounts payable

(191.0)

(116.3)
Accrued expenses and other liabilities

(13.5)

(71.9)
Other, net

(4.6)

(8.2)
Net cash provided by operating activities

298.8

229.6
Cash flows from investing activities:

Capital expenditures

(374.9)

(467.7)
Acquisition of Nordic Cinemas Group, net of cash and restricted cash acquired

—

(577.6)
Acquisition of Carmike Cinemas, Inc., net of cash and restricted cash acquired

—

0.1
Proceeds from sale leaseback transactions

50.1

128.4
Proceeds from disposition of NCM

162.5

89.4
Proceeds from Screenvision merger

45.8

—
Proceeds from disposition of Open Road

—

9.2
Proceeds from disposition of long-term assets

13.9

22.5
Investments in non-consolidated entities, net

(11.0)

(10.0)
Other, net

(0.7)

(3.6)
Net cash used in investing activities

(114.3)

(809.3)
Cash flows from financing activities:

Proceeds from issuance of Senior Unsecured Convertible Notes due 2024

600.0

—
Proceeds from issuance of Senior Subordinated Sterling Notes due 2024

—

327.8
Proceeds from issuance of Senior Subordinated Notes due 2027

—

475.0
Payment of Nordic SEK Term Loan

—

(144.4)
Payment of Nordic EUR Term Loan

—

(169.5)
Net proceeds from equity offering

—

616.8
Borrowings (repayments) under revolving credit facilities

6.6

60.0
Principal payment of Bridge Loan due 2017

—

(350.0)
Principal payments under Term Loan

(10.3)

(9.1)

Principal payments under capital and financing lease obligations

(53.5)

(54.1)
Cash used to pay for deferred financing costs

(14.3)

(29.8)
Cash used to pay dividends

(237.4)

(78.7)
Taxes paid for restricted unit withholdings

(1.7)

(6.5)
Retirement of Class B common stock

(422.9)

—
Purchase of treasury stock

(21.8)

(16.5)
Net cash provided by (used in) financing activities

(155.3)

621.0
Effect of exchange rate changes on cash and cash equivalents and restricted cash

(3.2)

19.9
Net increase (decrease) in cash and cash equivalents and restricted cash

26.0

61.2
Cash and cash equivalents and restricted cash at beginning of period

318.3

230.2
Cash and cash equivalents and restricted cash at end of period

$
344.3

$
291.4
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

Cash paid during the period for:

Interest (including amounts capitalized of $0.4 million and $0.2 million)

$
175.1

$
161.5
Income taxes paid, net

$
9.9

$
9.6
Schedule of non-cash activities:

Investment in NCM (See Note 5-Investments)

$
(6.3)

$
235.2
Construction payables at period end

$
102.3

$
106.7

Net cash used in financing activities		(72.9)		(155.3)
Effect of exchange rate changes on cash and cash equivalents and restricted cash		(2.3)		(3.2)
Net increase (decrease) in cash and cash equivalents and restricted cash		(213.4)		26.0
Cash and cash equivalents and restricted cash at beginning of period		324.0		318.3
Cash and cash equivalents and restricted cash at end of period	$	110.6	$	344.3
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the period for:
Interest (including amounts capitalized of $0.6 million and $0.4 million)	$	184.1	$	175.1
Income taxes paid, net	$	0.1	$	9.9
Schedule of non-cash activities:
Investment in NCM (See Note 5—Investments)	$	1.6	$	(6.3)
Construction payables at period end	$	89.1	$	102.3

See Notes to Condensed Consolidated Financial Statements.

AMC ENTERTAINMENT HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, ~~2018~~2019

(Unaudited)

NOTE 1—BASIS OF PRESENTATION

AMC Entertainment Holdings, Inc. (“Holdings”), through its direct and indirect subsidiaries, including American Multi-Cinema, Inc. and its subsidiaries, (collectively with Holdings, unless the context otherwise requires, the “Company” or “AMC”), is principally involved in the theatrical exhibition business and owns, operates or has interests in theatres located in the United States and Europe. Holdings is an indirect subsidiary of Dalian Wanda Group Co., Ltd. (“Wanda”), a Chinese private conglomerate.

As of September 30, ~~2018,~~2019, Wanda owned approximately ~~50.01%~~49.85% of Holdings’ outstanding common stock and ~~75.01%~~74.89% of the combined voting power of Holdings’ outstanding common stock and has the power to control Holdings’ affairs and policies, including with respect to the election of directors (and, through the election of directors, the appointment of management), entering into mergers, sales of substantially all of the Company’s assets and other extraordinary transactions.

Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but not limited to: (1) Impairments, (2) Income and operating taxes, (3) Fair value of acquired assets and liabilities, and (4) Gift card and exchange ticket income. Actual results could differ from those estimates.

Principles of Consolidation: The accompanying unaudited condensed consolidated financial statements include the accounts of ~~Holdings and all subsidiaries,~~AMC, as discussed above, and should be read in conjunction with the Company’s Annual Report on Form 10–K for the year ended December 31, ~~2017.~~2018. The accompanying condensed consolidated balance sheet as of December 31, ~~2017,~~2018, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions to Form 10–Q. Accordingly, they do not include all of the information and footnotes required by the accounting principles generally accepted in the United States of America for complete consolidated financial statements. In the opinion of management, these interim financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the Company’s financial position and results of operations. All significant intercompany balances and transactions have been eliminated in consolidation. There are no0 noncontrolling ~~(minority)~~ interests in the Company’s consolidated subsidiaries; consequently, all of its stockholders’ equity, net earnings (loss) and total comprehensive income (loss) for the periods presented are attributable to controlling interests. Due to the seasonal nature of the Company’s business, results for the nine months ended September 30, ~~2018~~2019 are not necessarily indicative of the results to be expected for the year ending December 31, ~~2018.~~2019. The Company manages its business under ~~two~~2 reportable segments for its theatrical exhibition operations, U.S. ~~markets~~Markets and International ~~markets.~~Markets.

Accumulated depreciation and amortization: Accumulated depreciation was ~~$1,587.4~~$1,708.1 million and ~~$1,266.9~~$1,697.1 million at September 30, ~~2018~~2019 and December 31, ~~2017,~~2018, respectively, related to property. Accumulated amortization of intangible assets was ~~$68.5~~$21.3 million and ~~$55.5~~$72.9 million at September 30, ~~2018~~2019 and December 31, ~~2017,~~2018, respectively.

~~Leases:~~ During the nine months ended September 30, 2018, the Company modified the terms of an existing operating lease to reduce the lease term. The Company received a $35.0 million incentive from the landlord to enter into the new lease agreement. The Company has recorded amortization of the lease incentive as a reduction to rent expense on a straight-line basis over the remaining lease term which reduced rent expense by $35.0 million during the nine

~~months ended September 30, 2018.~~

~~Sale and Leaseback Transaction:~~ On June 18, 2018, the Company completed the sale and leaseback of the real estate assets associated with one theatre for proceeds, net of closing costs of $50.1 million. The gain on the sale of approximately $27.3 million has been deferred and will be amortized over the remaining lease term.

~~Presentation:~~ ~~Certain reclassifications have been made to the prior period financial statements to conform to the current year presentation.~~

Other ~~Expense (Income)~~expense (income): The following table sets forth the components of other expense (income):



	Three Months Ended				Nine Months Ended

									Three Months Ended				Nine Months Ended
(In thousands)	September 30, 2018		September 30, 2017		September 30, 2018		September 30, 2017		September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
Derivative liability fair value adjustment for embedded conversion feature in the Convertible Notes due 2024	$	54.1	$	—	$	54.1	$	—	$	5.7	$	54.1	$	(14.9)	$	54.1
Loss on GBP forward contract		—		—		0.4		—
Foreign currency transactions (gains) losses		—		(0.4)		1.1		(3.2)
Derivative asset fair value adjustment for contingent call option related to the Class B common stock purchase and cancellation agreement										(8.5)		—		(0.5)		—
Loss on Pound sterling forward contract										0.7		—		1.7		0.4
Foreign currency transactions losses										0.1		—		0.7		1.1
Non-operating components of net periodic benefit cost		—		0.2		0.1		0.4		0.3		—		0.8		0.1
Loss on extinguishment of Bridge Loan		—		—		—		0.4
Loss on repayment of indebtedness										—		—		16.6		—
Fees related to modification of term loans		0.4		—		0.4		1.0		—		0.4		—		0.4
Other		(0.4)		(0.2)		1.4		(0.5)		0.4		(0.4)		0.7		1.4
Other expense (income)	$	54.1	$	(0.4)	$	57.5	$	(1.9)
Total other expense (income)									$	(1.3)	$	54.1	$	5.1	$	57.5

Accounting Pronouncements Recently Adopted

~~Revenue from Contracts with Customers~~.Leases.The Company adopted the guidance of ~~Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers,~~ASU No. 2016-02, Leases (“ASC ~~606”~~842”) as of January 1, ~~2018~~2019 using the modified retrospective ~~method. ASC 606 requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The Company recognized~~transition approach with the cumulative effect recognized at the date of ~~initially applying the new revenue standard as an adjustment to the opening balance of accumulated deficit. ASC 606 was applied only to contracts that were not completed at January 1, 2018.~~initial application. The comparative information in the prior year has not been adjusted and continues to be reported under ASC ~~605, Revenue Recognition,~~840, Leases, which was the accounting standard in effect for ~~those periods. See Note 2—Revenue for the required disclosures of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers per the guidance in~~that period. ASC ~~606.~~

~~Reclassification of Certain Tax Effects.~~ In February 2018, the FASB issued ASU No. 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (“ASU 2018-02”), which allows a reclassification from accumulated other comprehensive income to accumulated deficit for stranded tax effects resulting from the U.S. Tax Cuts and Jobs Act signed into law in December 2017. ASU 2018-02 is effective for the Company on January 1, 2019 and early adoption of the amendments is permitted, including adoption in any interim period. The Company early adopted ASU 2018-02, effective January 1, 2018, and recorded a reclassification related to the stranded tax effects that increased accumulated other comprehensive income and increased accumulated deficit by $5.0 million in the consolidated balance sheets as of January 1, 2018. See Note 8—Income Taxes for further information.

~~Modification Accounting for Stock-Based Compensation.~~ In May 2017, the FASB issued ASU No. 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting (“ASU 2017-09”), which amends the scope of modification accounting for share-based payment arrangements and provides guidance on the types of changes to the terms or conditions of the share-based payment awards to which an entity would be required to apply modification accounting under ASC 718. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. The Company adopted ASU 2017-09 on January 1, 2018 and will apply the guidance in ASU 2017-09 to any future changes to the terms or conditions of stock-based payment awards should they

~~occur. The Company’s adoption of ASU 2017-09 did not have an impact on its consolidated financial statements.~~

~~Improving Presentation of Net Benefit Costs.~~ In March 2017, the FASB issued ASU No. 2017-07, Compensation – Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (“ASU 2017-07”). The guidance requires the service cost component of defined benefit pension plans and other post-retirement benefit plans to be reported in the same line item as other compensation costs arising from the services rendered by the pertinent employees while the other components of net benefit cost are required to be presented in the income statement separately from the service cost component and reported outside a subtotal of operating income. The amendments in this guidance should be applied retrospectively for the presentation of the service cost component and the other components of net benefit cost in the consolidated statements of operations. The Company adopted ASU 2017-07 effective January 1, 2018 and recorded a prior period adjustment for the three and nine months ended September 30, 2017 in the consolidated statements of operations to decrease general and administrative other by $0.3 million and $0.6 million, respectively, related to the other components of net benefit cost, with a corresponding increase to other expense (income) of $0.3 million and decrease to other income of $0.6 million, respectively. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

~~Restricted Cash in Statement of Cash Flows.~~ In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (A Consensus of the FASB Emerging Issues Task Force) (“ASU 2016-18”). ASU 2016-18 requires that restricted cash be included with cash and cash equivalents when reconciling the beginning and end-of-period total amounts shown on the statement of cash flows. This guidance must be applied retrospectively to all periods presented. The Company adopted ASU 2016-18 effective January 1, 2018 and the prior period has been adjusted to conform to the current period presentation. This guidance also requires a new disclosure to reconcile the cash balances within the consolidated statement of cash flows to the consolidated balance sheets. The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows:

(In millions)

September 30, 2018

December 31, 2017
Cash and cash equivalents

$
333.3

$
310.0
Restricted cash

11.0

8.3
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows

$
344.3

$
318.3

~~Classification of certain cash receipts and cash payments.~~ In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). The amendments in this update provide guidance on eight specific cash flow classification issues. The update provides specific guidance on each of the eight issues, thereby reducing the diversity in practice in how certain transactions are classified in the statement of cash flows. The Company adopted ASU 2016-15 on January 1, 2018 and made an election to continue using the “nature of the distribution approach” to classify distributions received from equity method investments. The adoption of this guidance did not have an impact on the Company’s consolidated statements of cash flows.

~~Classification and measurement of financial instruments.~~ In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). ASU 2016-01 amends various aspects of the recognition, measurement, presentation, and disclosure of financial instruments. The amendments require that equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) are to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company adopted ASU 2016-01 on January 1, 2018 and recorded a decrease to accumulated other comprehensive income of $0.6 million, net of tax, related to the unrealized gains on available-for-sale securities that are equity instruments with a corresponding decrease to accumulated deficit in the consolidated balance sheets as of the beginning of the year. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

~~Stockholders’ equity disclosure.~~ ~~On August 17, 2018, the Securities and Exchange Commission adopted~~

amendments to certain disclosure requirements in Securities Act Release No. 33-10532, Disclosure Update and Simplification. Disclosures are required to be provided for the current and comparative quarter and year-to-date interim periods. The amendments are effective for all filings made on or after November 5, 2018. The Company adopted this disclosure requirement during the third quarter of 2018. See Note 7 - Stockholders’ Equity for the consolidated statements of stockholders’ equity disclosure.

~~Accounting Pronouncements Issued Not Yet Adopted~~

~~Leases.~~ ~~In February 2016, the FASB issued ASU No. 2016-02, Leases, (“ASC 842”) which~~842 requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. The new standard establishes a right-of-use ~~model~~ (“ROU”) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases ~~will be~~are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the ~~income statement. The new standard is effective~~condensed consolidated statements of operations. See Note 2—Leases for the ~~Company on January 1, 2019, with early adoption permitted. The Company plans to adopt~~required disclosures of the ~~guidance on January 1, 2019, using a modified retrospective transition approach with the cumulative effect recognized at the date~~nature, amount, timing, and uncertainty of initial application, whereby comparative prior period financial information and disclosures will not be adjusted to reflect the new standard. In January 2018, the FASB issued ASU No. 2018-01, Leases, which permits an entity to elect an optional transition practical expedient to not evaluate under ASU 842 land easements that exist or expired before the entity’s adoption of ASC 842 and that were not previously accounted for as leases.

The Company expects that this standard will have a material effect on its consolidated financial statements. While the Company is continuing to assess the effect of adoption, the Company currently believes the most significant changes relate to (1) the recognition of new ROU assets and lease liabilities on its balance sheet for theatres currently subject to operating leases; (2) the derecognition of existing assets and liabilities for certain sale-leaseback transactions (thosecash flows arising from build-to-suit lease arrangements for which construction is complete and the Company is leasing the constructed asset) that currently do not qualify for sale accounting and the recognition of new ROU assets and operating lease liabilities on its balance sheet; and (3) providing new disclosures about the Company’s leasing activities. On January 1, 2019, the Company expects to recognize additional operating liabilities ranging from an estimated $5 billion to $7 billion, with corresponding ROU assets of the same amount based on the present value of the remaining minimum rental payments for the Company’s existing operating leases. ~~The Company has not finalized the effects of these expected changes from the new standard and expects that this estimated range of~~ ~~impact will narrow as the Company continues its assessment of the adoption of ASC 842. The Company does not expect a significant change in its leasing activity between now and adoption.~~

Accounting Pronouncements Issued Not Yet Adopted

Financial Instruments. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which provides new guidance regarding the measurement and recognition of credit impairment for certain financial assets. Such guidance will impact how the Company determines its allowance for estimated uncollectible receivables and evaluates its available-for-sale investments for impairment. ASU 2016-13 is effective for the Company in the first quarter of ~~2020, with early adoption permitted in the first quarter of 2019.~~2020. The Company is currently evaluating the effect that ASU 2016-13 will have on its consolidated financial statements and related disclosures.

Fair Value Measurement. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework–Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”), which eliminates, adds, and modifies certain disclosure requirements for fair value measurements as part of its disclosure framework project. Entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, but will be required to disclose the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU 2018-13 is effective for the Company in the first quarter of 2020. Early adoption is permitted. The Company ~~is currently evaluating the effect that~~plans to adopt ASU 2018-13 ~~will have on its fair value measurement disclosures.~~in the first quarter of 2020.

Cloud Computing Arrangement. In August 2018, the FASB issued ASU 2018-15, Intangibles–Goodwill and ~~Other–Internal-Use~~Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU 2018-15”). ASU 2018-15 requires a customer in a cloud computing arrangement (i.e., hosting arrangement) that is a service contract to follow the internal-use software guidance in ASC 350-40 to determine which implementation, setup, and other upfront costs to capitalize as assets or expense as incurred. ASU 2018-15 is effective for the Company in the first quarter of 2020. Early adoption is permitted. Entities

have the option to apply the guidance prospectively to all implementation costs incurred after the date of adoption or retrospectively in accordance with ASC 250-10-45. The Company expects to adopt prospectively and is currently evaluating the effect that ASU 2018-15 will have on its consolidated financial ~~statements.~~statements and related disclosures.

NOTE 2—~~REVENUE RECOGNITION~~LEASES

The Company adopted ASC ~~606~~842 on January 1, ~~2018~~2019 using the modified retrospective transition method; and therefore, the comparative information has not been adjusted for the three months and nine months ended September 30, ~~2017.~~2018 or as of December 31, 2018. Upon transition to the new standard, the Company elected the package of practical expedients, which permitted the Company not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs.

The Company leases theatres and equipment under operating and finance leases. The majority of the Company’s operations are conducted in premises occupied under lease agreements with initial base terms ranging generally from 12 to 15 years, with certain leases containing options to extend the leases for up to an additional 20 years. The Company typically does not believe that exercise of the renewal options is reasonably assured at the inception of the lease agreements and, therefore, considers the initial base term as the lease term. Lease terms vary but generally the leases provide for fixed and escalating rentals, contingent escalating rentals based on the Consumer Price Index and other indexes not to exceed certain specified amounts and variable rentals based on a percentage of revenues. The Company often receives contributions from landlords for renovations at existing locations. The Company records the amounts received from landlords as an adjustment to the right-of-use asset and amortizes the balance as a reduction to rent expense over the base term of the lease agreement.

Operating lease right-of-use assets and lease liabilities were recognized at commencement date based on the present value of minimum lease payments over the remaining lease term. The minimum lease payments include base rent and other fixed payments, including fixed maintenance costs. The Company’s leases have remaining lease terms of approximately 1 year to 25 years, which may include the option to extend the lease when it is reasonably certain the Company will exercise that option. The present value of the lease payments is calculated using the incremental borrowing rate for operating leases, which was determined using a portfolio approach based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term. Operating lease expense is recognized on a straight-line basis over the lease term.

The Company elected the practical expedient to not separate lease and non-lease components and also elected the short-term practical expedient for all leases that qualify. As a result, the Company will not recognize right-of-use assets or liabilities for short-term leases that qualify for the short-term practical expedient, but instead will recognize the lease payments as lease cost on a straight-line basis over the lease term. The Company’s lease agreements do not contain residual value guarantees. Short-term leases and sublease arrangements are immaterial. Equipment leases primarily consist of digital projectors and food and beverage equipment.

As a result of adopting ASC 842, the Company’s condensed consolidated balance sheet includes additional operating ROU assets and total operating lease liabilities of $4,794.9 million and $5,425.7 million, respectively, at September 30, 2019. The difference between the ROU assets and total lease liabilities upon initial measurement at January 1, 2019 was primarily due to the reclassification of: (i) deferred rent, landlord allowances, unfavorable lease balances, and theatre closure liabilities previously recorded in other long-term liabilities; (ii) current portions of theatre closure liabilities previously recorded in accrued expenses and other liabilities; (iii) favorable lease balances previously recorded in intangible assets; and, (iv) prepaid rents recorded in other current assets within the condensed consolidated balance sheets as an offset or addition to the opening ROU asset balances, as required by ASC 842.

Table of Contents

The following table provides the operating and finance ROU assets and lease liabilities:


(In millions)	Balance Sheet Classification	September 30, 2019
Assets
Operating lease right-of-use assets (1)	Operating lease right-of-use assets	$	4,794.9
Finance lease right-of-use assets (2)	Property, net		72.4
Total leased assets		$	4,867.3

Liabilities
Current
Operating lease liabilities (1)	Current maturities of operating lease liabilities	$	568.1
Finance lease liabilities (2)	Current maturities of finance lease liabilities		10.0
Noncurrent
Operating lease liabilities (1)	Operating lease liabilities		4,857.6
Finance lease liabilities (2)	Finance lease liabilities		89.5
Total lease liabilities		$	5,525.2

(1)Included in the operating lease right-of-use assets and operating lease liabilities are assets and liabilities for leases related to previous build-to-suit failed sale leaseback transactions, that were derecognized and recorded as a cumulative effect adjustment to accumulated deficit upon adoption of ASC 842. These leases were classified and remeasured at January 1, 2019 as operating right-of-use assets and operating lease liabilities.

(2)Corresponding with the adoption of ASC 842, the Company renamed previously classified capital lease assets and capital lease obligations under ASC 840 as finance lease right-of-use assets and finance lease liabilities, respectively. The Company recognized the finance lease right-of-use assets and finance lease liabilities on January 1, 2019 at the carrying amount of the capital lease asset and capital lease obligation as of December 31, 2018.

The cumulative effect ~~of the changes made~~adjustment to ~~the consolidated balance sheet~~accumulated deficit at January 1, ~~2018 for the adoption~~2019 is as follows:


	Accumulated
(In millions)	Deficit
Balance as of December 31, 2018	$	(550.9)
Derecognition of existing assets for certain sale leaseback transactions previously recorded in property, net		(405.9)
Derecognition of existing liabilities for certain sale leaseback transactions previously recorded in current maturities of corporate borrowings and capital and financing lease obligations		427.5
Derecognition of deferred gains from the sale leaseback transactions previously recorded in other long-term liabilities		102.4
Difference in fair value compared to the basis of the right-of-use assets for previously impaired asset groups		(49.0)
Deferred taxes		1.2
Cumulative effect adjustment to accumulated deficit		76.2
Balance as of January 1, 2019	$	(474.7)

Table of ~~ASC 606, are included in the following table:~~Contents

(In millions)

Balance at
December 31, 2017 Without Adoption of ASC 606

Adjustments Due to ASC 606

Balance at
January 1, 2018
Assets:

Other long-term assets

$
475.9

$
11.1

$
487.0
Current liabilities:

Deferred revenues and income

401.0

(10.0)

391.0
Long-term liabilities:

Exhibitor services agreement

530.9

52.9

583.8
Stockholders' equity:

Accumulated deficit

(207.9)

(31.8)

(239.7)

The ~~disclosure of~~following is the impact of the adoption of ASC ~~606~~842 on the Company’s condensed consolidated statement of operations for the three months ended September 30, 2019:


	Three Months Ended September 30, 2019
	Without Adoption of		U.S. Markets		International Markets
(In millions)	ASC 842		Adjustments		Adjustments		As Reported
Operating costs and expenses
Rent (1)(2)(4)	$	209.9	$	17.4	$	11.4	$	238.7
Depreciation and amortization (2)(3)		136.1		(13.4)		(10.6)		112.1
Operating costs and expenses		1,291.2		4.0		0.8		1,296.0
Operating income		25.6		(4.0)		(0.8)		20.8

Other expense (income)
Interest expense:
Capital and financing lease obligations (1)		8.7		(3.3)		(3.6)		1.8
Net loss		(56.9)		(0.7)		2.8		(54.8)

(1)Cash rent payments for build-to-suit failed sale leasebacks of $11.0 million and $9.9 million for U.S. Markets and International Markets, respectively, are accounted for as operating leases under ASC 842 that were previously accounted for as financing leases under ASC 840.

(2)Non-cash amortization expense for favorable lease terms of $4.6 million and $1.5 million, for U.S. Markets and International Markets, respectively, reclassified to rent expense and amortized over the shorter base lease term under ASC 842.

(3)Depreciation on build-to-suit failed sale leaseback buildings that are eliminated upon adoption of ASC 842.

(4)Amortization of deferred gains on sale leaseback transactions of $1.8 million for U.S. Markets is ~~as follows:~~

Three Months Ended September 30, 2018
(In millions)

Without Adoption of ASC 606

Adjustments

As Reported
Revenues:

Admissions

$
751.7

$
(0.3)

$
751.4
Food and beverage

384.9

(0.1)

384.8
Other theatre

73.9

11.3

85.2
Total revenues

1,210.5

10.9

1,221.4
Operating costs and expenses:

Operating expense, excluding depreciation and amortization

395.2

5.3

400.5
Non-cash interest expense related to NCM exhibitor service agreement

—

10.3

10.3
Net loss

(95.7)

(4.7)

(100.4)
eliminated upon adoption of ASC 842.

The following is the impact of the adoption of ASC 842 on the Company’s condensed consolidated statement of operations for the nine months ended September 30, 2019:


	Nine Months Ended September 30, 2019
	Without Adoption of		U.S. Markets		International Markets
(In millions)	ASC 842		Adjustments		Adjustments		As Reported
Operating costs and expenses
Rent (1)(2)(4)	$	639.0	$	52.1	$	35.5	$	726.6
Depreciation and amortization (2)(3)		409.1		(40.2)		(31.8)		337.1
Operating costs and expenses		3,915.1		11.9		3.7		3,930.7
Operating income		108.2		(11.9)		(3.7)		92.6

Other expense (income)
Interest expense:
Capital and financing lease obligations (1)		26.7		(9.9)		(10.8)		6.0
Net loss		(140.7)		(2.0)		7.1		(135.6)

(1)

Cash rent payments for build-to-suit failed sale leasebacks of $33.0 million and $29.7 million for U.S. Markets and International Markets, respectively, are accounted for as operating leases under ASC 842 that were previously accounted for as financing leases under ASC 840.

(2)

Non-cash amortization expense for favorable lease terms of $13.7 million and $5.8 million, for U.S. Markets and International Markets, respectively, reclassified to rent expense and amortized over the shorter base lease term under ASC 842.

(3)

Depreciation on build-to-suit failed sale leaseback buildings that are eliminated upon adoption of ASC 842.

(4)

Amortization of deferred gains on sale leaseback transactions of $5.4 million for U.S. markets is eliminated upon adoption of ASC 842.

Table of Contents

The following table reflects the lease costs for the three and nine months ended September 30, 2019:


	Condensed Consolidated	Three Months Ended		Nine Months Ended
(In millions)	Statement of Operations	September 30, 2019		September 30, 2019
Operating lease cost
Theatre properties	Rent	$	219.0	$	658.6
Theatre properties	Operating expense		1.6		4.5
Equipment	Operating expense		3.5		10.5
Office and other	General and administrative: other		1.4		4.1
Finance lease cost
Amortization of finance lease assets	Depreciation and amortization		2.1		7.3
Interest on lease liabilities	Finance lease liabilities		1.8		6.0
Variable lease cost
Theatre properties	Rent		19.7		68.0
Equipment	Operating expense		7.4		37.2
Total lease cost		$	256.5	$	796.2

The following table represents the weighted-average remaining lease term and discount rate as of September 30, 2019:


	As of September 30, 2019
	Weighted Average		Weighted Average
	Remaining		Discount
Lease Term and Discount Rate	Lease Term (years)		Rate
Operating leases		10.2		7.2%
Finance leases		12.9		6.5%

Cash flow and supplemental information is presented below:


	Nine Months Ended
(In millions)	September 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used in finance leases	$	(6.0)
Operating cash flows used in operating leases		(703.5)
Financing cash flows used in finance leases		(8.5)

Landlord contributions:
Operating cashflows provided by operating leases		89.0
Supplemental disclosure of noncash leasing activities:
Right-of-use assets obtained in exchange for new operating lease liabilities (1)		304.4

(1)

Includes lease extensions and an option exercise.

Table of Contents

Minimum annual payments required under existing operating and finance lease liabilities, (net present value thereof) as of September 30, 2019 are as follows:


	Operating Lease		Financing Lease
(In millions)	Payments (1)(2)		Payments
Three months ending December 31, 2019	$	234.1	$	4.0
2020		927.3		16.1
2021		872.1		15.1
2022		811.4		14.6
2023		720.8		11.5
2024		644.5		10.3
Thereafter		3,550.8		77.2
Total lease payments		7,761.0		148.8
Less imputed interest		(2,335.3)		(49.3)
Total	$	5,425.7	$	99.5

(1)Included in this column upon adoption of ASC 842 are liabilities for leases that were previously classified as build-to-suit failed sale leaseback transactions that were included in the capital and finance lease obligations columns in the prior year.

Nine Months Ended September 30, 2018
(In millions)

Without Adoption of ASC 606

Adjustments

As Reported
Revenues:

Admissions

$
2,523.7

$
(1.0)

$
2,522.7
Food and beverage

1,236.7

(0.3)

1,236.4
Other theatre

252.3

36.1

288.4
Total revenues

4,012.7

34.8

4,047.5
Operating costs and expenses:

Operating expense, excluding depreciation and amortization

1,216.4

20.5

1,236.9
Non-cash interest expense related to NCM exhibitor service agreement

—

31.2

31.2
Net loss

(43.6)

(16.9)

(60.5)
(2)Included in this column upon adoption of ASC 842 are fixed executory costs that were previously excluded as part of the minimum lease payments. Fixed executory costs, which primarily consist of common area maintenance, insurance and taxes that meet the classification of fixed payments are included as part of the minimum lease payments.

~~Revenues:~~ As of September 30, 2019, the Company had signed additional operating lease agreements for 14 theatres that have not yet commenced of approximately $308.1 million, which are expected to commence between 2019 and 2022, and carry lease terms of approximately 5 to 25 years. The timing of lease commencement is dependent on the landlord providing the Company with control and access to the related facility.

Minimum annual payments required under operating lease liabilities and capital and failed sale leaseback, finance lease obligations, (net present value thereof) that have initial or remaining non-cancelable terms in excess of one year as of December 31, 2018 were as follows:


			Capital and Finance Lease Obligations
	Minimum Operating		Minimum Lease
(In millions)	Lease Payments		Payments		Less Interest		Principal
2019	$	810.2	$	100.7	$	33.7	$	67.0
2020		801.9		96.6		29.4		67.2
2021		748.9		87.8		25.2		62.6
2022		687.5		82.7		21.1		61.6
2023		597.1		70.4		17.3		53.1
Thereafter		3,367.6		331.5		82.7		248.8
Total minimum payments required	$	7,013.2	$	769.7	$	209.4	$	560.3

During the nine months ended September 30, 2018, the Company modified the terms of an existing operating lease to reduce the lease term. The Company ~~recognizes revenue, net of sales tax, when it satisfies~~received a ~~performance obligation by transferring control over a product or service~~$35.0 million incentive from the landlord to a customer. Admissions and food and beverage revenues are recognized at a point in time when a film is exhibited to a customer and when a customer takes possession of food and beverage offerings. The Company defers 100% ofenter into the ~~revenue associated with the sales of gift cards and exchange tickets until such time as the items are redeemed or estimated income from non-redemption is recorded.~~

The Company recognizes income from non-redeemed or partially redeemed gift cards in proportion to the pattern of rights exercised by the customer (“proportional method”) where it applies an estimated non-redemption rate for its gift card sales channels, which range from 12% to 18% of the current month sales, and the Company recognizes in other theatre revenues the total amount of expected income for non-redemption for that current month’s sales as income over the next 24 months in proportion to the pattern of actual redemptions.new lease agreement. The Company has determined its non-redeemed rates and redemption patterns using data accumulated over ten years. Prior to January 1, 2018, income for non-redeemed exchange tickets were recognized 18 months after purchase when the redemption of these items was determined to be remote. At January 1, 2018, the Company changed its method for recognizing income from non-redeemed exchange tickets to the proportional method, where it applies a non-redemption rate of 10% to the current month sales, and the Company recognizes the total amount of income for that current month’s sales as income over the next 24 months in proportion to the pattern of actual redemptions. Management believes the 24-month estimate is supported by its continued development of redemption history and that it is reflective of management’s current best estimate. The adoptionrecorded amortization of the ~~proportional method of recognizing income from non-redeemed exchange tickets did not have a material impact on the Company’s consolidated financial statements.~~

Prior to January 1, 2018, the Company recorded online ticket fee revenues net of third-party commission or service fees. In accordance with ASC 606 guidance, the Company believes that it is a principal (as opposed to agent) in the arrangement with third-party internet ticketing companies in regard to the sale of online tickets because the Company controls the online tickets before it is transferred to the customer. Upon adoption of ASC 606 on January 1, 2018, the Company recognizes ticket fee revenues based on a gross transaction price. The online ticket fee revenues and the third-party commission or service fees are recorded in the line items other theatre revenues and operating expense, respectively, in the consolidated statements of operations. These changes did not have any impact on net income or cash flows from operations.

~~Exhibitor Services Agreement:~~The Company recognizes advertising revenues, which are included in other theatre revenues in the consolidated statements of operations, when it satisfies a performance obligation by transferring a promised good or service to the customers. The advertising contracts with customers generally consist of a series of distinct periods of service, satisfied over time, to provide rights to advertising services. The Company’s ESA with NCM includes a significant financing component due to the significant length of time between receiving the noncash consideration and fulfilling the performance obligation. The Company receives the non-cash consideration in the form of common membership units from NCM, in exchange for rights to exclusive access to the Company’s theatre screens and attendees through February 2037. Upon adoption of ASC 606, the Company’s advertising revenues have significantly increased with a similar offsetting increase in non-cash interest expense, which is recorded to non-cash NCM exhibitor service agreement in the consolidated statements of operations. Upon adoption of ASC 606 and pursuant to the calculation requirements for the time value of money, the amortization method reflects the front-end loading of the significant financing component where more interest expense is recognized earlier during the term of the agreement than

~~Table of Contents~~

the back-end recognition of the deferred revenue amortization where more revenue is recognized later in the term of the agreement. See Note 5—Investments for further information regarding the common unit adjustment and the fair value measurement of the noncash consideration. The interest expense was calculated using discount rates that ranged from 6.5% to 8.5%, which are the rates at which the Company believes it could borrow in separate financing transactions. The Company recognized a cumulative effect transition adjustment of initially applying ASC 606 by increasing accumulated deficit on January 1, 2018 by approximately $52.9 million, including income tax effect of $0, as a result of this change. These changes did not have any impact on the Company’s cash flows from operations.

~~Customer Frequency Program:~~ ~~AMC Stubs~~® is a customer loyalty program which allows members to earn rewards, receive discounts and participate in exclusive members-only offerings and services. In July 2016, the Company completed a national relaunch of its AMC Stubs® ~~loyalty program featuring both a traditional paid tier called AMC Stubs Premiere~~TM ~~and a new non-paid tier called AMC Stubs Insider~~TM~~. Both programs reward loyal guests for their patronage of AMC Theatres. The AMC Stubs Insider~~TM tier rewards guests for simply coming to the movies, and benefits include free refills on certain food items, discount ticket offers, a birthday gift and 20 reward points earned for every dollar spent. For a $15.00 annual membership fee, AMC Stubs PremiereTM members enjoy express service with specially marked shorter lines at the box office and concession stand, free size upgrades on certain food and beverage items, discount ticket offers, a birthday gift, discounted online ticketing fees and 100 reward points for every dollar spent. Some of the rewards earned are redeemable on future purchases at AMC locations. Once an AMC Stubs PremiereTM ~~or AMC Stubs Insider~~TM ~~member accumulates 5,000 points they will earn a $5.00 virtual reward.~~

~~The portion of the admissions and food and beverage revenues attributed to the rewards is deferred~~lease incentive as a reduction ~~of admissions~~to rent expense on a straight-line basis over the remaining lease term which reduced rent expense by $0 and ~~food~~$35.0 million during the three and beverage revenues and is allocated between admissions and food and beverage revenues based on expected member redemptions. Upon redemption, deferred rewards are recognized as revenues along with associated cost of goods. Converted rewards not redeemed within nine months ~~are forfeited and recognized as admissions or food and beverage revenues. Prior to January 1, 2018, rewards for expired memberships were forfeited based upon specified periods~~ended September 30, 2018.

Table of inactivity of the membership and recognized as admissions or food and beverage revenues. As of January 1, 2018, the Company changed its method for recognizing forfeited rewards from the remote method to the proportional method, where the Company estimates point breakage in assigning value to the points at the time of sale based on historical trends. The program’s annual membership fee is allocated to the material rights for discounted or free products and services and is initially deferred, net of estimated refunds, and recognized as the rights are redeemed based on estimated utilization, over the one-year membership period in admissions, food and beverage, and other revenues. Contents

A portion of the revenues related to a material right are deferred as a virtual rewards performance obligation using the relative standalone selling price method and are recognized as the rights are redeemed or expire.

NOTE 3—REVENUE RECOGNITION

Disaggregation of Revenue: Revenue is disaggregated in the following tables by major revenue types and by timing of revenue recognition:


	Three Months Ended		Three Months Ended
(In millions)	September 30, 2019		September 30, 2018
Major revenue types
Admissions	$	797.3	$	751.4
Food and beverage		420.0		384.8
Other theatre:
Advertising		32.1		31.2
Other theatre		67.4		54.0
Other theatre		99.5		85.2
Total revenues	$	1,316.8	$	1,221.4


	Three Months Ended		Three Months Ended
(In millions)	September 30, 2019		September 30, 2018
Timing of revenue recognition
Products and services transferred at a point in time	$	1,215.2	$	1,162.4
Products and services transferred over time (1)		101.6		59.0
Total revenues	$	1,316.8	$	1,221.4

Three Months Ended

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2018
Major revenue types

Admissions

$
751.4

$
2,522.7
Food and beverage

384.8

1,236.4
Other theatre:

Advertising

31.2

102.5
Other theatre

54.0

185.9
Other theatre

85.2

288.4
Total revenues

$
1,221.4

$
4,047.5

(1)Amounts primarily include subscription and advertising revenues.


	Nine Months Ended		Nine Months Ended
(In millions)	September 30, 2019		September 30, 2018
Major revenue types
Admissions	$	2,424.3	$	2,522.7
Food and beverage		1,281.3		1,236.4
Other theatre:
Advertising		102.3		102.5
Other theatre		215.4		185.9
Other theatre		317.7		288.4
Total revenues	$	4,023.3	$	4,047.5


	Nine Months Ended		Nine Months Ended
(In millions)	September 30, 2019		September 30, 2018
Timing of revenue recognition
Products and services transferred at a point in time	$	3,735.4	$	3,891.8
Products and services transferred over time (1)		287.9		155.7
Total revenues	$	4,023.3	$	4,047.5

Three Months Ended

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2018
Timing of revenue recognition

Products and services transferred at a point in time

$
1,162.4

$
3,891.8
Products and services transferred over time (1)

59.0

155.7
Total revenues

$
1,221.4

$
4,047.5

(1)

Amounts primarily include subscription and advertising revenues.

~~Table of Contents~~

The following tables provide the balances of receivables and deferred revenue income:



(In millions)	September 30, 2018		December 31, 2017		September 30, 2019		December 31, 2018
Current assets:
Receivables related to contracts with customers	$	74.3	$	204.3	$	62.1	$	183.2
Miscellaneous receivables		80.9		67.2		95.8		76.3
Receivables, net	$	155.2	$	271.5	$	157.9	$	259.5

(In millions)

September 30, 2018

December 31, 2017
Current liabilities:

Deferred revenue related to contracts with customers

$
288.6

$
376.1
Miscellaneous deferred income

4.6

24.9
Deferred revenue and income

$
293.2

$
401.0

Table of Contents


(In millions)	September 30, 2019		December 31, 2018
Current liabilities:
Deferred revenue related to contracts with customers	$	345.7	$	412.8
Miscellaneous deferred income		1.8		2.0
Deferred revenue and income	$	347.5	$	414.8

The significant changes in contract liabilities with customers included in deferred revenues and income are as follows:


	Deferred Revenues
	Related to Contracts
(In millions)	with Customers
Balance as of December 31, 2018	$	412.8
Cash received in advance (1)		253.6
Customer loyalty rewards accumulated, net of expirations:
Admission revenues (2)		22.7
Food and beverage (2)		49.5
Other theatre (2)		2.1
Reclassification to revenue as the result of performance obligations satisfied:
Admission revenues (3)		(250.5)
Food and beverage (3)		(73.0)
Other theatre (4)		(68.0)
Disposition of Austria theatres		(1.5)
Foreign currency translation adjustment		(2.0)
Balance as of September 30, 2019	$	345.7

Deferred Revenues

Related to Contracts
(In millions)

with Customers
Balance as of December 31, 2017

$
376.1
Cumulative effect of initially applying ASC 606

(10.0)
Cash received in advance (1)

285.6
Customer loyalty rewards accumulated, net of expirations:

Admission revenues (2)

21.8
Food and beverage (2)

39.1
Other theatre (2)

3.9
Reclassification to revenue as the result of performance obligations satisfied:

Admission revenues (3)

(304.0)
Food and beverage (3)

(61.5)
Other theatre (4)

(61.6)
Business combination - Nordic purchase price allocation (5)

(2.3)
Foreign currency translation adjustment

1.5
Balance as of September 30, 2018

$
288.6

~~(1)~~

~~Includes movie tickets, food and beverage, gift cards, exchange tickets, and AMC Stubs~~® ~~loyalty membership fees.~~

~~(2)~~

~~Amount of rewards accumulated, net of expirations, that are attributed to AMC Stubs~~® ~~and other loyalty programs.~~

~~(3)~~

~~Amount of rewards redeemed that are attributed to gift cards, exchange tickets, movie tickets, AMC Stubs~~® ~~loyalty programs and other loyalty programs.~~

~~(4)~~

~~Amounts relate to income from non-redeemed or partially redeemed gift cards, non-redeemed exchange tickets, AMC Stubs~~® ~~loyalty membership fees and other loyalty programs.~~

~~(5)~~

~~See Note 3 – Acquisitions for further information.~~

(1)Includes movie tickets, food and beverage, gift cards, exchange tickets, and AMC Stubs^® loyalty membership fees.

~~Table~~(2)Amount of ~~Contents~~rewards accumulated, net of expirations, that are attributed to AMC Stubs^® and other loyalty programs.

(3)Amount of rewards redeemed that are attributed to gift cards, exchange tickets, movie tickets, AMC Stubs^® loyalty programs and other loyalty programs.

(4)Amounts relate to income from non-redeemed or partially redeemed gift cards, non-redeemed exchange tickets, AMC Stubs^® loyalty membership fees and other loyalty programs.

The significant changes to contract liabilities included in the exhibitor services agreement, classified as long-term liabilities in the condensed consolidated balance sheets, are as follows:


	Exhibitor Services
(In millions)	Agreement
Balance as of December 31, 2018	$	564.0
Common Unit Adjustment–additions of common units (1)		1.4
Reclassification of the beginning balance to other theatre revenue, as the result of performance obligations satisfied		(11.6)
Balance as of September 30, 2019	$	553.8

Exhibitor Services
(In millions)

Agreement
Balance as of December 31, 2017

$
530.9
Cumulative effect of initially applying ASC 606

52.9
Common Unit Adjustment – surrender of common units (1)

(5.2)
Reclassification of the beginning balance to other theatre revenue, as the result of performance obligations satisfied

(10.9)
Balance as of September 30, 2018
$
567.7

(1)Represents the fair value amount of the National CineMedia, LLC (“NCM”) common units that were received under the annual Common Unit Adjustment (“CUA”). Such amount will increase the deferred revenues that are being amortized to other theatre revenues over the remainder of the 30-year term of the Exhibitor Service Agreement (“ESA”) ending in February 2037. See Note 5—Investments for further information.

~~(1)~~

Represents the fair value amount of the NCM common units that were surrendered due to the annual Common Unit Adjustment. Such amount will reduce the deferred revenues that are being amortized to other theatre revenues over the remainder of the 30-year term of the ESA ending in February 2037. See Note 5—Investments for further information.

Table of Contents

Transaction Price Allocated to the Remaining Performance Obligations: The following table includes the amount of NCM ESA, included in ~~deferred revenues and income~~exhibitor services agreement in the Company’s condensed consolidated balance sheets, that is expected to be recognized as revenues in the future related to performance obligations that are unsatisfied as of September 30, ~~2018:~~2019:



(In millions)	Three Months Ended December 31, 2018		Year Ended 2019		Year Ended 2020		Year Ended 2021		Year Ended 2022		Years Ended 2023 through February 2037		Exhibitor services agreement
Exhibitor services agreement	$	3.7	$	15.7	$	16.8	$	18.1	$	19.4	$	494.0
Three Months ending December 31, 2019													$	4.1
Year Ended 2020														16.9
Year Ended 2021														18.1
Year Ended 2022														19.5
Year Ended 2023														20.9
Year Ended 2024														22.5
Years Ended 2025 through February 2037														451.8
Total													$	553.8

The total amount of non-redeemed gifts cards and exchange tickets included in deferred revenues and income as of September 30, ~~2018~~2019 was ~~$220.8~~$257.8 million. This will be recognized as revenues as the gift cards and exchange tickets are redeemed or as the non-redeemed gift card and exchange ticket revenues are recognized in proportion to the pattern of actual redemptions, which is estimated to occur over the next 24 months.

As of September 30, ~~2018,~~2019, the amount of deferred revenue allocated to the AMC Stubs^® loyalty programs included in deferred revenues and income was ~~$45.6~~$56.2 million. The earned points will be recognized as revenue as the points are redeemed, which is estimated to occur over the next 24 months. The annual membership fee is recognized ratably over the one-year membership period.

The Company applies the practical expedient in ASC 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.

~~NOTE 3—ACQUISITIONS~~

~~Nordic Cinema Group Holding AB~~

On March 28, 2017, the Company completed the acquisition of Nordic Cinema Group Holding AB (“Nordic”) for cash. The purchase price for Nordic was approximately SEK 5,756 million ($654.9 million), which includes payment of interest on the equity value and repayment of shareholder loans. As a result of the acquisition, the Company assumed the indebtedness of Nordic of approximately SEK 1,269 million ($144.4 million) and indebtedness of approximately €156 million ($169.5 million) as of March 28, 2017, which was refinanced subsequent to the acquisition. The Company also assumed approximately SEK 13.5 million ($1.6 million) and approximately €1.0 million ($1.1 million) of interest rate swaps related to the indebtedness which were repaid following the acquisition. All amounts have been converted into US Dollar amounts assuming an SEK/USD exchange rate of 0.11378 and an EUR/USD exchange rate of 1.0865, which were the exchange rates on March 27, 2017.

~~Table of Contents~~

The acquisition is being treated as a purchase in accordance with Accounting Standards Codification Topic 805, Business Combinations (“ASC 805, Business Combinations”), which requires allocation of the purchase price to the estimated fair values of assets and liabilities acquired in the transaction. The allocation of purchase price is based on management’s judgment after evaluating several factors, including a valuation assessment. The Company finalized the appraisals for both tangible and intangible assets and liabilities during the three months ended March 31, 2018. The following is a summary of the final allocation of the purchase price:

(In millions)

March 28, 2017

Changes

March 31, 2018
Cash

$
70.5

$
0.9

$
71.4
Restricted cash

—

5.9

5.9
Receivables

25.0

(11.6)

13.4
Other current assets

14.0

9.6

23.6
Property (1)

89.8

43.4

133.2
Intangible assets (1) (2)

—

22.1

22.1
Goodwill (3)

872.1

(79.2)

792.9
Deferred tax asset

5.5

(4.6)

0.9
Other long-term assets (6)

41.0

34.2

75.2
Accounts payable

(30.3)

0.1

(30.2)
Accrued expenses and other liabilities

(26.5)

(9.6)

(36.1)
Deferred revenues and income

(43.5)

2.3

(41.2)
Term Loan Facility (SEK)

(144.4)

—

(144.4)
Term Loan Facility (EUR)

(169.5)

—

(169.5)
Capital lease and financing lease obligations (1)(4)

(29.2)

19.2

(10.0)
Deferred tax liability

(5.2)

(13.5)

(18.7)
Other long-term liabilities (5)

(14.4)

(19.2)

(33.6)
Total estimated purchase price

$
654.9

$
—

$
654.9

~~(1)~~

~~Amounts recorded for property include land, buildings, capital lease assets, leasehold improvements, furniture, fixtures and equipment.~~ During the year ended March 31, 2018, the Company recorded measurement period adjustments primarily related to the valuation of property, intangible assets, equity method investments, financing lease obligations and related tax adjustments.

~~(2)~~

~~Additional information for intangible assets acquired on March 28, 2017 is presented below:~~

Weighted Average

Gross
(In millions)

Amortization Period

Carrying Amount
Acquired intangible assets:

Amortizable intangible assets:

Favorable leases

7.0 years

$
3.5
Favorable subleases

4.0 years

1.1
Screen advertising agreement

5.0 years

6.6
Trade name agreement

4.0 years

0.4
Total, amortizable

5.5 years

$
11.6
Unamortized intangible assets:

Trade names

$
10.5

~~(3)~~

~~Amounts recorded for goodwill are not expected to be deductible for tax purposes.~~

~~(4)~~

~~Including current portion of approximately $1.1 million.~~

~~(5)~~

~~Amounts recorded for other long-term liabilities include unfavorable leases of approximately $20.0 million with an amortization period of 9.3 years.~~

~~(6)~~

~~Includes equity method investments of $64.7 million.~~

The fair value measurement of tangible and intangible assets and liabilities were based on significant inputs not observable in the market and thus represent Level 3 measurements within the fair value measurement hierarchy. Level 3

~~Table of Contents~~

~~fair market values were determined using a variety of information, including estimated future cash flows, appraisals, and market comparables.~~

The purchase price paid by the Company in the acquisition resulted in recognition of goodwill because it exceeded the estimated fair value of the assets acquired and liabilities assumed. The Company paid a price in excess of estimated fair value of the assets acquired and liabilities assumed because the acquisition of Nordic enhances its position as the largest movie exhibition company in Europe and broadens and diversifies its European platform. The Company also expects to realize synergy and cost savings related to the acquisition because of purchasing and procurement economies of scale.

During the three and nine months ended September 30, 2018, the Company incurred acquisition-related and transition costs for Nordic of approximately $1.4 million and $4.1 million, respectively, which were included in general and administrative expense: merger, acquisition and transaction costs in the Consolidated Statements of Operations. The revenues for Nordic during the three and nine months ended September 30, 2018 were $85.1 million and $264.9 million, respectively. Nordic net earnings during the three and nine months ended September 30, 2018 were $7.7 million and $22.2 million, respectively.

~~Pro Forma Results of Operations (Unaudited)~~

The following selected comparative unaudited pro forma results of operations information for the nine months ended September 30, 2017 assumes that the Nordic acquisition occurred at the beginning of 2017 and reflects the full results of operations for the periods presented. The pro forma results have been prepared for comparative purposes only and do not purport to indicate the results of operations which would actually have occurred had the combination been in effect on the dates indicated, or which may occur in the future. These amounts have been calculated after applying the Company’s accounting policies and adjusting the results of Nordic to reflect the fair value adjustments to property and equipment and financing obligations. The pro forma financial information presented includes the effects of adjustments related to fair values assigned to long-lived assets, including depreciation charges from acquired property and equipment, interest expense and incremental shares issued from financing the acquisitions and the related income tax effects, and the elimination of Carmike Cinemas, Inc. (“Carmike”) and AMC historical revenues and expenses for theatres in markets that were divested as required by the final judgement with the Department of Justice (“DOJ”) in connection with the acquisition of Carmike. Merger, acquisition and transaction costs directly related to the acquisitions have not been removed.

Actual
Nine Months Ended

Pro Forma
Nine Months Ended
(In millions)

September 30, 2018

September 30, 2017
Revenues

$
4,047.5

$
3,739.2
Operating income (loss)

$
177.7

$
38.4
Net earnings (loss)

$
(60.5)

$
(209.0)
Earnings (loss) per share:

Basic

$
(0.48)

$
(1.63)
Diluted

$
(0.48)

$
(1.63)

NOTE 4—GOODWILL

The following table summarizes the changes in goodwill by ~~reportable operating segment~~reporting unit for the nine months ended September 30, ~~2018:~~2019:

(In millions)

U.S. Markets

International Markets (1)

Total
Balance as of December 31, 2017

$
3,072.6

$
1,859.1

$
4,931.7
Adjustments to acquisition of Nordic

—

(6.4)

(6.4)
Currency translation adjustment

—

(104.5)

(104.5)
Balance as of September 30, 2018

$
3,072.6

$
1,748.2

$
4,820.8

~~(1)~~

~~As of September 30, 2018, the goodwill for the Odeon Theatres reporting unit and the Nordic Theatres reporting unit was $965.6 million and $782.6 million, respectively.~~


(In millions)	Domestic Theatres		International Theatres		Total
Balance as of December 31, 2018	$	3,072.6	$	1,716.1	$	4,788.7
Currency translation adjustment		—		(94.9)		(94.9)
Balance as of September 30, 2019	$	3,072.6	$	1,621.2	$	4,693.8

The Company evaluates goodwill for impairment annually as of the beginning of the fourth fiscal quarter and any time an event occurs or circumstances change that would more likely than not reduce the fair value for a reporting unit below its carrying amount. The impairment test for goodwill involves estimating the fair value of the reporting unit and comparing that value to its carrying value. If the estimated fair value of the reporting unit is less than its carrying value, the difference is recorded as goodwill impairment charge, not to exceed the total amount of goodwill allocated to that reporting unit.

Prior to January 1, 2019, the Company had 3 reporting units, Domestic Theatres, Odeon Theatres and Nordic Theatres. Effective January 1, 2019, the Company combined the Odeon Theatres and Nordic Theatres into a single reporting unit, International Theatres, to reflect how the international business is now managed. The Company tested goodwill for impairment both prior to and subsequent to the combining of these reporting units into the single reporting unit.

A decline in the common stock price and the resulting impact on market capitalization is one of several factors considered when making this evaluation. Based on recent sustained declines in the trading price of the Company’s Class A common stock, the Company performed a Step 1 quantitative goodwill impairment test of the Domestic and International reporting units as of September 30, 2019.

In performing the Step 1 quantitative goodwill impairment test as of September 30, 2019, the Company used an

Table of Contents

enterprise value approach to measure fair value of the reporting units, as compared to an equity value approach used previously. This change in estimate is preferable due to the impact of the change in the capital structure of the Domestic Theatres reporting unit late in the third quarter of 2018 as a result of the issuance of $600 million of the Company’s Senior Unsecured Notes due 2024, the negative equity value carrying amount for the Domestic Theatres reporting unit, and the decline in the market capitalization since May 2019, which has increased the Company’s leverage ratio. See additional discussion in Note 6—Corporate Borrowings.

The enterprise fair values of the Domestic Theatres and International Theatres reporting units exceeded their carrying values by approximately 9.9% and 11.8%, respectively. Accordingly, there was no goodwill impairment recorded as of September 30, 2019. The Domestic Theatres reporting unit to which $3.1 billion of goodwill is allocated had a negative equity value carrying amount as of September 30, 2019.

NOTE 5—INVESTMENTS

Investments in non-consolidated affiliates and certain other investments accounted for under the equity method generally include all entities in which the Company or its subsidiaries have significant influence, but not more than 50% voting control, and are recorded in the ~~Consolidated Balance Sheets~~condensed consolidated balance sheets in other long-term assets. Investments in non-consolidated affiliates as of September 30, ~~2018~~2019 include interests in Digital Cinema Implementation Partners, LLC (“DCIP”) of 29.0%, Digital Cinema Distribution Coalition, LLC (“DCDC”) of 14.6%, AC JV, LLC (“AC JV”) owner of Fathom Events, of 32.0%, SV Holdco LLC, owner of Screenvision, ~~21.2%~~18.2%, ~~and~~ Digital Cinema Media Ltd. (“DCM”) of 50.0%, and Saudi Cinema Company LLC (“SCC”) of 10.0%. The Company also has partnership interests in ~~four~~4 U.S. motion picture theatres ~~and one IMAX~~® ~~screen of 50.0%~~ (“Theatre Partnerships”) and approximately 50.0% interest in 5758 theatres in Europe (“Nordic theatre JVs”) acquired in the Odeon and UCI Cinemas Holdings Limited (“Odeon”) and Nordic Cinema Group Holding AB (“Nordic”) acquisitions. Indebtedness held by equity method investees is non-recourse to the Company.

~~Amounts payable~~NCM Transaction. In March 2019, the NCM CUA resulted in a positive adjustment of 197,118 common units for the Company. The Company received the units and recorded the common units as an addition to ~~U.S. Theatre Partnerships were $0.7~~deferred revenues for the ESA at fair value of $1.3 million, ~~and $2.8 million as~~based upon a price per share of ~~September 30, 2018 and~~

~~December 31, 2017, respectively.~~

~~Dreamscape and Central Services Studios Preferred Stock.~~ ~~During the nine months ended September 30, 2018, the Company invested an additional $5.0 million in Dreamscape Immersive,~~National CineMedia, Inc. (“~~Dreamscape”~~NCM, Inc.”) ~~and invested an additional $5.0 million in Central Services Studios, Inc. (“Central Services Studios”) as a part~~ of ~~its virtual reality technologies strategy.~~$7.24 on March 14, 2019. The ~~investments are recorded at cost following the measurement alternative as there is no established market for the securities and the~~ Company does not have significant influence over ~~these entities.~~

~~RealD.~~ ~~During~~this entity and the nine months ended September 30, 2018, the Company entered into a Stock Issuance and Restrictions Agreement with RealD Holdings Inc. (“RealD”). The new agreement replaces a similar agreement with RealD for the lease of RealD 3D systems where rental payments continue to be variable and based on paid admissions and extends the term of the agreement to December 31, 2024. The investments areinvestment is recorded at ~~cost following the measurement alternative as there is no established market for the securities and the Company does not have significant influence over these entities.~~fair value each period.

Equity in Earnings ~~(Loss)~~ of Non-Consolidated Entities

Aggregated condensed financial information of the Company’s significant non-consolidated equity method ~~investments (DCIP and NCM)~~investment (DCIP) is shown below:

Three Months Ended

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
Revenues

$
43.4

$
156.3

$
320.9

$
417.9
Operating costs and expenses

19.1

99.3

230.8

303.6
Net earnings

$
24.3

$
57.0

$
90.1

$
114.3


	Three Months Ended				Nine Months Ended
(In millions)	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
Revenues	$	40.1	$	43.4	$	125.8	$	127.0
Operating costs and expenses		17.8		19.1		56.5		59.0
Net earnings	$	22.3	$	24.3	$	69.3	$	68.0

Note: The revenues, operating costs and expense, and net earnings for the three months ended September 30, 2018 above includes DCIP only, as the sale of the Company’s investment in NCM closed on July 5, 2018.

The components of the Company’s recorded equity in earnings ~~(loss)~~ of non-consolidated entities are as follows:


	Three Months Ended				Nine Months Ended

									Three Months Ended				Nine Months Ended
(In millions)	September 30, 2018		September 30, 2017		September 30, 2018		September 30, 2017		September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
NCM and NCM, Inc.	$	28.9	$	(11.1)	$	17.3	$	(216.8)	$	—	$	28.9	$	—	$	17.3
Digital Cinema Implementation Partners, LLC		7.4		6.0		20.9		21.2
DCIP										6.5		7.4		21.1		20.9
Screenvision		30.1		1.0		30.5		0.8		—		30.1		—		30.5
Other		3.6		2.3		5.3		(4.3)		1.0		3.6		3.1		5.3
The Company’s recorded equity in earnings (loss)	$	70.0	$	(1.8)	$	74.0	$	(199.1)
The Company’s recorded equity in earnings									$	7.5	$	70.0	$	24.2	$	74.0

~~NCM Transactions.~~ ~~In March 2018, the NCM Common Unit Adjustment ("CUA") resulted in a negative adjustment of 915,150 common units for the Company. The Company elected to return the units and recorded the~~

As of

As of

(In millions)

September 30, 2018

December 31, 2017

Due from NCM for on-screen advertising revenue

$
1.8

$
2.5

Due to NCM for Exhibitor Services Agreement

5.3

9.4

Promissory note payable to NCM

2.8

2.8

Accumulated






Exhibitor

Other


Equity in

Investment in

Services

Comprehensive

Cash

(Earnings)

Advertising
(In millions)

NCM (1)

Agreement (2)

(Income)/Loss

Received (Paid)

Loss (3)

(Revenue)
Ending balance at December 31, 2017

$
161.1

$
(530.9)

$
(1.8)

ASC 606 revenue recognition change in amortization method

—

(52.9)

—

Surrender of common units for common unit adjustment

(6.3)

5.2

—

$
—

$
1.1

—
Receipt of excess cash distributions

(15.3)

—

—

15.3


—

—
Impairment loss - held for sale (4)

(14.4)

—

—

—


14.4

—
Expenses on sale of NCM common units

—

—

—

1.4

1.4

—
Sale of NCM common units

(128.3)

—

1.7

156.8

(30.2)

—
Equity in earnings

3.2

—

0.1

—


(3.3)

—
Amortization of ESA

—

10.9

—

—


—

(10.9)
For the period ended or balance as of September 30, 2018

$
—

$
(567.7)

$
—

$
173.5

$
(16.6)

$
(10.9)

(1)

The ~~following table represents AMC’s investment in NCM, Inc. common shares~~Company pays equipment rent monthly and ~~NCM common membership units including units received under~~records the ~~Common Unit Adjustment Agreement dated as of February 13, 2007:~~

equipment rental expense on a straight-line basis over 12 years.

Common

Membership Units

Common Shares


Tranche 1

Tranche 2 (a)

NCM, Inc. (5)
Beginning balance at December 31, 2012

17,323,782

—

—
Additional units received in the quarter ended June 30, 2013

—

1,728,988

—
Additional units received in the quarter ended June 30, 2014

—

141,731

—
Additional units received in the quarter ended June 30, 2015

—

469,163

—
Additional units received in the quarter ended December 31, 2015

—

4,399,324

—
Units exchanged for NCM, Inc. shares in December 2015

—

(200,000)

200,000
Additional units received in the quarter ended March 31, 2017

—

18,787,315

—
Surrender of units for transferred theatres in March 2017

—

(2,850,453)

—
Surrender of units for exclusivity waiver in March 2017

—

(1,807,220)

—
Conversion of units to NCM, Inc. common shares in September 2017

—

(14,600,000)

14,600,000
Sale of NCM, Inc. common shares in September 2017

—

—

(14,800,000)
Conversion of units to NCM, Inc. common shares in October 2017

—

(1,000,000)

1,000,000
Surrender of units in the quarter ended March 31, 2018

—

(915,150)

—
Sale of NCM, Inc. common shares in June 2018

—

—

(1,000,000)
Sale of NCM common units in July 2018

(17,323,782)

(4,153,698)

—
Ending balance at September 30, 2018

—

—

—

~~(a)~~

The additional units received (surrendered) in June 2013, June 2014, June 2015, December 2015, March 2017, and March 2018 were measured at fair value (Level 1) using NCM, Inc.’s stock price of $15.22, $15.08, $14.52, $15.75, $12.52, and $5.64, respectively.

~~(2)~~

Represents the unamortized portion of the ESA with NCM. Such amounts are being amortized to other theatre revenues over the remainder of the 30-year term of the ESA ending in 2037. See Note 1–Basis of Presentation and Note 2–Revenue Recognition for information on the effects of adopting ASC 606.

~~(3)~~

Excludes a lower of carrying value or fair value impairment loss of $1.6 million related to the Company’s common stock investment in NCM, Inc. See Note 9–Fair Value Measurements for further information regarding a lower of carrying value or fair value impairment losses.

~~(4)~~

The Company recorded an impairment loss on held-for-sale units and shares for NCM, Inc. of $1.6 million and NCM of $14.4 million for a total impairment of $16.0 million during the three months ended March 31, 2018. The charges reflect recording our units and shares at the publicly quoted per share price on March 31, 2018 of $5.19. See Note 9–Fair Value Measurements for further information regarding a ~~lower of carrying value or fair value~~ ~~impairment loss.~~

~~(5)~~

~~The following table represents AMC’s investment in NCM, Inc. common shares.~~

Cash

NCM Inc.

Investment in

Received

Equity in
(In millions)

NCM Inc.

(Paid)

(Earnings) Loss
Ending balance December 31, 2017

$
6.8

$
—

$
—
Held-for-sale impairment loss (4)

(1.6)

—

1.6
Expenses from the sale of NCM Inc. common shares

—

(0.1)

0.1
Dividend received NCM, Inc. common shares

(0.3)

0.3

—
Sale of NCM Inc. common shares

(4.9)

7.2

(2.3)
Ending balance at September 30, 2018

$
—

$
7.4

$
(0.6)

During the nine months ended September 30, 2018 and September 30, 2017, the Company recorded cash received as investment income of $5.4 million and $5.5 million, respectively, related to the NCM tax receivable agreement. During the nine months ended September 30, 2018, the Company sold 1,000,000 shares of NCM, Inc. for net proceeds of $7.2 million and a gain of $2.3 million. During the three months ended September 30, 2018, the Company sold 21,477,480 common membership units of NCM, LLC for net proceeds of $156.8 million and a gain of $28.9 million.

~~NCM Agreement~~

On March 9, 2017, the Company reached an agreement with NCM to implement the requirements of the final judgment entered in connection with the DOJ approval of the Carmike transaction. Pursuant to the NCM agreement, the Company received 18,425,423 NCM common units in March 2017 related to annual attendance at the Carmike theatres and 361,892 NCM common units related to the 2016 common unit adjustment. Because the Carmike theatres were subject to a pre-existing agreement with a third party and will not receive advertising services from NCM, the Company will be obligated to make quarterly payments to NCM reflecting the estimated value of the advertising services at the Carmike theatres as if NCM had provided such services. The quarterly payments will continue until the earlier of (i) the date the theatres are transferred to the NCM network or (ii) expiration of the ESA with NCM. All calculations will be made pursuant to the terms of the existing ESA and Common Unit Adjustment Agreement with NCM. With regard to the existing AMC theatres on the NCM network that are required under the final judgment with the DOJ to be transferred to another advertising provider, the Company returned 2,850,453 (valued at $36.4 million) NCM common units to NCM in March 2017, calculated under the Common Unit Adjustment Agreement as if such theatres had been disposed of on March 3, 2017. The Company is not obligated to make quarterly payments with respect to the transferred theatres. In addition, the Company returned 1,807,220 additional NCM common units (valued at $22.6 million) in exchange for a waiver of exclusivity by NCM as to the required transferred theatres for the term of the final judgment, which was classified as general and administrative: Merger, acquisition and transaction costs when the common units were returned to NCM during the three months ended March 31, 2017. The Company recorded a loss of $1.2 million on the return of NCM common units as per the Common Unit Adjustment Agreement and exclusivity waiver for the difference between the average carrying value of the units and the fair value on the date of return. As a result of the agreement, the Company received 14,129,642 net additional NCM common units, valued at $176.9 million based on the market price of NCM, Inc. stock on March 16, 2017 of $12.52. Due to the structure of the transactions, the Company will no longer anticipate recognizing taxable gain upon receipt of new NCM common units. The Company also agreed to reimburse NCM up to $1.0 million for expenses related to the negotiation of this agreement.

The final judgment with the DOJ also requires the Company to divest the majority of its equity interests in NCM, so that by June 20, 2019, AMC owns no more than 4.99% of NCM’s outstanding equity interests on a fully converted basis per the following schedule: (i) on or before December 20, 2017, AMC must own no more than 15% of NCM’s outstanding equity interests; (ii) on or before December 20, 2018, AMC must own no more than 7.5% of NCM’s outstanding equity interests; and (iii) on or before June 20, 2019 AMC must own no more than 4.99% of NCM’s outstanding equity interests. The Company sold 14,800,000 NCM, Inc. shares during the three months ending September 30, 2017 and satisfied the DOJ divestiture requirements related to NCM dispositions for calendar 2017. As of June 30, 2018, the Company has 21,477,480 common units of NCM classified as held-for-sale, which were sold on July 5, 2018 and the Company is in full compliance with the DOJ final judgment. In March 2018, the Company recorded in equity in (earnings) loss of non-consolidated entities a lower of carrying value or fair value impairment charge of $16.0 million to reduce the carrying value of its held-for-sale investment in NCM to Level 1 fair value. The impairment charge reflected recording our held-for-sale units and shares at the lower of carrying value or publicly quoted per share price on March 31, 2018 of $5.19.

On June 18, 2018, the Company entered into two Agreements with each of Regal and Cinemark pursuant to which Regal and Cinemark each separately agreed to purchase 10,738,740 common units of NCM at a sales price of $7.30 per unit and aggregate consideration of approximately $156.8 million. The Sales closed on July 5, 2018. Following the closing of the Sales, the Company no longer owns any shares of common stock in NCM, Inc. or common units in NCM. NCM consented to the Sales and waived its rights under the memorandum of understanding that provided the Company would not reduce its combined ownership of NCM and NCM, Inc. below 4.5%. The Company recorded a $28.9 million gain on the sale of its NCM investment during the three months ended September 30, 2018.

~~Screenvision Merger.~~ On May 30, 2018 Screenvision entered into an Agreement and Plan of Merger under which a change of control in Screenvision occurred upon consummation of the transactions contemplated therein. The Company received distributions and merger consideration of $45.9 million on July 2, 2018 upon consummation of the Screenvision merger and retains a 21.2% common membership interest. The Company reduced the carrying value of its investment in Screenvision to $0 and recorded equity in earnings for the excess distribution of $30.1 million during the three months ended September 30, 2018.

~~Digital Cinema Media.~~ The Company acquired its equity investment in DCM on November 30, 2016 in connection with the acquisition of Odeon. The Company receives advertising services from DCM for its Odeon theatres in International markets through a joint venture in which it has a 50.0% ownership interest.

~~The Company recorded the following related party transactions with DCM:~~

As of

As of
(In millions)

September 30, 2018

December 31, 2017
Due from DCM for on-screen advertising revenue

$
0.7

$
4.6

Three Months Ended

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
DCM screen advertising revenues

$
4.2

$
4.8

$
13.4

$
14.3

~~DCIP Transactions.~~ ~~The Company pays equipment rent monthly and records the equipment rental expense on a straight-line basis over 12 years.~~

~~The Company recorded the following related party transactions with DCIP:~~

As of

As of

(In millions)

September 30, 2018

December 31, 2017

Due from DCIP for warranty expenditures

$
3.3

$
2.8

Deferred rent liability for digital projectors

7.9

8.1

Three Months Ended

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
Digital equipment rental expense

$
1.4

$
1.4

$
4.4

$
4.3

~~AC JV Transactions.The Company recorded the following related party transactions with AC JV:~~

As of

As of

(In millions)

September 30, 2018

December 31, 2017

Due to AC JV for Fathom Events programming

1.2

0.5

Three Months Ended

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
Film exhibition costs:

Gross exhibition cost on Fathom Events programming

$
3.5

$
2.2

$
8.5

$
9.0

~~Screenvision Transactions.The Company recorded the following related party transactions with Screenvision:~~

As of

As of
(In millions)

September 30, 2018

December 31, 2017
Due from Screenvision for on-screen advertising revenue

$
1.8

$
3.1

Three Months Ended

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
Screenvision screen advertising revenues

$
3.8

$
3.5

$
11.3

$
9.9

~~Nordic JV’s.~~ ~~The Company recorded the following related party transactions with the Nordic theatre JV’s:~~

As of

As of
(In millions)

September 30, 2018

December 31, 2017
Due from Nordic JVs

$
3.8

$
5.7
Due to Nordic JVs for management services

2.2

2.5

NOTE 6—CORPORATE BORROWINGS

A summary of the carrying value of corporate borrowings and capital and ~~financing~~finance lease obligations is as follows:



(In millions)	September 30, 2018		December 31, 2017		September 30, 2019		December 31, 2018
Revolving Credit Facility Due 2020 (4.63% as of September 30, 2018)	$	—	$	—
Odeon Revolving Credit Facility Due 2022 (2.5% + Base Rate of 0.75% as of September 30, 2018)		6.6		—
Senior Secured Credit Facility-Term Loan due 2022 (4.3844% as of September 30, 2018)		856.4		863.0
Senior Secured Credit Facility-Term Loan due 2023 (4.3844% as of September 30, 2018)		492.5		496.3
Odeon Revolving Credit Facility Due 2022 (2.5% + Base Rate of 0.75% as of September 30, 2019)					$	10.0	$	11.9
Senior Secured Credit Facility-Term Loan due 2026 (5.23% as of September 30, 2019)						1,990.0		—
Senior Secured Credit Facility-Term Loan due 2022						—		854.2
Senior Secured Credit Facility-Term Loan due 2023						—		491.2
6.0% Senior Secured Notes due 2023		230.0		230.0		—		230.0
2.95% Senior Unsecured Convertible Notes due 2024		600.0		—		600.0		600.0
5.0% Promissory Note payable to NCM due 2019		2.8		2.8		1.3		1.3
5.875% Senior Subordinated Notes due 2022		375.0		375.0		—		375.0
6.375% Senior Subordinated Notes due 2024 (£500 million par value)		651.5		675.1		614.9		634.1
5.75% Senior Subordinated Notes due 2025		600.0		600.0		600.0		600.0
5.875% Senior Subordinated Notes due 2026		595.0		595.0		595.0		595.0
6.125% Senior Subordinated Notes due 2027		475.0		475.0		475.0		475.0
Capital and financing lease obligations, 5.75% - 11.5%		584.5		651.4
Finance lease obligations						99.5		560.3
Debt issuance costs		(107.6)		(103.7)		(90.7)		(104.4)
Net premiums and (discounts)		(66.2)		26.8
Net discounts						(73.1)		(64.4)
Derivative liability		144.5		—		9.1		24.0
		5,440.0		4,886.7
						4,831.0		5,283.2
Less:
Current maturities		(83.0)		(87.7)
	$	5,357.0	$	4,799.0
Current maturities corporate borrowings						(21.4)		(15.2)
Current maturities finance lease obligations						(10.0)		—
Current maturities capital and financing lease obligations						—		(67.0)
					$	4,799.6	$	5,201.0

~~Fifth Amendment to~~Senior Secured Credit ~~Agreement~~Facility – Term Loan due 2026

On ~~August 14, 2018,~~April 22, 2019, the Company entered into the ~~Fifth~~Sixth Amendment to Credit Agreement ~~with Citicorp North America, Inc, as administrative agent and the other lenders party thereto~~ (the ~~“Fifth~~“Sixth Amendment”), amending the Credit Agreement dated ~~as of~~ April 30, ~~2013.~~2013, by and among the Company, each lender party thereto and Citicorp North America, Inc. (“Citi”), as administrative agent. After giving effect to the Sixth Amendment, the Credit Agreement provides for senior secured financing of $2,225.0 million in aggregate, consisting of (1) $2,000.0 million in aggregate principal amount of senior secured tranche B loans maturing April 22, 2026 (the “Term Loan Facility”) and (2) a $225.0 million senior secured revolving credit facility (which includes borrowing capacity available for letters of credit) maturing April 22, 2024 (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Credit Facilities”). The ~~Fifth Amendment~~ ~~made certain changes~~loans were used to ~~certain covenants~~repay all of the Company’s existing term loans in an aggregate principal amount of approximately $1,338.5 million and ~~definitions. These amendments~~ to fund the redemptions of the 5.875% Senior Subordinated Notes due 2022 and the 6.0% Senior Secured Notes due 2023. The Company recorded a loss of $16.6 million related to these transactions, comprised of $14.1 million of extinguishment losses and $2.5 million of third party costs related to the modification of the Term Loans under the Senior Secured Credit Facility.

All obligations under the Credit Agreement ~~were executed in order~~are guaranteed by, subject to ~~facilitate~~certain exceptions, each of the Company’s current and future wholly-owned material domestic restricted subsidiaries. All obligations under the Credit Agreement, and the guarantees of those obligations, are secured by substantially all of the assets of the Company and each guarantor, subject to customary exceptions, including:

●

a pledge of 100% of the equity interests directly held by the Company and each guarantor in any wholly-owned material subsidiary of the Company or any guarantor (which pledge, in the case of any non-U.S. subsidiary of a U.S. subsidiary, will not include more than 65% of the voting stock of such non-U.S. subsidiary), subject to certain exceptions; and

Table of Contents

●

a security interest in substantially all other tangible and intangible assets of the Company and each guarantor, subject to certain exceptions.

The Credit Facilities will require the Company to prepay outstanding term loans, subject to certain exceptions, with:

●

50% (which percentage will be reduced to 0% if the Company attains a certain secured net leverage ratio) of the Company’s annual excess cash flow;

●

100% of the net cash proceeds of certain non-ordinary course asset sales by the Company and its restricted subsidiaries (including casualty and condemnation events, subject to de minimis thresholds), and subject to the right to reinvest 100% of such proceeds, subject to certain qualifications; and

●

100% of the net proceeds of any issuance or incurrence of debt by the Company or any of its restricted subsidiaries, other than certain debt permitted under the Credit Agreement.

The foregoing mandatory prepayments will be used to reduce the installments of principal on the Term Loan Facility. The Company may voluntarily repay outstanding loans under the Credit Facilities at any time without premium or penalty, except (1) for customary “breakage” costs with respect to LIBOR loans under the Credit Facilities and (2) during the six months following the Amendment Closing Date, with respect to certain voluntary prepayments or refinancings of the Term Loan Facility that reduce the effective yield of the Term Loan Facility, which will be subject to a 1.00% prepayment premium.

Borrowings under the Term Loan Facility will bear interest at a rate per annum equal to, at the Company’s option, either (1) an ~~internal reorganization due~~applicable margin plus a base rate determined by reference to ~~recent tax changes~~the highest of (a) 0.50% per annum plus the Federal Funds Effective Rate, (b) the prime rate of Citi and (c) LIBOR determined by reference to ~~make modifications which clarified~~the cost of funds for U.S. dollar deposits for an interest period of one month adjusted for certain ~~ambiguities in~~additional costs, plus 1.00% or (2) an applicable margin plus LIBOR determined by reference to the ~~Senior Secured Credit Agreement.~~

~~The cash flows~~costs of funds for U.S. dollar deposits for the ~~term loans due 2022 and 2023 were not changed as a result of the August 14, 2018 modification and the Borrowing Capacity~~interest period relevant to such borrowing adjusted for certain additional costs. Borrowings under the Revolving Credit ~~Agreement was not changed. As~~Facility will bear interest at a ~~result,~~rate per annum equal to an applicable margin based upon a leverage-based pricing grid, plus, at the ~~Company has accounted~~Company’s option, either (1) a base rate determined by reference to the highest of (a) 0.50% per annum plus the Federal Funds Effective Rate, (b) the prime rate of Citi and (c) LIBOR determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month adjusted for certain additional costs, plus 1.00% or (2) LIBOR determined by reference to the costs of funds for U.S. dollar deposits for the ~~Fifth Amendment as~~interest period relevant to such borrowing adjusted for certain additional costs. As of the date hereof, the applicable margins for LIBOR borrowings under the Term Loan Facility and the Revolving Credit Facility are 3.00% and 2.25%, respectively.

The Credit Agreement contains other customary terms, including (1) representations, warranties and affirmative covenants, (2) negative covenants, including limitations on indebtedness, liens, mergers and acquisitions, asset sales, investments, distributions, prepayments of subordinated debt and transactions with affiliates, in each case subject to baskets, thresholds and other exceptions, and (3) customary events of default.

The availability of certain baskets and the ability to enter into certain transactions will also be subject to compliance with certain financial ratios. In addition, the Revolving Credit Facility includes a modification. The Company expensed $0.3 million of third-party costs during the three and nine months ended September 30, 2018 and capitalized $1.5 million debt issuance costs for amounts paid to lenders. maintenance covenant that requires, in certain circumstances, compliance with a certain secured leverage ratio.

~~Table of Contents~~

Senior Unsecured Convertible Notes due 2024

Carrying value (in millions) as of September 30, ~~2018:~~2019:


	Carrying Value				Carrying Value
	as of		Increase to		as of
	December 31, 2018		Expense (Income)		September 30, 2019
Principal balance	$	600.0	$	—	$	600.0
Discount		(86.7)		9.6		(77.1)
Debt issuance costs		(13.0)		1.4		(11.6)
Derivative liability		24.0		(14.9)		9.1
Carrying Value	$	524.3	$	(3.9)	$	520.4

Carrying Value

Carrying Value

at Issuance on

Charges to

as of

September 14, 2018

Earnings

September 30, 2018
Principal balance

$
600.0

$
—

$
600.0
Discount

(90.4)

0.6

(89.8)
Debt issuance costs

(12.5)

0.1

(12.4)
Derivative liability

90.4

54.1

144.5
Carrying Value

$
587.5

$
54.8

$
642.3

Table of Contents

On September 14, 2018, the Company issued $600.0 million aggregate principal amount of its 2.95% Senior Unsecured Convertible Notes due 2024 (the "Convertible Notes due 2024"). The Convertible Notes due 2024 mature on September 15, 2024, subject to earlier conversion by the holders thereof, repurchase by the Company at the option of the holders or redemption by the Company upon the occurrence of certain contingencies, as discussed below. Upon maturity, the $600.0 million principal amount of the Convertible Notes due 2024 will be payable in cash. The Company will pay interest in cash on the Convertible Notes due 2024 at 2.95% per annum, semi-annually in arrears on September 15th and March 15th, commencing on March 15, 2019. The Company used the net proceeds from the sale of the Convertible Notes due 2024 to repurchase and retire 24,057,143 shares of Class B common stock held by Wanda for $17.50 per share or approximately $421.0 million, associated legal fees of ~~$1.9~~$2.6 million, and to pay a special dividend of $1.55 per share of Class A common stock and Class B common stock, or approximately $160.5 million on September 28, 2018 to shareholders of record on September 25, 2018.

The Company bifurcated the conversion feature from the principal balance of the Convertible Notes due 2024 as a derivative liability because (1) a conversion feature is not clearly and closely related to the debt instrument and the reset of the conversion price discussed in the following paragraph causes the conversion feature to not be considered indexed to the Company’s equity, (2) the conversion feature standing alone meets the definition of a derivative, and (3) the Convertible Notes due 2024 are not remeasured at fair value each reporting period with changes in fair value recorded in the condensed consolidated statement of operations. The initial derivative liability of $90.4 million is offset by a discount to the principal balance and is amortized to interest expense resulting in an effective rate of 5.98% over the term of the Convertible Notes due 2024. The Company also recorded debt issuance costs of approximately ~~$12.5~~$13.6 million related to the issuance of the Convertible Notes due 2024 and will amortize those costs to interest expense under the effective interest method over the term of the Convertible Notes due 2024. The Company recorded interest expense for the ~~period from September 14, 2018 to~~three and nine months ended September 30, ~~2018~~2019 of ~~$1.5 million.~~$8.2 million and $24.2 million, respectively. The derivative liability is remeasured at fair value each reporting period with changes in fair value recorded in the condensed consolidated statement of operations as other expense or income. See Note 9 – —Fair Value Measurements for a discussion of the valuation methodology. For the three and nine months ended September 30, ~~2018,~~2019, this resulted in ~~a charge~~other (expense) income of ~~$54.1 million.~~$(5.7) million and $14.9 million, respectively. The if-converted value of the Convertible Notes due 2024 ~~exceeded~~is less than the principal balance by approximately ~~$49.1~~$261.2 million as of September 30, ~~2018~~2019 based on the closing price per share of the Company’s common stock of ~~$20.50~~$10.70 per share.

~~The Convertible Notes due 2024 are generally not convertible to equity in the first year after issuance.~~ Upon conversion by a holder ~~thereof,~~of the Convertible Notes due 2024, the Company shall deliver, at its election, either cash, shares of the Company’s Class A common stock or a combination of cash and shares of the Company’s Class A common stock at a conversion rate of 52.7704 per $1,000 principal amount of the Convertible Notes due 2024 (which represents an initial conversion price of $18.95), in each case subject to customary anti-dilution adjustments. As of September 30, ~~2018,~~2019, the $600.0 million principal balance of the Convertible Notes due 2024 would be convertible into 31,662,269 shares of Class A common stock. In addition to typical anti-dilution adjustments, in the event that the then-applicable conversion price is greater than 120% of the average of the volume-weighted average price of the Company’s Class A common stock for the ~~ten~~10 days prior to the second anniversary of issuance (the “Reset Conversion Price”), the conversion price for the Convertible Notes due 2024 is subject to a reset provision that would adjust the conversion price downward to such Reset Conversion Price. However, this conversion price reset provision is subject to a conversion price floor such that the shares of the Company’s Class A common stock issuable upon conversion would not exceed 30% of the Company’s then outstanding fully-diluted share capital after giving effect to the conversion. In addition, a trigger of the reset provision would result in up to 5,666,000 shares of the Company’s Class B common stock held by Wanda becoming subject to forfeiture and retirement by the Company at no additional cost pursuant to the stock repurchase agreement between the

~~Table of Contents~~

Company and Wanda discussed in Note 7 – —Stockholders’ Equity. This cancellation agreement is a contingent call option for the forfeiture shares, which is a freestanding derivative measured at fair value on a recurring basis. The feature is contingent on the same reset of the conversion price which is part of the conversion feature. The initial derivative asset of $10.7 million is offset by a credit to stockholders’ equity related to the Class B common stock purchase and cancellation. The forfeiture shares feature is not clearly and closely related to the Convertible Notes due 2024 host and it is bifurcated and accounted for as a derivative asset measured at fair value through earnings each reporting period with changes in fair value recorded in the condensed consolidated statement of operations as other expense or income. See Note 9—Fair Value Measurements for a discussion of the valuation methodology. For the three and nine months ended September 30, 2019, this resulted in other income of $8.5 million and $0.5 million, respectively. Additionally, the conversion rate will be adjusted if any cash dividend or distribution is made to all or substantially all holders of the Company’s common stock (other than the special dividend referenced above and a regular, quarterly cash dividend that does not exceed $0.20 per share until the second anniversary of issuance and $0.10 per share thereafter). Any Convertible Notes due 2024 that are converted in connection with a Make-Whole Fundamental Change (as defined in the Indenture (the “Indenture”) governing the Convertible Notes due 2024) are,

Table of Contents

under certain circumstances, entitled to an increase in the conversion rate.

The Company has the option to redeem the Convertible Notes due 2024 for cash on or after the fifth anniversary of issuance at par if the price for the Company’s Class A common stock is equal to or greater than 150% of the then applicable conversion price for 20 or more trading days out of a consecutive 30 day trading period (including the final three trading days), at which time the holders have the option to convert. The Company also has the option to redeem the Convertible Notes due 2024, between the second and third anniversary of issuance, if the reset provision described above is triggered at a redemption price in cash that would result in the noteholders realizing a 15% ~~IRR~~internal rate of return from the date of issuance regardless of when any particular noteholder acquired its Convertible Notes due 2024. The Company also bifurcated this redemption feature from the principal balance of the Convertible Notes due 2024 and considered it as a part of the overall fair value of the derivative liability. For the three and nine months ended September 30, 2019, the Company recorded other expense (income) of $5.7 million and $(14.9) million, respectively, related to the decrease in fair value of its derivative liability for the Convertible Notes due 2024.

With certain exceptions, upon a change of control of the Company or if the Company’s Class A common stock is not listed for trading on The New York Stock Exchange, The NASDAQ Global Select Market or The NASDAQ Global Market, the holders of the Convertible Notes due 2024 may require that the Company repurchase in cash all or part of the principal amount of the Convertible Notes due 2024 at a purchase price equal to the principal amount plus accrued and unpaid interest up to, but excluding, the date of repurchase. The Indenture includes restrictive covenants that, subject to specified exceptions and parameters, limit the ability of the Company to incur additional debt and limit the ability of the Company to incur liens with respect to the Company’s senior subordinated notes or any debt incurred to refinance the Company’s senior subordinated notes. The Indenture also includes customary events of default, which may result in the acceleration of the maturity of the Convertible Notes due 2024 under the Indenture.

The Convertible Notes due 2024 are general unsecured senior obligations of the Company and are fully and unconditionally guaranteed on a joint and several senior unsecured basis by all the Company’s existing and future domestic restricted subsidiaries that guarantee its other indebtedness.

On September 14, 2018, in connection with the issuance of the Convertible Notes due 2024, the Company entered into an investment agreement (the “Investment Agreement”) providing for, among other things, registration rights with respect to the Convertible Notes due 2024 and the shares of Class A common stock underlying the Convertible Notes due 2024. Subject to the terms of the Investment Agreement, the Company iswas required to file a registration statement with the SEC not later than three months from the issuance date of the Convertible Notes in order to provide for resales of the Convertible Notes due 2024 and the shares of Class A common stock underlying the Convertible Notes to be made on a delayed or continuous basis pursuant to Rule 415 under the Securities Act. The Company filed a registration statement with the SEC on December 14, 2018 to fulfill this requirement.

NOTE 7—STOCKHOLDERS’ EQUITY

Dividends

The following is a summary of dividends and dividend equivalents paid to stockholders during the three and nine months ended September 30, ~~2018:~~2019:

Amount per

Total Amount






Share of

Declared
Declaration Date

Record Date

Date Paid

Common Stock

(In millions)
February 28, 2018

March 12, 2018

March 26, 2018

$
0.20

$
26.0
May 3, 2018

June 11, 2018

June 25, 2018

0.20

26.0
July 24, 2018

September 10, 2018

September 24, 2018

0.20

25.8
September 14, 2018

September 25, 2018

September 28, 2018

1.55

162.9


			Amount per		Total Amount
			Share of		Declared
Declaration Date	Record Date	Date Paid	Common Stock		(In millions)
February 15, 2019	March 11, 2019	March 25, 2019	$	0.20	$	21.3
May 3, 2019	June 10, 2019	June 24, 2019		0.20		21.3
August 2, 2019	September 9, 2019	September 23, 2019		0.20		21.3

~~Table of Contents~~

On ~~September 14, 2018,~~October 24, 2019, the Holdings’ Board of Directors declared a special cash dividend in the amount of $1.55 per share of Class A and Class B common stock, payable on September 28, 2018 to stockholders of record on September 25, 2018.

~~On November 1, 2018,~~ Holdings’ Board of Directors declared a cash dividend in the amount of $0.20 per share ofon its Class A and Class B common stock, payable on December ~~26, 2018~~16, 2019 to stockholders of record on December ~~10, 2018.~~2, 2019.

Table of Contents

Related Party Transactions

As of September 30, ~~2018~~2019 and December 31, ~~2017,~~2018, the Company recorded a receivable due from Wanda of ~~$0.8~~$0.6 million and ~~$0.6~~$0.9 million, respectively, for reimbursement of general administrative and other expense incurred on behalf of Wanda. ~~During~~For the three and nine months ended September 30, ~~2018,~~2019, the Company recorded ~~$0.7~~less than $0.1 million and $0.2 million, respectively, of cost reductions for general and administrative services provided on behalf of Wanda. Wanda owns Legendary Entertainment, a motion picture production company. The Company will occasionally play Legendary’s films in its theatres as a result of transactions with independent film distributors.

On September 14, 2018, the Company entered into the Investment Agreement with Silver Lake Alpine, L.P., an affiliate of Silver Lake Group, L.L.C. (“Silver Lake”), relating to the issuance to Silver Lake (or its designated affiliates) of ~~$600~~$600.0 million principal amount of the Convertible Notes due 2024. See Note 6—Corporate Borrowings - Senior Unsecured Convertible Notes due 2024 for more information.

On September 14, 2018, the Company, Silver Lake and Wanda entered into a Right of First Refusal Agreement (the “ ROFR Agreement”), which provides Silver Lake certain rights to purchase shares of the Company’s common stock that Wanda proposes to sell during a period of two years from the date of execution of the ROFR Agreement or, if earlier, until such time that Wanda and its affiliates cease to beneficially own at least 50.1% of the total voting power of the Company’s voting stock. The right of first refusal applies to both registered and unregistered transfers of shares. Under the ROFR Agreement, in the event that Wanda and its affiliates cease to beneficially own at least 50.1% of the total voting power of the Company’s voting stock, then the Company will have the same right of first refusal over sales of the Company’s common stock by Wanda as described above until the expiration of the two-year period beginning on the date of execution of the ROFR Agreement. In such event, the Company may exercise such right to purchase shares from Wanda from time to time pursuant to the ROFR Agreement in its sole discretion, subject to approval by the disinterested directors of the Board. If the Company determines to exercise its right to purchase shares from Wanda pursuant to the ROFR Agreement, it will have the obligation under the Investment Agreement to offer to sell to Silver Lake a like number of shares of the Company’s Class A Common Stock, at the same per share price at which it purchased the Wanda shares.

On September 14, 2018, the Company used the proceeds from the Convertible Notes due 2024, and pursuant to a stock repurchase agreement between the Company and Wanda, repurchased 24,057,143 shares of Class B common stock at a price of $17.50 per share or $421.0 million and associated legal fees of ~~$1.9~~$2.6 million. As of September 30, ~~2018,~~2019, Wanda owns ~~50.01%~~49.85% of AMC through its 51,769,784 shares of Class B common stock. With the three-to-one voting ratio between ~~our~~the Company’s Class B and Class A common stock, Wanda retains voting control of AMC with ~~75.01%~~74.89% of the voting power of the Company’s common stock. As discussed in Note 6—Corporate Borrowings up to 5,666,000 shares of Class B common stock are subject to forfeiture for no consideration in connection with the reset provision contained in the Indenture.

Temporary Equity

Certain members of management ~~have~~had the right to require Holdings to repurchase the Class A common stock held by them under certain limited circumstances pursuant to the terms of a stockholders’ agreement. Beginning on January 1, 2016 (or upon the termination of a management stockholder’s employment by the Company without cause, by the management stockholder for good reason, or due to the management stockholder’s death or disability) management stockholders ~~will have~~had the right, in limited circumstances, to require Holdings to purchase shares that ~~are~~were not fully and freely tradeable at a price equal to the price per share paid by such management stockholder with appropriate adjustments for any subsequent events such as dividends, splits, or combinations. The shares of Class A common stock, subject to the stockholder agreement, ~~are~~were classified as temporary equity, apart from permanent equity, as a result of the contingent redemption feature contained in the stockholder agreement. The Company determined the amount reflected in temporary equity for the Class A common ~~stock-based~~stock based on the price paid per share by the management stockholders and Wanda on August 30, 2012, the date Wanda acquired Holdings.

~~Table~~As of ~~Contents~~

~~During~~January 1, 2019, the ~~nine months ended September 30, 2018, two~~temporary equity program expired and management employees who held ~~37,105~~75,712 shares relinquished their put rights, therefore the related share amount of $0.4 million was reclassified to additional paid in capital, a component of stockholders’ equity.

Table of Contents

Stock-Based Compensation

Holdings adopted a stock-based compensation plan in December of 2013.

~~The~~For the three and nine months ended September 30, 2019, the Company recognized stock-based compensation expense of $2.1 million and $11.5 million, respectively, within general and administrative: other. For the three and nine months ended September 30, 2018, the Company recognized stock-based compensation expense of $4.2 million and ~~$(0.1)~~$10.9 million, respectively, within general and administrative: other during the three months ended September 30, 2018 and September 30, 2017, respectively. The Company recognized stock-based compensation expense of $10.9 million and $3.9 million within general and administrative: other during the nine months ended September 30, 2018 and September 30, 2017, respectively.other.

The components of the Company’s recorded and unrecognized stock-based compensation expense are as follows:


							Additional
	Amount Recognized		Amount Recognized		Amount		Expected to		Expected to		Expected to
	Three Months Ended		Nine Months Ended		Unrecognized		Recognize		Recognize		Recognize
Grant Tranche	September 30, 2019		September 30, 2019		September 30, 2019		2019		2020		2021
2019 Board of Directors	$	—	$	0.5	$	—	$	—	$	—	$	—
2019 RSU awards		1.0		2.5		8.2		1.1		3.6		3.5
2019 PSU awards (1)		(0.1)		2.5		—		—		—		—
2018 RSU awards		0.7		2.4		3.9		0.8		3.1		—
2018 PSU awards (1)		(0.2)		1.3		—		—		—		—
2017 RSU awards		0.4		1.3		0.4		0.4		—		—
2017 RSU NEO awards		0.3		1.0		0.3		0.3		—		—
2017 PSU awards (2)		—		—		—		—		—		—
	$	2.1	$	11.5	$	12.8	$	2.6	$	6.7	$	3.5

Additional

Amount

Expected to

Expected to

Expected to

Three Months Ended

Nine Months Ended

Unrecognized

Recognize

Recognize

Recognize
Grant

September 30, 2018

September 30, 2018

September 30, 2018

2018

2019

2020
2018 Board of Directors

$
—

$
0.5

$
—

$
—

$
—

$
—
2018 RSU awards

1.0

2.4

7.8

1.0

3.4

3.4
2018 PSU awards

1.8

4.1

6.0

1.8

3.0

1.2
2017 RSU awards

0.5

1.3

2.4

0.5

1.9

—
2017 RSU NEO awards

0.3

1.0

1.7

0.3

1.4

—
2017 PSU awards (1)

—

—

—

—

—

—
2016 RSU awards

0.3

0.8

0.3

0.3

—

—
2016 RSU NEO awards

0.3

0.8

0.3

0.3

—

—
2016 PSU awards (1)

—

—

—

—

—

—

$
4.2

$
10.9

$
18.5

$
4.2

$
9.7

$
4.6

(1)

During the three months ended September 30, 2019, the Company determined that achieving the three-year net profit performance thresholds of the 2018 and 2019 Performance Stock Units was no longer probable and ceased accruing any additional expense on these units. If the Company later determines that achieving the performance thresholds is improbable, the Company would reverse all previously recorded expense. If the Company later determines that the performance thresholds are probable, then historical expense would be reinstated, and the Company would resume recognizing expense.

(2)

During the year ended December 31, 2017, the Company determined that achieving the three-year performance thresholds of the 2017 ~~Performance Stock Units and the 2016~~ Performance Stock Units was improbable and reversed all previously recorded expense and ceased accruing any additional expense on these units. If the Company later determines that the performance thresholds ~~become~~are probable, then historical expense would be reinstated, and the Company would resume recognizing expense.

Awards Granted in ~~2018~~2019

The Company’s Board of Directors approved awards of stock, restricted stock units (“RSUs”), and performance stock units (“PSUs”) to certain of the Company’s employees and directors under the Plan. The fair value of the stock at the grant date of March ~~12, 2018~~6, 2019 was ~~$15.65~~$15.13 per share and was based on the closing price of Holdings’ stock.

The award agreements generally had the following features:

●

Stock Award: On March ~~12, 2018, five~~6, 2019, 5 members of Holdings’ Board of Directors were granted awards of ~~28,055~~25,703 fully vested shares of Class A common stock in the aggregate. On May 7, 2019 1 member of Holdings’ Board of Directors was granted an award of 3,096 vested shares of Class A common stock and on July 8, 2019 1 member of Holdings’ Board of Directors was granted an award of 3,665 restricted shares of Class A common stock. The Company recognized approximately $0.5 million of expense in general and administrative: other expense during the nine months ended September 30, ~~2018,~~2019, in connection with these share grants.

Table of Contents

●

Restricted Stock Unit Awards: On March ~~12, 2018,~~6, 2019, RSU awards of ~~653,669~~730,167 units were granted to certain members of management and executive officers. The grant date fair value was approximately ~~$10.2~~$11.0 million based on a stock price of ~~$15.65~~$15.13 on March ~~12, 2018.~~6, 2019. Each RSU represents the right to receive ~~one~~1 share of Class A common stock at a future date. The RSUs vest over 3 years with 1/3 vesting on each of January 2, ~~2019,~~ 2020, 2021, and ~~2021.~~2022. The RSUs will be settled within 30 days of vesting. A dividend equivalent equal to the amount paid in respect of one share of Class A common stock underlying the RSUs began to accrue with respect to the RSUs on the date of grant. Such accrued dividend equivalents are paid to the holder upon vesting of the RSUs.

●

Performance Stock Unit Award: On March ~~12, 2018,~~6, 2019, PSU awards of ~~653,669~~730,167 were granted to certain members of management and executive officers, with three-year cumulative adjusted EBITDA, diluted earnings per share, and net profit performance target conditions and service conditions, covering a performance period beginning January 1, ~~2018~~2019 and ending on December 31, ~~2020.~~2021. The PSUs will vest based on achieving 80% to 120% of the performance targets with the corresponding vested unit amount ranging from 30% to 200%. If the performance target is met at 100%, the PSU awards granted on March ~~12, 2018,~~6, 2019, will vest at ~~653,669~~730,167 units in the aggregate. NoNaN PSUs will vest if Holdings does not achieve 80% of the three-year cumulative adjusted EBITDA, diluted earnings per share, and net profit performance target. Additionally, unvested PSU’s shall be ratably forfeited upon termination of service prior to December 31, ~~2020.~~2021. If service terminates prior to January 2, ~~2019,~~2020, all unvested PSU’s shall be forfeited, if service terminates prior to January 2, ~~2020,~~2021, 2/3 of unvested PSU’s shall be forfeited and if service terminates prior to January 4, ~~2021,~~2022, 1/3 of unvested PSU’s shall be forfeited. The vested PSUs will be settled within 30 days of vesting which will occur upon certification of performance results by the Compensation Committee of the Board of Directors. A dividend equivalent equal to the amount paid in respect of one share of Class A common stock underlying the PSUs began to accrue with respect to the PSUs on the date of grant. Such accrued dividend equivalents are paid to the holder upon vesting of the PSUs.

The following table represents the nonvested RSU and PSU activity for the nine months ended September 30, ~~2018:~~2019:


		Weighted
		Average
	Shares of RSU	Grant Date
	and PSU	Fair Value
Beginning balance at January 1, 2019	1,934,447	$	21.50
Granted	1,460,334		15.13
Vested	(303,201)		21.76
Forfeited	(153,871)		16.94
Cancelled (1)	(100,840)		21.46
Nonvested at September 30, 2019	2,836,869	$	17.62

Weighted

Average

Shares of RSU

Grant Date

and PSU

Fair Value
Beginning balance at January 1, 2018

1,083,841

$
28.61
Granted

1,313,152

15.65
Vested

(195,432)

28.46
Forfeited

(27,870)

20.49
Nonvested at September 30, 2018

2,173,691

$
20.90

(1)

Represents vested RSUs surrendered in lieu of taxes and returned to the 2013 Equity Incentive Plan.

2926

Condensed Consolidated Statements of Stockholders’ Equity

For the Nine Months Ended September 30, 2019


												Accumulated
	Class A Voting			Class B Voting			Additional					Other		Accumulated		Total
	Common Stock			Common Stock			Paid-in		Treasury Stock			Comprehensive		Earnings		Stockholders’
(In millions, except share and per share data)	Shares	Amount		Shares	Amount		Capital		Shares	Amount		Income (Loss)		(Deficit)		Equity
Balances December 31, 2018	55,401,325	$	0.5	51,769,784	$	0.5	$	1,998.4	3,732,625	$	(56.4)	$	5.5	$	(550.9)	$	1,397.6
Cumulative effect adjustments for the adoption of new accounting principles (ASU 842)	—		—	—		—		—	—		—		—		78.8		78.8
Net loss	—		—	—		—		—	—		—		—		(130.2)		(130.2)
Other comprehensive loss	—		—	—		—		—	—		—		(24.9)		—		(24.9)
Dividends declared:
Class A common stock, $0.20/share, net of forfeitures	—		—	—		—		—	—		—		—		(10.7)		(10.7)
Class B common stock, $0.20/share	—		—	—		—		—	—		—		—		(10.4)		(10.4)
Taxes paid for restricted unit withholdings	—		—	—		—		(1.1)	—		—		—		—		(1.1)
Reclassification from temporary equity	75,712		—	—		—		0.4	—		—		—		—		0.4
Stock-based compensation	328,904		—	—		—		4.0	—		—		—		—		4.0
Balances March 31, 2019	55,805,941	$	0.5	51,769,784	$	0.5	$	2,001.7	3,732,625	$	(56.4)	$	(19.4)	$	(623.4)	$	1,303.5
Cumulative effect adjustments for the adoption of new accounting principles (ASU 842)	—		—	—		—		—	—		—		—		(2.6)		(2.6)
Net earnings	—		—	—		—		—	—		—		—		49.4		49.4
Other comprehensive loss	—		—	—		—		—	—		—		(9.2)		—		(9.2)
Dividends declared:
Class A common stock, $0.20/share, net of forfeitures	—		—	—		—		—	—		—		—		(10.7)		(10.7)
Class B common stock, $0.20/share	—		—	—		—		—	—		—		—		(10.4)		(10.4)
Taxes paid for restricted unit withholdings	—		—	—		—		(0.3)	—		—		—		—		(0.3)
Stock-based compensation	3,096		—	—		—		5.4	—		—		—		—		5.4
Balances June 30, 2019	55,809,037	$	0.5	51,769,784	$	0.5	$	2,006.8	3,732,625	$	(56.4)	$	(28.6)	$	(597.7)	$	1,325.1
Net loss	—		—	—		—		—	—		—		—		(54.8)		(54.8)
Other comprehensive loss	—		—	—		—		—	—		—		(68.1)		—		(68.1)
Dividends declared:
Class A common stock, $0.20/share, net of forfeitures	—		—	—		—		—	—		—		—		(10.6)		(10.6)
Class B common stock, $0.20/share	—		—	—		—		—	—		—		—		(10.4)		(10.4)
Stock-based compensation	3,665		—	—		—		2.1	—		—		—		—		2.1
Balances September 30, 2019	55,812,702	$	0.5	51,769,784	$	0.5	$	2,008.9	3,732,625	$	(56.4)	$	(96.7)	$	(673.5)	$	1,183.3

Condensed Consolidated Statements of Stockholders’ Equity

For the Nine Months Ended September 30, 2018

Dividends declared:

Class A common stock, $0.20/share

—

—

—

—

—

—

—

—

(10.6)

(10.6)
Class B common stock, $0.20/share

—

—

—

—

—

—

—

—

(15.3)

(15.3)
Special dividend declared:

Class A common stock, $1.55/share

—

—

—

—

—

—

—

—

(82.7)

(82.7)
Class B common stock, $1.55/share

—

—

—

—

—

—

—

—

(80.2)

(80.2)
Stock-based compensation

—

—

—

—

4.2

—

—

—

—

4.2
Class B common stock repurchase and cancellation

—

—

(24,057,143)

(0.3)

(256.7)

—

—

—

(165.9)

(422.9)
Balances September 30, 2018

55,401,325

$
0.5

51,769,784

$
0.5

$
1,994.5

3,732,625

$
(56.4)

$
26.0

$
(710.6)

$
1,254.5

~~Consolidated Statements of Stockholder’s Equity~~

~~For the Nine Months Ended September 30, 2017~~

Accumulated

Class A Voting

Class B Voting

Additional

Other

Accumulated

Total

Common Stock

Common Stock

Paid-in

Treasury Stock

Comprehensive

Earnings

Stockholders’
(In millions, except share and per share data)

Shares

Amount

Shares

Amount

Capital

Shares

Amount

Income (Loss)

(Deficit)

Equity
Balances December 31, 2016

34,236,561

$
0.3

75,826,927

$
0.8

$
1,627.3

36,769

$
(0.7)

$
(2.5)

$
384.4

$
2,009.6
Net earnings

—

—

—

—

—

—

—

—

8.4

8.4
Other comprehensive loss

—

—

—

—

—

—

—

(1.9)

—

(1.9)
Dividends declared:

Class A common stock, $0.20/share

—

—

—

—

—

—

—

—

(11.1)

(11.1)
Class B common stock, $0.20/share

—

—

—

—

—

—

—

—

(15.2)

(15.2)
Additional offering

20,330,874

0.2

—

—

617.5

—

—

—

—

617.7
RSUs surrendered to pay for payroll taxes

393,413

—

—

—

(6.5)

—

—

—

—

(6.5)
Stock-based compensation

13,684

—

—

—

(0.4)

—

—

—

—

(0.4)
Balances March 31, 2017

54,974,532

$
0.5

75,826,927

$
0.8

$
2,237.9

36,769

$
(0.7)

$
(4.4)

$
366.5

$
2,600.6
Net loss

—

—

—

—

—

—

—

—

(176.5)

(176.5)
Other comprehensive income

—

—

—

—

—

—

—

76.5

—

76.5
Dividends declared:

Class A common stock, $0.20/share

—

—

—

—

—

—

—

—

(11.2)

(11.2)
Class B common stock, $0.20/share

—

—

—

—

—

—

—

—

(15.2)

(15.2)
Additional offering

—

—

—

—

(0.9)

—

—

—

—

(0.9)
Stock-based compensation

—

—

��

3.0

—

—

—

—

3.0
RSUs surrendered to pay for payroll taxes

795

—

—

—

—

—

—

—

—

—
Reclassification from temporary equity

27,197

—

—

—

0.3

—

—

—

—

0.3
Balances June 30, 2017

55,002,524

$
0.5

75,826,927

$
0.8

$
2,240.3

36,769

$
(0.7)

$
72.1

$
163.6

$
2,476.6
Net loss

—

—

—

—

—

—

—

—

(42.7)

(42.7)
Other comprehensive income

—

—

—

—

—

—

—

33.7

—

33.7
Dividends declared:

Class A common stock, $0.20/share

—

—

—

—

—

—

—

—

(11.2)

(11.2)
Class B common stock, $0.20/share

—

—

—

—

—

—

—

—

(15.2)

(15.2)
Stock-based compensation

—

—

—

—

(0.3)

—

—

—

—

(0.3)

Class A common stock repurchases

—

—

—

—

—

1,068,300

(16.5)

—

—

(16.5)
Balances September 30, 2017

55,002,524

$
0.5

75,826,927

$
0.8

$
2,240.0

1,105,069

$
(17.2)

$
105.8

$
94.5

$
2,424.4

NOTE 8—INCOME TAXES

The Company’s worldwide effective income tax rate is based on expected income, statutory rates, valuation allowances against deferred tax assets and tax planning opportunities available in the various jurisdictions in which it operates. For interim financial reporting, the Company estimates the worldwide annual income tax rate based on projected taxable income (loss) for the full year and records a quarterly income tax provision or benefit in accordance with the anticipated annual rate, adjusted for discrete items, if any. The Company refines the estimates of the year’s taxable income (loss) as new information becomes available, including actual year-to-date financial results. This continual estimation process often results in a change to the expected worldwide effective income tax rate for the year. When this occurs, the Company adjusts the income tax provision during the quarter in which the change in estimate occurs so that the year-to-date provision reflects the expected income tax rate. Significant judgment is required in determining the effective tax rate. The Company recognizes income tax-related interest expense and penalties as income tax expense and general and administrative expense, respectively.

At September 30, ~~2018~~2019 and December 31, ~~2017,~~2018, the Company has net deferred tax liabilities of ~~$14.8~~$19.1 million and ~~$20.7~~$13.0 million, respectively. During the fourth quarter of 2017, the Company determined that it was appropriate to record a valuation allowance against U.S. deferred tax assets. In addition, several international jurisdictions carry valuation allowances against their deferred tax assets. As a result, the effective tax rate for the ~~period~~nine months ended September 30, ~~2018~~2019 reflects the impact of these valuation allowances against U.S. and international deferred tax assets generated during the nine month period. For the remainder of ~~2018,~~2019, the Company anticipates income tax expense will relate ~~solely~~ to domestic state tax expense, changes in domestic indefinite-lived liabilities, and international tax expense incurred in certain profitable jurisdictions. The Company evaluates its deferred tax assets each period to determine if a valuation allowance is required based on whether it is “more likely than not” that some portion of the deferred tax assets would not be realized. The ultimate realization of these deferred tax assets is dependent upon the generation of sufficient taxable income during future periods on a federal, state and foreign jurisdiction basis. The Company conducts its evaluation by considering all available positive and negative evidence, including historical operating results, forecasts of future profitability, the duration of statutory carryforward periods, and the outlooks for the U.S. motion picture and broader economy, among others.

The projected worldwide effective tax rate based on annual projected earnings for the year ending December 31, ~~2018~~2019 is ~~(3.4)~~(8.0)%. The actual effective rate for the nine months ended September 30, ~~2018~~2019 was ~~(27.9)~~(8.7)%. The Company’s consolidated tax rate for the nine months ended September 30, ~~2018~~2019 differs from the U.S. statutory tax rate primarily due to the valuation allowances in U.S. and foreign jurisdictions, foreign tax rate differences, federal and state tax credits, partially offset by state income taxes, permanent differences related to interest, compensation, and other discrete items.

Tax contingencies and other income tax liabilities were ~~$18.1~~$25.8 million and ~~$15.3~~$22.0 million as of September 30, ~~2018~~2019 and December 31, ~~2017,~~2018, respectively, and are included in other long-term liabilities. The increase relates primarily to state income taxes and state income tax credits. The Company also continues to be subject to examination by the IRS and the fiscal year ended March 29, 2012 (tax year 2011) is currently under extended statute. The Company’s operations in certain jurisdictions outside of the U.S. remain subject to examination for tax years 2012 to ~~2016,~~2018, some of which are currently under audit by local tax authorities. The resolutions of these audits are not expected to be material to the Company’s condensed consolidated financial statements. The Company believes its allowances for income tax contingencies are adequate. Based on the information currently available, the Company does not anticipate a material (or significant) increase or decrease to its tax contingencies within the next 12 months.

On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the “Tax Reform Act”). The legislation significantly changed U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system and imposing a repatriation tax on deemed repatriated earnings of foreign subsidiaries. The Tax Reform Act permanently reduced the U.S. corporate income tax rate from a maximum of 35% to a 21% rate, effective January 1, 2018.

While the Tax Reform Act provides for a territorial tax system, beginning in 2018, it includes the global intangible low-taxed income (“GILTI”) provisions. The GILTI provisions require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. For ~~2018,~~2019, the Company ~~has determined the~~does not anticipate a GILTI provisions could accelerate the utilization of its domestic net operating loss carryforwards. However, the Company’s effective tax rate is not impacted due to the valuation allowance established against domestic deferred tax assets in the fourth quarter of 2017.inclusion.

Level 1:	Quoted market prices in active markets for identical assets or liabilities.
Level 2:	Observable market based inputs or unobservable inputs that are corroborated by market data.
Level 3:	Unobservable inputs that are not corroborated by market data.

(1)

The investments relate to a non-qualified deferred compensation ~~arrangement~~arrangements on behalf of certain members of management. The Company has an equivalent liability for this related-party transaction recorded in other long-term liabilities for the deferred compensation obligation.

all impact the value of the derivative ~~instrument.~~instruments. The Company re-values the derivative ~~instrument~~instruments at the end of each reporting period and any changes are recorded in other expense (income) in the condensed consolidated statements of operations.

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2017
Beginning balance, December 31, 2017 and December 31, 2016, respectively

$
27.5

$
34.6
Theatre and other closure expense

3.1

1.1
Transfer of assets and liabilities

1.0

1.2
Foreign currency translation adjustment

(0.3)

1.0
Cash payments

(9.9)

(8.3)
Ending balance

$
21.4

$
29.6

~~NOTE 11—~~ACCUMULATED OTHER COMPREHENSIVE ~~INCOME~~LOSS

The following table presents the change in accumulated other comprehensive income (loss) by component:

Unrealized Net

Unrealized Net

Pension and

Gain from

Gain from Equity

Foreign

Other

Marketable

Method Investees’

(In millions)

Currency

Benefits

Securities

Cash Flow Hedge

Total

Balance, December 31, 2017

$
129.9

$
(6.6)

$
0.6

$
1.7

$
125.6

Other comprehensive income (loss) before reclassifications

(101.6)

(1.4)

—

0.2

(102.8)

Amounts reclassified from accumulated other comprehensive income

1.0

—

—

(2.2)

(1.2)

Other comprehensive income (loss)

(100.6)

(1.4)

—

(2.0)

(104.0)

Adoption of ASU 2016-01 - reclassification to retained earnings

—

—

(0.6)

—

(0.6)

Adoption of ASU 2018-02 - reclassification to retained earnings

4.0

0.6

—

0.4

5.0

Balance, September 30, 2018

$
33.3

$
(7.4)

$
—

$
0.1

$
26.0


					Unrealized Net
						Gain (Loss)
			Pension and		from Equity
	Foreign		Other		Method Investees’
(In millions)	Currency		Benefits (1)		Cash Flow Hedge		Total
Balance, December 31, 2018	$	7.2	$	(1.8)	$	0.1	$	5.5
Other comprehensive income (loss) before reclassifications		(102.9)		0.2		(0.1)		(102.8)
Amounts reclassified from accumulated other comprehensive income		0.6		—		—		0.6
Balance, September 30, 2019	$	(95.1)	$	(1.6)	$	—	$	(96.7)

The tax effects allocated to each component of other comprehensive ~~income (loss)~~loss during the three months ended September 30, ~~2018~~2019 and September 30, ~~2017~~2018 are as follows:


	Three Months Ended
	September 30, 2019						September 30, 2018
			Tax						Tax
	Pre-Tax		(Expense)		Net-of-Tax		Pre-Tax		(Expense)		Net-of-Tax
(In millions)	Amount		Benefit		Amount		Amount		Benefit		Amount
Unrealized foreign currency translation adjustment (1)	$	(68.2)	$	—	$	(68.2)	$	(5.7)	$	—	$	(5.7)
Pension and other benefit adjustments:
Net gain (loss) arising during the period		0.1		—		0.1		0.2		(0.1)		0.1
Equity method investee's cash flow hedge:
Realized net (gain) loss reclassified into equity in earnings of non-consolidated entities		—		—		—		(2.5)		0.6		(1.9)
Other comprehensive income (loss)	$	(68.1)	$	—	$	(68.1)	$	(8.0)	$	0.5	$	(7.5)

Three Months Ended

September 30, 2018

September 30, 2017




Tax





Tax


Pre-Tax

(Expense)

Net-of-Tax

Pre-Tax

(Expense)

Net-of-Tax
(In millions)

Amount

Benefit

Amount

Amount

Benefit

Amount
Unrealized foreign currency translation adjustment (1)

$
(5.7)

$
—

$
(5.7)

$
39.0

$
(4.6)

$
34.4
Pension and other benefit adjustments:

Net gain arising during the period

0.2

(0.1)

0.1

—

—

—
Marketable securities:

Unrealized net holding gain (loss) arising during the period

—

—

—

0.4

(0.2)

0.2
Equity method investees' cash flow hedge:

Unrealized net holding loss arising during the period

—

—

—

0.1

—

0.1
Realized net loss reclassified into equity in earnings of non-consolidated entities

(2.5)

0.6

(1.9)

(1.6)

0.6

(1.0)
Other comprehensive income (loss)

$
(8.0)

$
0.5

$
(7.5)

$
37.9

$
(4.2)

$
33.7

(1)

Deferred tax impacts of foreign currency translation for the ~~Odeon and Nordic~~ international operations have not been recorded due to the Company’s intent to remain permanently invested.

(1)

Deferred tax impacts of foreign currency translation for the ~~Odeon and Nordic~~ international operations have not been recorded due to the Company’s intent to remain permanently invested.

Three Months Ended

Nine Months Ended
Adjusted EBITDA (1) (In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
U.S. markets (2)

$
105.0

$
107.6

$
535.6

$
420.6
International markets

37.4

39.8

129.5

113.7
Total Adjusted EBITDA

$
142.4

$
147.4

$
665.1

$
534.3

(1)

The Company presents Adjusted EBITDA as a supplemental measure of its performance. The Company defines Adjusted EBITDA as net earnings (loss) plus (i) income tax provision (benefit), (ii) interest expense and (iii) depreciation and amortization, as further adjusted to eliminate the impact of certain items that the Company does not consider indicative of its ongoing operating performance and to include attributable

(2)

Distributions from NCM are reported entirely within the U.S. markets segment.

As of

As of
Long-term assets, net (In millions)

September 30, 2018

December 31, 2017
United States

$
5,775.9

$
5,866.8
International

2,900.6

3,066.7
Total long-term assets (1)

$
8,676.5

$
8,933.5

(1)

Long-term assets are comprised of property, intangible assets, goodwill, deferred income tax assets and other long-term assets, and for 2019, right-of-use assets.

(1)

Amounts represent preopening expense related to temporarily closed screens under renovation, theatre and other closure expense for the permanent closure of screens including the related accretion of interest, non-cash deferred digital equipment rent expense, and disposition of assets and other non-operating gains or losses included in operating expenses. The Company has excluded these items as they are non-cash in nature, include components of interest cost for the time value of money or are non-operating in nature.

(2)

~~During~~For the three and nine months ended September 30, 2019, the Company recorded $6.5 million and $21.1 million, respectively, in earnings from DCIP. For the three months ended September 30, 2018, wethe Company recorded equity in earnings related to ~~our~~its sale of all remaining NCM units of $28.9 million and a gain of $30.1 million related to the Screenvision merger. Equity in ~~loss~~earnings of non-consolidated entities also includes loss on the surrender (disposition) of a portion of ~~our~~the Company’s investment in NCM of $1.1 million during the ~~three~~nine months ended ~~March 31,~~September 30, 2018. Equity in ~~(earnings) loss~~earnings of non-consolidated entities ~~includes a lower of carrying value or fair value impairment loss of the held-for sale portion of our investment in NCM of $16.0 million~~ for the nine months ended September 30, ~~2018. The nine months ended September 30, 2017 included an other-than-temporary~~2018 includes a lower of carrying value impairment ~~loss of $204.5 million, on our investment in NCM. The three months ended September 30, 2017 included a~~ loss on the ~~sale~~held-for-sale portion of NCM ~~shares~~ of ~~$21.0~~$16.0 million. The impairment charges reflect recording our held-for-sale units and other-than-temporary impaired shares at the publicly quoted per share price on March 31, 2018 of $5.19 and June 30, 2017 of $7.42.

(3)

IncludesU.S. non-theatre distributions from equitymethod investments and International ~~non-theatre~~ non-theatredistributions fromequitymethod investments to the extent received. The Company believes includingcash distributionsis an appropriatereflection ofthe contribution of ~~the contribution of~~ these investments to its operations.

(4)

Attributable EBITDA includes the EBITDA from equity investments in theatre operators in certain international markets. See below for a reconciliation of the Company’s equity loss of non-consolidated entities to attributable EBITDA. Because these equity investments are in theatre operators in regions where the Company holds a significant market share, the Company believes attributable EBITDA is more indicative of the performance of these equity investments and management uses this measure to monitor and evaluate these equity investments. The Company also provides services to these theatre operators including information technology systems, certain on-screen advertising services and ~~our~~its gift card and package ticket program. ~~As these investments relate only~~

Three Months Ended

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
Equity in (earnings) loss of non-consolidated entities

$
(70.0)

$
1.8

$
(74.0)

$
199.1
Less:

Equity in (earnings) loss of non-consolidated entities excluding international theatre JV's

(68.5)

2.1

(72.1)

199.6
Equity in earnings (loss) of International theatre JV's

1.5

0.3

1.9

0.5
Income tax provision

0.1

—

0.2

—
Investment income

(0.1)

—

(0.3)

—
Depreciation and amortization

0.6

0.5

1.9

1.3
Attributable EBITDA

$
2.1

$
0.8

$
3.7

$
1.8

~~(5)~~

$54.1 million as a result of an increase in fair value of the derivative liability for the Convertible Notes due 2024. Other expense (income) for the three and nine months ended September 30, 2018 includes financing losses and financing related foreign currency transaction losses. ~~During~~

(6)

Reflects amortization of certain intangible assets reclassified from depreciation and amortization to rent expense, due to the ~~three months ended September 30, 2018, we recorded expense~~adoption of ~~$54.1 million as a result of an increase in fair value of our derivative liability for the Convertible Notes due 2024.~~

ASC 842.

~~(6)~~

(7)

Merger, acquisition and ~~transition~~other costs are excluded as they are non-operating in nature.

~~(7)~~

(8)

Stock-based compensation expense is non-cash ~~or non-recurring~~ expense included in general and administrative: other.

NOTE ~~13—EMPLOYEE BENEFIT PLANS~~

The Company sponsors frozen non-contributory qualified and non-qualified defined benefit pension plans generally covering all employees who, prior to the freeze, were age 21 or older and had completed at least 1,000 hours of service in their first twelve months of employment, or in a calendar year ending thereafter, and who were not covered by a collective bargaining agreement. The Company also sponsors a postretirement deferred compensation plan.

~~Net periodic benefit cost (credit) recognized for the plans in other expense (income)~~ ~~during the three months ended September 30, 2018 and September 30, 2017 consists of the following:~~

U.S. Pension Benefits

International Pension Benefits

Three Months Ended

Three Months Ended
(In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017

Components of net periodic benefit cost:

Interest cost

$
1.0

$
1.1

$
0.6

$
0.7
Expected return on plan assets

(0.8)

(0.8)

(0.8)

(0.8)
Net periodic benefit cost (credit)

$
0.2

$
0.3

$
(0.2)

$
(0.1)

~~Net periodic benefit cost (credit) recognized for the plans in other expense (income) during the nine months ended September 30, 2018 and September 30, 2017 consist of the following:~~

U.S. Pension Benefits

International Pension Benefits

Nine Months Ended

Nine Months Ended

(In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017

Components of net periodic benefit cost:

Interest cost

$
3.0

$
3.2

$
2.0

$
2.0

Expected return on plan assets

(2.4)

(2.4)

(2.5)

(2.4)

Net periodic benefit cost (credit)

$
0.6

$
0.8

$
(0.5)

$
(0.4)

~~Net periodic service cost (credit) recognized for the plans in general and administrative: other:~~ ~~during the three months ended September 30, 2018 and September 30, 2017 consists of the following:~~

~~Net periodic service cost (credit) recognized for the plans in general and administrative: other:~~ ~~during the nine months ended September 30, 2018 and September 30, 2017 consists of the following:~~

~~NOTE 14—~~12—COMMITMENTS AND CONTINGENCIES

The Company, in the normal course of business, is a party to various ordinary course claims from vendors (including food and beverage suppliers and film distributors), landlords, competitors, and other legal proceedings. If management believes that a loss arising from these actions is probable and can reasonably be estimated, the Company records the amount of the loss, or the minimum estimated liability when the loss is estimated using a range and no point is more probable than another. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of such matters discussed below, individually and in the aggregate, will not have a material adverse effect on the Company’s ~~consolidated~~ financial position or overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur. An unfavorable outcome might include monetary damages. If an unfavorable outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods.

On January 12, 2018 and January 19, 2018, ~~two~~2 putative federal securities class actions, captioned Hawaii Structural ~~Iron workers~~Ironworkers Pension Trust Fund v. AMC Entertainment Holdings, Inc., et al., Case No. 1:18-cv-00299-AJN (the “Hawaii Action”), and Nichols v. AMC Entertainment Holdings, Inc., et al., Case No. 1:18-cv-00510-AJN (the “Nichols Action,” and together with the Hawaii Action, the “Actions”), respectively, were filed against the Company in the U.S. District Court for the Southern District of New York. The Actions, which name certain of the Company’s officers and directors and, in the case of the Hawaii Action, the underwriters of the Company’s February 8, 2017 secondary public offering, as defendants, ~~asserted~~assert claims under ~~some or all of~~ Sections 11, 12(a)(2) and 15 of the Securities Act of 1933

and Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 with respect to alleged material misstatements and omissions in the registration statement for the secondary public offering and in certain other public disclosures. On May 30, 2018, the court consolidated the ~~Actions and appointed~~Actions. On January 22, 2019, the International Union of Operating Engineers Pension Fund of Eastern Pennsylvania and Delaware as lead plaintiff. On August 13, 2018, lead plaintiff and additional named plaintiff Hawaii Structural Iron Workers Pension Trust Fund filed a Consolidateddefendants moved to dismiss the Second Amended Class Action Complaint. On ~~October 12, 2018, the defendants filed motions to dismiss the Consolidated Class Action Complaint. On October 24, 2018,~~September 23, 2019, the court granted ~~lead plaintiff’s~~the motion to dismiss in part and ~~Hawaii Structural Iron Workers Pension Trust Fund’s request that they be permitted to file an amended complaint on or before November 21, 2018.~~ denied it in part.

On May 21, 2018, a stockholder derivative complaint, captioned Gantulga v. Aron, et al., Case No. 2:18-cv-02262-JAR-TJJ (the “Gantulga Action”), was filed against certain of the Company’s officers and directors in the U.S. District Court for the District of Kansas. The Gantulga Action, which was filed on behalf of the Company, asserts claims under Section 14(a) of the Securities Exchange Act of 1934 and for breaches of fiduciary duty and unjust enrichment based on allegations substantially similar to the Actions.On August 27, 2018, defendants and the Company as nominal defendant filed a motion to dismiss or, in the alternative, to transfer the action to the U.S. District Court for the Southern District of New York. On September 17, 2018, plaintiff filed an amended complaint. On October 12, 2018, the parties filed a joint motion to transfer the action to the U.S. District Court for the Southern District of New York, which the court granted on October 15, 2018. When the action was transferred to the Southern District of New York, it was re-captioned Gantulga v. Aron, et al., Case No. 1:18-cv-10007-AJN. The parties filed a joint stipulation to stay the action, which the court granted on December 17, 2018.

On October 2, 2019, a stockholder derivative complaint, captioned Kenna v. Aron, et al., Case No. 1:19-cv-09148 (the “Kenna Action”), was filed in the U.S. District Court for the Southern District of New York. The Kenna Action asserts the same claims as the Gantulga Action based on substantially similar allegations. The parties filed a joint stipulation to stay the action, which the court granted on October 17, 2019.

On ~~June 25, 2018,~~April 22, 2019, a putative stockholder class and derivative complaint, captioned Lao v. Dalian Wanda Group Co., Ltd., et al., C.A. No. 2019-0303-JRS (the “Lao Action”), was filed against certain of the Company’s directors, Wanda, two of Wanda’s affiliates, Silver Lake, and one of Silver Lake’s affiliates in the Delaware Court of Chancery. The Lao Action asserts claims directly, on behalf of a putative class of Company stockholders, and derivatively, on behalf of the Company, ~~received a letter from a purported stockholder demanding~~for breaches of fiduciary duty and aiding and abetting breaches of fiduciary duty with respect to ~~inspect certain~~transactions that the Company entered into with affiliates of

$1.55 per share of common stock that was payable on September 28, 2018 to the Company’s ~~books and records pursuant to 8~~ ~~Del. C.~~ ~~§ 220 in order~~stockholders of record as of September 25, 2018. On July 18, 2019, the Company’s Board of Directors formed a Special Litigation Committee to investigate and evaluate the claims and allegations ~~substantially similar to those alleged~~asserted in the ~~Actions (the “Demand”).~~ ~~On July 2, 2018,~~Lao Action and make a determination as to how the Company ~~rejected~~should proceed with respect to the ~~Demand~~.Lao Action. On October 25, 2019, the court granted a motion to stay the action for six months to allow the Special Litigation Committee to complete its investigation.

The Company ~~believes~~remains contingently liable for lease payments under certain leases of theatres that it previously divested, in the ~~claims lack merit and intends~~event that such assignees are unable to ~~vigorously defend all claims asserted.~~

~~On May 28, 2015,~~fulfill their future lease payment obligations. Due to the variety of remedies available, the Company ~~received~~believes that if the current tenant defaulted on the leases it would not have a ~~Civil Investigative Demand (“CID”) from~~material effect on the ~~Antitrust Division~~Company’s financial condition, results of the United States Department of Justice in connection with an investigation under Sections 1 and 2 of the Sherman Antitrust Act. Beginning in May 2015, the Company also received CIDs from the Attorneys General for the States of Ohio, Texas, Washington, Florida, New York, Kansas, and from the District of Columbia, regarding similar inquiries under those states’ antitrust laws. The CIDs requested the production of documents and answers to interrogatories concerning potentially anticompetitive conduct, including film clearances and participation in certain joint ventures. On September 17, 2018, the Attorney General for the State of Texas closed its investigation without taking action. The Company does not believe it has violated federaloperations or ~~state antitrust laws and is cooperating with the relevant governmental authorities. However, the Company cannot predict the ultimate scope, duration or outcome of these investigations.~~cash flows.

NOTE ~~15—EARNINGS (LOSS)~~13—LOSS PER SHARE

Basic net ~~earnings (loss)~~loss per share is computed by dividing net ~~earnings (loss)~~loss by the weighted-average number of common shares outstanding. Diluted ~~earnings~~loss per share includes the effects of ~~unvested RSU’s with a service condition only and unvested contingently issuable RSUs and PSUs that have service and performance conditions, if dilutive, as well as~~ potential dilutive shares from the conversion feature of the Convertible Notes due 2024, if dilutive.

The following table sets forth the computation of basic and diluted earnings (loss) per common share:


	Three Months Ended				Nine Months Ended

									Three Months Ended				Nine Months Ended
(In millions)	September 30, 2018		September 30, 2017		September 30, 2018		September 30, 2017		September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
Numerator:
Net loss	$	(100.4)	$	(42.7)	$	(60.5)	$	(210.8)
Net loss for basic loss per share									$	(54.8)	$	(100.4)	$	(135.6)	$	(60.5)
Net loss for diluted loss per share									$	(54.8)	$	(100.4)	$	(135.6)	$	(60.5)

Denominator (shares in thousands):
Weighted average shares for basic earnings (loss) per common share		123,126		131,077		126,386		127,902
Common equivalent shares for RSUs and PSUs		—		—		—		—
Shares for diluted loss per common share		123,126		131,077		126,386		127,902
Weighted average shares for basic loss per common share										103,850		123,126		103,826		126,386
Common equivalent shares if converted: convertible notes 2024										—		—		—		—
Weighted average shares for diluted loss per common share										103,850		123,126		103,826		126,386
Basic loss per common share	$	(0.82)	$	(0.33)	$	(0.48)	$	(1.65)	$	(0.53)	$	(0.82)	$	(1.31)	$	(0.48)
Diluted loss per common share	$	(0.82)	$	(0.33)	$	(0.48)	$	(1.65)	$	(0.53)	$	(0.82)	$	(1.31)	$	(0.48)

Vested RSUs and PSU’s have dividend rights identical to the Company’s Class A and Class B common stock and are treated as outstanding shares for purposes of computing basic and diluted earnings per share. Certain unvested RSUs and unvested PSUs are subject to performance conditions and are included in diluted earnings per share, if dilutive, based on the number of shares, if any, that would be issuable under the terms of the Company’s 2013 Equity Incentive Plan if the end of the reporting period were the end of the contingency period. ~~During~~For the nine months ended September 30, 2019, unvested PSU’s of 488,931 at the minimum performance target were not included in the computation of diluted loss per share because they would not be issuable if the end of the reporting period were the end of the contingency period. For the nine months ended September 30, 2019, unvested RSU’s of 1,207,102 were not included in the computation of diluted loss per share because they would be anti-dilutive.

For the nine months ended September 30, 2018, unvested PSU’s of 411,657 at the minimum performance target were not included in the computation of diluted ~~earnings (loss)~~loss per share since the shares would not be issuable under the terms of the Plan, if the end of the reporting period were the end of the contingency ~~period and they would also be anti-dilutive. During~~period. For the nine months ended September 30, 2018, unvested RSU’s of 902,004 were not included in the computation of diluted ~~earnings (loss)~~loss per share because they would be anti-dilutive.

The Company uses the if-converted method for calculating any potential dilutive effect of the Convertible Notes due ~~2024.~~2024 that were issued on September 14, 2018. The Company has not adjusted net loss for the three and nine months ended September 30, 2019 to eliminate the interest expense of $8.2 million and $24.2 million, respectively, and the loss (gain) for the derivative liability related to the Convertible Notes due 2024 of $5.7 million and $(14.9) million, respectively, in the computation of diluted loss per share because the effects would be anti-dilutive. The Company has not included in diluted weighted average shares of approximately 31.7 million shares issuable upon conversion for the three and nine months ended September 30, 2019, as the effects would be anti-dilutive. For the three and nine months ended September 30, 2018, the Company has not adjusted net loss to eliminate the interest expense or the ~~charge~~change for the derivative liability related to the Convertible Notes due 2024 of $1.5 million and $54.1 million, respectively. The Company has not included in diluted weighted average shares approximately 5.9 million shares and 2.0 million shares upon conversion for the three and nine months ended September 30, 2018, respectively, as the effects would be anti-dilutive. Based on the current conversion price of $18.95 per share the Convertible Notes due 2024 are convertible into 31,662,269 Class A common shares.

NOTE ~~16—~~14—CONDENSED CONSOLIDATING FINANCIAL INFORMATION

The accompanying condensed consolidating financial information has been prepared and presented pursuant to SEC Regulation S-X Rule 3-10, Financial statements of guarantors and issuers of guaranteed securities registered or being registered. Each of the subsidiary guarantors are 100% owned by Holdings. The subsidiary guarantees of the Company’s Sterling Notes due ~~2022,~~2024, the ~~Sterling~~Convertible Notes due 2024, the Notes due 2025, the Notes due 2026, and the Notes due 2027 are full and unconditional and joint and several and subject to customary release provisions. The Company and its subsidiary guarantors’ investments in its consolidated subsidiaries are presented under the equity method of accounting.

The condensed consolidating information for the guarantors/non-guarantors has been retrospectively revised based on the structure that exists as of September 30, 2019 and reflecting changes as a result of the Sixth Amendment.

Condensed Consolidating Statement of Operations

Three Months Ended September 30, 2019:


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Revenues
Admissions	$	—	$	578.1	$	219.2	$	—	$	797.3
Food and beverage		—		327.1		92.9		—		420.0
Other theatre		—		65.6		33.9		—		99.5
Total revenues		—		970.8		346.0		—		1,316.8
Operating costs and expenses
Film exhibition costs		—		321.6		95.2		—		416.8
Food and beverage costs		—		46.5		20.7		—		67.2
Operating expense, excluding depreciation and amortization		—		303.7		115.3		—		419.0
Rent		—		175.0		63.7		—		238.7
General and administrative:
Merger, acquisition and other costs		—		2.3		2.4		—		4.7
Other, excluding depreciation and amortization		—		22.1		15.4		—		37.5
Depreciation and amortization		—		84.2		27.9		—		112.1
Operating costs and expenses		—		955.4		340.6		—		1,296.0
Operating income		—		15.4		5.4		—		20.8
Other expense (income):
Equity in net loss of subsidiaries		72.6		15.5		—		(88.1)		—
Other expense (income)		(2.7)		1.1		0.3		—		(1.3)
Interest expense:
Corporate borrowings		72.6		73.3		0.7		(73.4)		73.2
Capital and financing lease obligations		—		0.5		1.3		—		1.8
Non-cash NCM exhibitor service agreement		—		10.1		—		—		10.1
Intercompany interest expense		—		—		18.8		(18.8)		—
Equity in earnings of non-consolidated entities		—		(7.1)		(0.4)		—		(7.5)
Investment income		(87.7)		(5.0)		—		92.2		(0.5)
Total other expense		54.8		88.4		20.7		(88.1)		75.8
Loss before income taxes		(54.8)		(73.0)		(15.3)		88.1		(55.0)
Income tax provision (benefit)		—		(0.4)		0.2		—		(0.2)
Net loss	$	(54.8)	$	(72.6)	$	(15.5)	$	88.1	$	(54.8)

Condensed Consolidating Statement of Operations

Three Months Ended September 30, 2018:


			Subsidiary		Subsidiary		Consolidating		Consolidated

													Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings		Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Revenues
Admissions	$	—	$	446.6	$	304.8	$	—	$	751.4	$	—	$	539.0	$	212.4	$	—	$	751.4
Food and beverage		—		240.5		144.3		—		384.8		—		301.4		83.4		—		384.8
Other theatre		—		49.4		35.8		—		85.2		—		55.2		30.0		—		85.2
Total revenues		—		736.5		484.9		—		1,221.4		—		895.6		325.8		—		1,221.4
Operating costs and expenses
Film exhibition costs		—		240.8		138.0		—		378.8		—		289.0		89.8		—		378.8
Food and beverage costs		—		37.2		26.4		—		63.6		—		43.9		19.7		—		63.6
Operating expense, excluding depreciation and amortization		—		227.3		173.2		—		400.5		—		283.6		116.9		—		400.5
Rent		—		127.9		75.8		—		203.7		—		152.1		51.6		—		203.7
General and administrative:
Merger, acquisition and transaction costs		—		9.0		9.1		—		18.1
Merger, acquisition and other costs												—		9.0		9.1		—		18.1
Other, excluding depreciation and amortization		—		31.7		16.7		—		48.4		—		31.7		16.7		—		48.4
Depreciation and amortization		—		69.2		61.0		—		130.2		—		94.2		36.0		—		130.2
Operating costs and expenses		—		743.1		500.2		—		1,243.3		—		903.5		339.8		—		1,243.3
Operating loss		—		(6.6)		(15.3)		—		(21.9)		—		(7.9)		(14.0)		—		(21.9)
Other expense (income):
Equity in net (earnings) loss of subsidiaries		42.5		(10.4)		—		(32.1)		—
Other expense (income)		54.1		0.5		(0.5)		—		54.1
Equity in net loss of subsidiaries												42.5		15.9		—		(58.4)		—
Other expense (income):												54.1		0.5		(0.5)		—		54.1
Interest expense:
Corporate borrowings		63.6		59.8		0.8		(59.9)		64.3		63.6		59.8		0.8		(59.9)		64.3
Capital and financing lease obligations		—		1.7		7.7		—		9.4		—		4.2		5.2		—		9.4
Non-cash NCM exhibitor service agreement		—		10.3		—		—		10.3		—		10.3		—		—		10.3
Equity in earnings of non-consolidated entities		—		(37.2)		(32.8)		—		(70.0)		—		(67.4)		(2.6)		—		(70.0)
Investment income		(59.8)		(0.9)		0.1		59.9		(0.7)		(59.8)		(0.8)		—		59.9		(0.7)
Total other expense (income)		100.4		23.8		(24.7)		(32.1)		67.4
Earnings (loss) before income taxes		(100.4)		(30.4)		9.4		32.1		(89.3)
Total other expense												100.4		22.5		2.9		(58.4)		67.4
Loss before income taxes												(100.4)		(30.4)		(16.9)		58.4		(89.3)
Income tax provision (benefit)		—		12.1		(1.0)		—		11.1		—		12.1		(1.0)		—		11.1
Net earnings (loss)	$	(100.4)	$	(42.5)	$	10.4	$	32.1	$	(100.4)
Net loss											$	(100.4)	$	(42.5)	$	(15.9)	$	58.4	$	(100.4)

Condensed Consolidating Statement of Operations

Nine Months Ended September 30, 2019:


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Revenues
Admissions	$	—	$	1,774.1	$	650.2	$	—	$	2,424.3
Food and beverage		—		1,015.8		265.5		—		1,281.3
Other theatre		—		209.2		108.5		—		317.7
Total revenues		—		2,999.1		1,024.2		—		4,023.3
Operating costs and expenses
Film exhibition costs		—		989.2		275.4		—		1,264.6
Food and beverage costs		—		145.6		59.5		—		205.1
Operating expense, excluding depreciation and amortization		—		910.2		349.0		—		1,259.2
Rent		—		531.1		195.5		—		726.6
General and administrative:
Merger, acquisition and other costs		—		5.8		5.4		—		11.2
Other, excluding depreciation and amortization		—		74.4		52.5		—		126.9
Depreciation and amortization		—		252.1		85.0		—		337.1
Operating costs and expenses		—		2,908.4		1,022.3		—		3,930.7
Operating income		—		90.7		1.9		—		92.6
Other expense (income):
Equity in net loss of subsidiaries		376.3		230.7		—		(607.0)		—
Other expense (income)		(14.7)		19.2		0.6		—		5.1
Interest expense:
Corporate borrowings		217.1		218.6		2.2		(219.2)		218.7
Capital and financing lease obligations		—		1.9		4.1		—		6.0
Non-cash NCM exhibitor service agreement		—		30.4		—		—		30.4
Intercompany interest expense		—		—		237.7		(237.7)		—
Equity in earnings of non-consolidated entities		—		(23.2)		(1.0)		—		(24.2)
Investment income		(443.1)		(19.5)		(13.0)		456.9		(18.7)
Total other expense		135.6		458.1		230.6		(607.0)		217.3
Loss before income taxes		(135.6)		(367.4)		(228.7)		607.0		(124.7)
Income tax provision		—		8.9		2.0		—		10.9
Net loss	$	(135.6)	$	(376.3)	$	(230.7)	$	607.0	$	(135.6)

Condensed Consolidating Statement of Operations

Nine Months Ended September, 2018:


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Revenues
Admissions	$	—	$	1,837.9	$	684.8	$	—	$	2,522.7
Food and beverage		—		982.2		254.2		—		1,236.4
Other theatre		—		187.0		101.4		—		288.4
Total revenues		—		3,007.1		1,040.4		—		4,047.5
Operating costs and expenses
Film exhibition costs		—		996.6		280.1		—		1,276.7
Food and beverage costs		—		142.4		59.6		—		202.0
Operating expense, excluding depreciation and amortization		—		866.0		370.9		—		1,236.9
Rent		—		430.8		162.3		—		593.1
General and administrative:
Merger, acquisition and other costs		—		15.2		11.9		—		27.1
Other, excluding depreciation and amortization		—		84.7		50.9		—		135.6
Depreciation and amortization		—		285.6		112.8		—		398.4
Operating costs and expenses		—		2,821.3		1,048.5		—		3,869.8
Operating income (loss)		—		185.8		(8.1)		—		177.7
Other expense (income):
Equity in net (earnings) loss of subsidiaries		(5.3)		23.4		—		(18.1)		—
Other expense		55.1		1.1		1.3		—		57.5
Interest expense:
Corporate borrowings		185.7		185.4		2.8		(185.7)		188.2
Capital and financing lease obligations		—		13.2		16.3		—		29.5
Non-cash NCM exhibitor service agreement		—		31.2		—		—		31.2
Equity in earnings of non-consolidated entities		—		(71.0)		(3.0)		—	��	(74.0)
Investment income		(175.0)		(17.4)		(0.7)		185.7		(7.4)
Total other expense (income)		60.5		165.9		16.7		(18.1)		225.0
Earnings (loss) before income taxes		(60.5)		19.9		(24.8)		18.1		(47.3)
Income tax provision (benefit)		—		14.6		(1.4)		—		13.2
Net earnings (loss)	$	(60.5)	$	5.3	$	(23.4)	$	18.1	$	(60.5)

Condensed Consolidating Statement of Comprehensive Loss

Three Months Ended September 30, ~~2017:~~2019:

Subsidiary

Subsidiary

Consolidating

Consolidated
(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings
Revenues















Admissions

$
—

$
438.2

$
315.3

$
—

$
753.5
Food and beverage

—

222.0

139.4

—

361.4
Other theatre

—

36.7

27.1

—

63.8
Total revenues

—

696.9

481.8

—

1,178.7
Operating costs and expenses

Film exhibition costs

—

221.5

143.3

—

364.8
Food and beverage costs

—

33.5

27.2

—

60.7
Operating expense, excluding depreciation and amortization

—

216.5

166.7

—

383.2
Rent

—

123.0

77.7

—

200.7
General and administrative:

Merger, acquisition and transaction costs

—

3.7

1.9

—

5.6
Other, excluding depreciation and amortization

0.3

16.4

15.9

—

32.6
Depreciation and amortization

—

72.9

62.3

—

135.2
Operating costs and expenses

0.3

687.5

495.0

—

1,182.8
Operating income (loss)

(0.3)

9.4

(13.2)

—

(4.1)
Other expense (income):

Equity in net (earnings) loss of subsidiaries

38.9

20.9

—

(59.8)

—
Other expense (income)

—

(0.1)

(0.3)

—

(0.4)
Interest expense:

Corporate borrowings

60.3

57.7

0.5

(57.7)

60.8
Capital and financing lease obligations

—

1.9

8.7

—

10.6
Equity in (earnings) loss of non-consolidated entities

—

3.8

(2.0)

—

1.8
Investment income

(56.8)

(17.0)

(0.5)

57.7

(16.6)
Total other expense

42.4

67.2

6.4

(59.8)

56.2
Loss before income taxes

(42.7)

(57.8)

(19.6)

59.8

(60.3)
Income tax benefit

—

(18.9)

1.3

—

(17.6)
Net loss

$
(42.7)

$
(38.9)

$
(20.9)

$
59.8

$
(42.7)


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Net loss	$	(54.8)	$	(72.6)	$	(15.5)	$	88.1	$	(54.8)
Other comprehensive income (loss):
Equity in other comprehensive loss of subsidiaries		(68.1)		(53.1)		—		121.2		—
Unrealized foreign currency translation adjustment, net of tax		—		(15.0)		(53.2)		—		(68.2)
Pension and other benefit adjustments:
Net gain arising during the period, net of tax		—		—		0.1		—		0.1
Other comprehensive loss		(68.1)		(68.1)		(53.1)		121.2		(68.1)
Total comprehensive loss	$	(122.9)	$	(140.7)	$	(68.6)	$	209.3	$	(122.9)

Condensed Consolidating Statement of ~~Operations~~Comprehensive Loss

Three Months Ended September 30, 2018:


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Net loss	$	(100.4)	$	(42.5)	$	(15.9)	$	58.4	$	(100.4)
Other comprehensive income (loss):
Equity in other comprehensive loss of subsidiaries		(7.5)		(5.4)		—		12.9		—
Unrealized foreign currency translation adjustment, net of tax		—		(0.2)		(5.5)		—		(5.7)
Pension and other benefit adjustments:
Net gain arising during period, net of tax		—		—		0.1		—		0.1
Equity method investee's cash flow hedge:
Realized net gain reclassified to equity in earnings of non-consolidated entities, net of tax		—		(1.9)		—		—		(1.9)
Other comprehensive loss		(7.5)		(7.5)		(5.4)		12.9		(7.5)
Total comprehensive loss	$	(107.9)	$	(50.0)	$	(21.3)	$	71.3	$	(107.9)

Condensed Consolidating Statement of Comprehensive Loss

Nine Months Ended September 30, 2019:


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Net loss	$	(135.6)	$	(376.3)	$	(230.7)	$	607.0	$	(135.6)
Other comprehensive income (loss):
Equity in other comprehensive loss of subsidiaries		(102.2)		(72.5)		—		174.7		—
Unrealized foreign currency translation adjustment, net of tax		—		(30.3)		(72.6)		—		(102.9)
Realized loss on foreign currency transactions reclassified into other expense, net of tax		—		0.6		—		—		0.6
Pension and other benefit adjustments:
Net gain arising during the period, net of tax		—		0.1		0.1		—		0.2
Equity method investee's cash flow hedge:
Unrealized net holding loss arising during the period, net of tax		—		(0.1)		—		—		(0.1)
Other comprehensive loss		(102.2)		(102.2)		(72.5)		174.7		(102.2)
Total comprehensive loss	$	(237.8)	$	(478.5)	$	(303.2)	$	781.7	$	(237.8)

Condensed Consolidating Statement of Comprehensive Loss

Nine Months Ended September 30, 2018:

Subsidiary

Subsidiary

Consolidating

Consolidated
(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings
Revenues















Admissions

$
—

$
1,514.8

$
1,007.9

$
—

$
2,522.7
Food and beverage

—

776.5

459.9

—

1,236.4
Other theatre

—

170.9

117.5

—

288.4
Total revenues

—

2,462.2

1,585.3

—

4,047.5
Operating costs and expenses

Film exhibition costs

—

824.0

452.7

—

1,276.7
Food and beverage costs

—

118.0

84.0

—

202.0
Operating expense, excluding depreciation and amortization

—

694.1

542.8

—

1,236.9
Rent

—

356.1

237.0

—

593.1
General and administrative:

Merger, acquisition and transaction costs

—

15.2

11.9

—

27.1
Other, excluding depreciation and amortization

—

84.7

50.9

—

135.6
Depreciation and amortization

—

211.4

187.0

—

398.4
Operating costs and expenses

—

2,303.5

1,566.3

—

3,869.8
Operating income

—

158.7

19.0

—

177.7
Other expense (income):

Equity in net earnings of subsidiaries

(5.3)

(26.6)

—

31.9

—
Other expense

55.1

1.1

1.3

—

57.5
Interest expense:

Corporate borrowings

185.7

185.4

2.8

(185.7)

188.2
Capital and financing lease obligations

—

5.2

24.3

—

29.5
Non-cash NCM exhibitor service agreement

—

31.2

—

—

31.2
Equity in earnings of non-consolidated entities

—

(40.1)

(33.9)

—

(74.0)
Investment income

(175.0)

(17.4)

(0.7)

185.7

(7.4)
Total other expense (income)

60.5

138.8

(6.2)

31.9

225.0
Earnings before income taxes

(60.5)

19.9

25.2

(31.9)

(47.3)
Income tax provision (benefit)

—

14.6

(1.4)

—

13.2
Net earnings (loss)

$
(60.5)

$
5.3

$
26.6

$
(31.9)

$
(60.5)


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Net earnings (loss)	$	(60.5)	$	5.3	$	(23.4)	$	18.1	$	(60.5)
Other comprehensive income (loss):
Equity in other comprehensive loss of subsidiaries		(103.9)		(75.4)		—		179.3		—
Unrealized foreign currency translation adjustment, net of tax		—		(27.5)		(74.1)		—		(101.6)
Realized loss on foreign currency transactions reclassified into other expense, net of tax		—		1.0		—				1.0
Pension and other benefit adjustments:
Net loss arising during the period, net of tax		—		—		(1.3)		—		(1.3)
Equity method investee's cash flow hedge:
Unrealized net holding gain arising during the period, net of tax		—		0.2		—		—		0.2
Realized net gain reclassified to equity in earnings of non-consolidated entities, net of tax		—		(2.2)		—		—		(2.2)
Other comprehensive loss		(103.9)		(103.9)		(75.4)		179.3		(103.9)
Total comprehensive loss	$	(164.4)	$	(98.6)	$	(98.8)	$	197.4	$	(164.4)

Condensed Consolidating Balance Sheet

As of September 30, 2019:


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Assets
Current assets:
Cash and cash equivalents	$	0.3	$	19.7	$	80.4	$	—	$	100.4
Restricted cash		—		—		10.2		—		10.2
Receivables, net		—		94.1		74.9		(11.1)		157.9
Other current assets		—		137.1		43.1		—		180.2
Total current assets		0.3		250.9		208.6		(11.1)		448.7
Investment in equity of subsidiaries		613.2		1,793.2		—		(2,406.4)		—
Property, net		—		1,976.2		605.2		—		2,581.4
Operating lease right-of-use assets, net		—		3,535.9		1,259.0		—		4,794.9
Intangible assets, net		—		131.4		62.5		—		193.9
Intercompany advances		5,277.1		(4,920.5)		(356.6)		—		—
Goodwill		(2.1)		3,074.7		1,621.2		—		4,693.8
Deferred tax asset, net		—		—		30.7		—		30.7
Other long-term assets		66.2		342.0		129.7		—		537.9
Total assets	$	5,954.7	$	6,183.8	$	3,560.3	$	(2,417.5)	$	13,281.3
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	—	$	274.1	$	98.6	$	(11.1)	$	361.6
Accrued expenses and other liabilities		51.3		175.1		112.2		—		338.6
Deferred revenues and income		—		278.1		69.4		—		347.5
Current maturities of corporate borrowings		20.0		1.4		—		—		21.4
Current maturities of finance lease liabilities		—		5.2		4.8		—		10.0
Current maturities of operating lease liabilities		—		441.3		126.8		—		568.1
Total current liabilities		71.3		1,175.2		411.8		(11.1)		1,647.2
Corporate borrowings		4,700.1		—		10.0		—		4,710.1
Finance lease liabilities		—		15.3		74.2		—		89.5
Operating lease liabilities		—		3,663.7		1,193.9				4,857.6
Exhibitor services agreement		—		553.8		—		—		553.8
Deferred tax liability, net		—		25.5		24.3		—		49.8
Other long-term liabilities		—		137.1		52.9		—		190.0
Total liabilities		4,771.4		5,570.6		1,767.1		(11.1)		12,098.0
Stockholders’ equity		1,183.3		613.2		1,793.2		(2,406.4)		1,183.3
Total liabilities and stockholders’ equity	$	5,954.7	$	6,183.8	$	3,560.3	$	(2,417.5)	$	13,281.3

Condensed Consolidating Balance Sheet

As of December 31, 2018:


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Assets
Current assets:
Cash and cash equivalents	$	0.3	$	177.8	$	135.2	$	—	$	313.3
Restricted cash		—		—		10.7		—		10.7
Receivables, net		—		163.0		100.9		(4.4)		259.5
Other current assets		—		140.7		57.1		—		197.8
Total current assets		0.3		481.5		303.9		(4.4)		781.3
Investment in equity of subsidiaries		719.0		1,430.1		—		(2,149.1)		—
Property, net		—		2,152.3		887.3		—		3,039.6
Intangible assets, net		—		225.6		126.5		—		352.1
Intercompany advances		5,362.3		(4,512.3)		(850.0)		—		—
Goodwill		(2.1)		3,074.7		1,716.1		—		4,788.7
Deferred tax asset, net		—		—		28.6		—		28.6
Other long-term assets		59.8		316.2		129.5		—		505.5
Total assets	$	6,139.3	$	3,168.1	$	2,341.9	$	(2,153.5)	$	9,495.8
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	—	$	327.2	$	129.9	$	(4.5)	$	452.6
Accrued expenses and other liabilities		31.5		197.5		149.4		0.1		378.5
Deferred revenues and income		—		314.0		100.8		—		414.8
Current maturities of corporate borrowings		13.8		1.4		—		—		15.2
Current maturities of capital and financing lease obligations		—		38.6		28.4		—		67.0
Total current liabilities		45.3		878.7		408.5		(4.4)		1,328.1
Corporate borrowings		4,696.0		—		11.8		—		4,707.8
Capital and financing lease obligations		—		194.3		298.9		—		493.2
Exhibitor services agreement		—		564.0		—		—		564.0
Deferred tax liability, net		—		17.7		23.9		—		41.6
Other long-term liabilities		—		794.4		168.7		—		963.1
Total liabilities		4,741.3		2,449.1		911.8		(4.4)		8,097.8
Temporary equity		0.4		—		—		—		0.4
Stockholders’ equity		1,397.6		719.0		1,430.1		(2,149.1)		1,397.6
Total liabilities and stockholders’ equity	$	6,139.3	$	3,168.1	$	2,341.9	$	(2,153.5)	$	9,495.8

Condensed Consolidating Statement of ~~Operations~~Cash Flows

Nine Months Ended September 30, ~~2017:~~2019:

Subsidiary

Subsidiary

Consolidating

Consolidated
(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings
Revenues















Admissions

$
—

$
1,402.3

$
930.1

$
—

$
2,332.4
Food and beverage

—

707.4

425.7

—

1,133.1
Other theatre

—

118.8

78.1

—

196.9
Total revenues

—

2,228.5

1,433.9

—

3,662.4
Operating costs and expenses

Film exhibition costs

—

738.8

425.4

—

1,164.2
Food and beverage costs

—

100.5

82.1

—

182.6
Operating expense, excluding depreciation and amortization

—

652.7

476.1

—

1,128.8
Rent

—

370.9

220.0

—

590.9
General and administrative:

Merger, acquisition and transaction costs

—

54.3

2.9

—

57.2
Other, excluding depreciation and amortization

1.8

65.2

46.0

—

113.0
Depreciation and amortization

—

219.4

174.5

—

393.9
Operating costs and expenses

1.8

2,201.8

1,427.0

—

3,630.6
Operating income (loss)

(1.8)

26.7

6.9

—

31.8
Other expense (income):

Equity in net (earnings) loss of subsidiaries

199.8

19.0

—

(218.8)

—
Other income

—

(1.3)

(0.6)

—

(1.9)
Interest expense:

Corporate borrowings

170.1

167.1

1.5

(167.0)

171.7
Capital and financing lease obligations

—

5.8

25.9

—

31.7
Equity in (earnings) loss of non-consolidated entities

—

201.2

(2.1)

—

199.1
Investment (income) expense

(160.9)

(27.3)

(0.4)

167.0

(21.6)
Total other expense

209.0

364.5

24.3

(218.8)

379.0
Earnings (loss) before income taxes

(210.8)

(337.8)

(17.4)

218.8

(347.2)
Income tax provision (benefit)

—

(138.0)

1.6

—

(136.4)
Net earnings (loss)

$
(210.8)

$
(199.8)

$
(19.0)

$
218.8

$
(210.8)


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Cash flows from operating activities:
Net cash provided by operating activities	$	75.9	$	63.0	$	71.3	$	—	$	210.2
Cash flows from investing activities:
Capital expenditures		—		(243.8)		(104.4)		—		(348.2)
Acquisition of theatre assets		—		(11.8)		—		—		(11.8)
Proceeds from disposition of long-term assets		—		6.1		15.3		—		21.4
Investments in non-consolidated entities, net		—		(0.1)		(9.4)		—		(9.5)
Other, net		—		(0.3)		—		—		(0.3)
Net cash used in investing activities		—		(249.9)		(98.5)		—		(348.4)
Cash flows from financing activities:
Proceeds from issuance of Term Loan due 2026		1,990.0		—		—		—		1,990.0
Payment of principal Senior Secured Notes due 2023		(230.0)		—		—		—		(230.0)
Payment of principal Senior Subordinated Notes due 2022		(375.0)		—		—		—		(375.0)
Call premiums paid for Senior Secured Notes due 2023 and Senior Subordinated Notes due 2022		(15.9)		—		—		—		(15.9)
Principal payments under Term Loans due 2022 and 2023		(1,338.5)		—		—		—		(1,338.5)
Repayments under Revolving Credit Facility		—		—		(1.7)		—		(1.7)
Scheduled principal payments under Term Loans		(16.9)		—		—		—		(16.9)
Principal payments under capital and financing lease obligations		—		(4.9)		(3.6)		—		(8.5)
Cash used to pay debt financing costs		(11.7)		—		—		—		(11.7)
Cash used to pay dividends		(63.4)		—		—		—		(63.4)
Taxes paid for restricted unit withholdings		(1.3)		—		—		—		(1.3)
Change in intercompany advances		5.8		14.1		(19.9)		—		—
Net cash provided by (used in) financing activities		(56.9)		9.2		(25.2)		—		(72.9)
Effect of exchange rate changes on cash and cash equivalents and restricted cash		(19.0)		19.6		(2.9)		—		(2.3)
Net increase (decrease) in cash and cash equivalents and restricted cash		—		(158.1)		(55.3)		—		(213.4)
Cash and cash equivalents and restricted cash at beginning of period		0.3		177.8		145.9		—		324.0
Cash and cash equivalents and restricted cash at end of period	$	0.3	$	19.7	$	90.6	$	—	$	110.6

Condensed Consolidating Statement of ~~Comprehensive Loss~~Cash Flows

~~Three Months Ended September 30, 2018:~~

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Net earnings (loss)

$
(100.4)

$
(42.5)

$
10.4

$
32.1

$
(100.4)

Other comprehensive income (loss)

Equity in other comprehensive income (loss) of subsidiaries

(8.0)

(5.3)

—

13.3

—

Unrealized foreign currency translation adjustment, net of tax

—

(0.2)

(5.5)

—

(5.7)

Pension and other benefit adjustments:

Net gain arising during the period, net of tax

—

—

0.1

—

0.1

Equity method investees’ cash flow hedge:

Realized net gain reclassified to equity in earnings of non-consolidated entities, net of tax

—

(1.9)

—

—

(1.9)

Other comprehensive loss

(8.0)

(7.4)

(5.4)

13.3

(7.5)

Total comprehensive income (loss)

$
(108.4)

$
(49.9)

$
5.0

$
45.4

$
(107.9)

~~Consolidating Statement of Comprehensive Income (Loss)~~

~~Three Months Ended September 30, 2017:~~

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Net loss

$
(42.7)

$
(38.9)

$
(20.9)

$
59.8

$
(42.7)

Other comprehensive income (loss)

Equity in other comprehensive income (loss) of subsidiaries

33.7

34.6

—

(68.3)

—

Unrealized foreign currency translation adjustment, net of tax

—

(0.2)

34.6

—

34.4

Marketable securities:

Unrealized holding gain arising during the period, net of tax

—

0.2

—

—

0.2

Equity method investees’ cash flow hedge:

Unrealized net holding gain arising during the period, net of tax

—

0.1

—

—

0.1

Realized net holding gain reclassified to equity in earnings of non-consolidated entities, net of tax

—

(1.0)

—

—

(1.0)

Other comprehensive income

33.7

33.7

34.6

(68.3)

33.7

Total comprehensive income (loss)

$
(9.0)

$
(5.2)

$
13.7

$
(8.5)

$
(9.0)

~~Consolidating Statement of Comprehensive Loss~~

Nine Months Ended September 30, 2018:

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Net earnings

$
(60.5)

$
5.3

$
26.6

$
(31.9)

$
(60.5)

Other comprehensive income (loss)

Equity in other comprehensive income (loss) of subsidiaries

(103.9)

(75.4)

—

179.3

—

Unrealized foreign currency translation adjustment, net of tax

—

(27.5)

(74.1)

—

(101.6)

Realized loss on foreign currency transactions, net of tax

—

1.0

—

—

1.0

Pension and other benefit adjustments:

Net loss arising during the period, net of tax

—

—

(1.3)

—

(1.3)

Equity method investees’ cash flow hedge:

Unrealized net holding (loss) gain arising during the period, net of tax

—

0.2

—

—

0.2

Realized net gain reclassified to equity in earnings of non-consolidated entities, net of tax

—

(2.2)

—

—

(2.2)

Other comprehensive loss

(103.9)

(103.9)

(75.4)

179.3

(103.9)

Total comprehensive loss

$
(164.4)

$
(98.6)

$
(48.8)

$
147.4

$
(164.4)


			Subsidiary		Subsidiary		Consolidating		Consolidated
(In millions)	Holdings		Guarantors		Non-Guarantors		Adjustments		Holdings
Cash flows from operating activities:
Net cash provided by operating activities	$	44.0	$	218.3	$	36.5	$	—	$	298.8
Cash flows from investing activities:
Capital expenditures		—		(264.9)		(110.0)		—		(374.9)
Proceeds from sale leaseback transactions		—		50.1		—		—		50.1
Proceeds from disposition of NCM, Inc. shares		—		162.5		—		—		162.5
Proceeds from Screenvision merger		—		45.8		—		—		45.8
Proceeds from disposition of long-term assets		—		8.2		5.7		—		13.9
Investments in non-consolidated entities, net		—		(11.0)		—		—		(11.0)
Other, net		—		(1.6)		0.9		—		(0.7)
Net cash used in investing activities		—		(10.9)		(103.4)		—		(114.3)
Cash flows from financing activities:
Proceeds from issuance of convertible note due 2024		600.0		—		—		—		600.0
Net borrowings under Revolving Credit Facility		—		—		6.6		—		6.6
Principal payments under Term Loan		(10.3)		—		—		—		(10.3)
Principal payments under capital and financing lease obligations		—		(30.2)		(23.3)		—		(53.5)
Cash used to pay deferred financing costs		(14.3)		—		—		—		(14.3)
Cash used to pay dividends		(237.4)		—		—		—		(237.4)
Taxes paid for restricted unit withholdings		(1.7)		—		—		—		(1.7)
Retirement of Class B stock		(422.9)								(422.9)
Purchase of treasury stock		(21.8)		—		—		—		(21.8)
Change in intercompany advances		87.2		(63.8)		(23.4)		—		—
Net cash used in financing activities		(21.2)		(94.0)		(40.1)		—		(155.3)
Effect of exchange rate changes on cash and cash equivalents and restricted cash		(23.4)		24.3		(4.1)		—		(3.2)
Net increase (decrease) in cash and cash equivalents and restricted cash		(0.6)		137.7		(111.1)		—		26.0
Cash and cash equivalents and restricted cash at beginning of period		1.1		95.9		221.3		—		318.3
Cash and cash equivalents and restricted cash at end of period	$	0.5	$	233.6	$	110.2	$	—	$	344.3

~~Consolidating Statement of Comprehensive Income (Loss)~~

~~Nine Months Ended September 30, 2017:~~

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Net earnings (loss)

$
(210.8)

$
(199.8)

$
(19.0)

$
218.8

$
(210.8)

Other comprehensive income (loss)

Equity in other comprehensive income (loss) of subsidiaries

108.3

109.0

—

(217.3)

—

Unrealized foreign currency translation adjustment, net of tax

—

(0.2)

109.5

—

109.3

Pension and other benefit adjustments:

Amortization of net loss (gain) reclassified into general and administrative: other, net of tax

—

—

(0.5)

—

(0.5)

Marketable securities:

Unrealized net holding gain arising during the period, net of tax

—

0.5

—

—

0.5

Realized net gain reclassified into net investment income, net of tax

—

(0.1)

—

—

(0.1)

Equity method investees’ cash flow hedge:

Realized net loss reclassified to equity in earnings of non-consolidated entities, net of tax

—

(0.9)

—

—

(0.9)

Other comprehensive income

108.3

108.3

109.0

(217.3)

108.3

Total comprehensive income (loss)

$
(102.5)

$
(91.5)

$
90.0

$
1.5

$
(102.5)

~~Consolidating Balance Sheet~~

~~As of September 30, 2018:~~

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Assets
















Current assets:

Cash and cash equivalents

$
0.4

$
229.3

$
103.6

$
—

$
333.3

Restricted cash

—

—

11.0

—

11.0

Receivables, net

—

84.3

76.0

(5.1)

155.2

Assets held for sale

—

—

—

—

—

Other current assets

—

107.4

79.6

—

187.0

Total current assets

0.4

421.0

270.2

(5.1)

686.5

Investment in equity of subsidiaries

686.5

1,468.7

—

(2,155.2)

—

Property, net

—

1,557.3

1,471.3

—

3,028.6

Intangible assets, net

—

211.8

147.5

—

359.3

Intercompany advances

5,471.4

(3,569.2)

(1,902.2)

—

—

Goodwill

(2.1)

2,422.1

2,400.8

—

4,820.8

Deferred tax asset, net

—

—

98.2

(68.7)

29.5

Other long-term assets

4.6

299.8

133.9

—

438.3

Total assets

$
6,160.8

$
2,811.5

$
2,619.7

$
(2,229.0)

$
9,363.0

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$
—

$
290.8

$
109.5

$
(5.2)

$
395.1

Accrued expenses and other liabilities

59.7

164.8

162.5

0.1

387.1

Deferred revenues and income

—

220.2

73.0

—

293.2

Current maturities of corporate borrowings and capital and financing lease obligations

13.8

11.3

57.9

—

83.0

Total current liabilities

73.5

687.1

402.9

(5.1)

1,158.4

Corporate borrowings

4,832.3

1.4

6.6

—

4,840.3

Capital and financing lease obligations

—

66.3

450.4

—

516.7

Exhibitor services agreement

—

567.7

—

—

567.7

Deferred tax liability, net

—

85.2

27.8

(68.7)

44.3

Other long-term liabilities

—

717.4

263.3

—

980.7

Total liabilities

4,905.8

2,125.1

1,151.0

(73.8)

8,108.1

Temporary equity

0.4

—

—

—

0.4

Stockholders’ equity

1,254.6

686.4

1,468.7

(2,155.2)

1,254.5

Total liabilities and stockholders’ equity

$
6,160.8

$
2,811.5

$
2,619.7

$
(2,229.0)

$
9,363.0

~~Consolidating Balance Sheet~~

~~As of December 31, 2017:~~

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Assets
















Current assets:

Cash and cash equivalents

$
1.1

$
85.0

$
223.9

$
—

$
310.0

Restricted cash

—

—

8.3

—

8.3

Receivables, net

0.4

186.4

84.7

—

271.5

Assets held for sale

—

80.0

—

—

80.0

Other current assets

—

118.0

84.6

—

202.6

Total current assets

1.5

469.4

401.5

—

872.4

Investment in equity of subsidiaries

2,450.6

1,513.4

—

(3,964.0)

—

Property, net

—

1,591.1

1,525.4

—

3,116.5

Intangible assets, net

—

218.9

161.6

—

380.5

Intercompany advances

3,914.1

(1,893.3)

(2,020.8)

—

—

Goodwill

(2.1)

2,422.1

2,511.7

—

4,931.7

Deferred tax asset, net

—

—

97.6

(68.7)

28.9

Other long-term assets

5.8

326.5

143.6

—

475.9

Total assets

$
6,369.9

$
4,648.1

$
2,820.6

$
(4,032.7)

$
9,805.9

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$
—

$
373.7

$
195.9

$
—

$
569.6

Accrued expenses and other liabilities

24.2

165.3

161.6

—

351.1

Deferred revenues and income

—

270.8

130.2

—

401.0

Current maturities of corporate borrowings and capital and financing lease obligations

13.8

11.8

62.1

—

87.7

Total current liabilities

38.0

821.6

549.8

—

1,409.4

Corporate borrowings

4,218.7

1.4

—

—

4,220.1

Capital and financing lease obligations

—

73.5

505.4

—

578.9

Exhibitor services agreement

—

530.9

—

—

530.9

Deferred tax liability, net

—

85.3

33.0

(68.7)

49.6

Other long-term liabilities

—

684.8

219.0

—

903.8

Total liabilities

4,256.7

2,197.5

1,307.2

(68.7)

7,692.7

Temporary equity

0.8

—

—

—

0.8

Stockholders’ equity

2,112.4

2,450.6

1,513.4

(3,964.0)

2,112.4

Total liabilities and stockholders’ equity

$
6,369.9

$
4,648.1

$
2,820.6

$
(4,032.7)

$
9,805.9

~~Consolidating Statement of Cash Flows~~

~~Nine Months Ended September 30, 2018:~~

Subsidiary

Subsidiary

Consolidating

Consolidated

(In millions)

Holdings

Guarantors

Non-Guarantors

Adjustments

Holdings

Cash flows from operating activities:
















Net cash provided by operating activities

$
44.0

$
141.7

$
113.1

$
—

$
298.8

Cash flows from investing activities:

Capital expenditures

—

(194.2)

(180.7)

—

(374.9)

Proceeds from sale leaseback transactions

—

50.1

—

—

50.1

Proceeds from Screenvision merger

—

—

45.8

—

45.8

Proceeds from disposition of NCM

—

162.5

—

—

162.5

Proceeds from disposition of long-term assets

—

4.5

9.4

—

13.9

Investments in non-consolidated entities, net

—

(11.0)

—

—

(11.0)

Other, net

—

(2.4)

1.7

—

(0.7)

Net cash provided by (used in) investing activities

—

9.5

(123.8)

—

(114.3)

Cash flows from financing activities:

Proceeds from issuance of Senior Unsecured Convertible Notes due 2024

600.0

—

—

—

600.0

Net borrowings under Revolving Credit Facility

—

—

6.6

—

6.6

Principal payments under Term Loan

(10.3)

—

—

—

(10.3)

Principal payments under capital and financing lease obligations

—

(7.8)

(45.7)

—

(53.5)

Cash used to pay deferred financing costs

(14.3)

—

—

—

(14.3)

Cash used to pay dividends

(237.4)

—

—

—

(237.4)

Taxes paid for restricted unit withholdings

(1.7)

—

—

—

(1.7)

Retirement of Class B common stock

(422.9)

—

—

—

(422.9)

Purchase of treasury stock

(21.8)

—

—

—

(21.8)

Change in intercompany advances

87.2

(23.5)

(63.7)

—

—

Net cash used in financing activities

(21.2)

(31.3)

(102.8)

—

(155.3)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

(23.4)

24.3

(4.1)

—

(3.2)

Net increase (decrease) in cash and cash equivalents and restricted cash

(0.6)

144.2

(117.6)

—

26.0

Cash and cash equivalents and restricted cash at beginning of period

1.1

85.0

232.2

—

318.3

Cash and cash equivalents and restricted cash at end of period

$
0.5

$
229.2

$
114.6

$
—

$
344.3

��

~~Consolidating Statement of Cash Flows~~

~~Nine Months Ended September 30, 2017:~~

Subsidiary

Subsidiary

Consolidating

Consolidated
(In millions)

Holdings
Guarantors

Non-Guarantors

Adjustments

Holdings
Cash flows from operating activities:















Net cash provided by operating activities

$
42.0

$
64.0

$
123.6

$
—

$
229.6
Cash flows from investing activities:

Capital expenditures

—

(320.5)

(147.2)

—

(467.7)
Acquisition of Nordic, net of cash and restricted cash acquired

—

(654.9)

77.3

—

(577.6)
Acquisition of Carmike Cinemas, Inc., net of cash and restricted cash acquired

—

0.1

—

—

0.1
Proceeds from sale leaseback transaction

—

128.4

—

—

128.4
Proceeds from disposition of NCM, Inc. shares

—

89.4

—

—

89.4
Proceeds from disposition of Open Road

9.2

9.2
Proceeds from disposition of long-term assets

—

9.1

13.4

—

22.5
Investments in non-consolidated entities, net

—

(11.6)

1.6

—

(10.0)
Other, net

—

(3.4)

(0.2)

—

(3.6)
Net cash used in investing activities

—

(754.2)

(55.1)

—

(809.3)
Cash flows from financing activities:

Proceeds from the issuance of Senior Subordinated Sterling Notes due 2024

327.8

—

—

—

327.8
Proceeds from the issuance of Senior Subordinated Notes due 2027

475.0

—

—

—

475.0
Payment of Nordic SEK Term Loan

(144.4)

—

—

—

(144.4)
Payment of Nordic EUR Term Loan

(169.5)

—

—

—

(169.5)
Net proceeds from equity offering

616.8

—

—

—

616.8
Net borrowings under Revolving Credit Facility

60.0

60.0
Principal payment of Bridge Loan due 2017

(350.0)

—

—

—

(350.0)
Principal payments under Term Loan

(9.1)

—

—

—

(9.1)
Principal payments under capital and financing lease obligations

—

(6.9)

(47.2)

—

(54.1)
Cash used to pay deferred financing costs

(29.8)

—

—

—

(29.8)
Cash used to pay dividends

(78.7)

—

—

—

(78.7)
Taxes paid for restricted unit withholdings

(6.5)

(6.5)
Purchase of treasury stock

(16.5)

(16.5)
Change in intercompany advances

(771.4)

773.7

(2.3)

—

—
Net cash provided by (used in) financing activities

(96.3)

766.8

(49.5)

—

621.0
Effect of exchange rate changes on cash and cash equivalents and restricted cash

51.4

(44.5)

13.0

—

19.9
Net decrease in cash and cash equivalents and restricted cash

(2.9)

32.1

32.0

—

61.2
Cash and cash equivalents and restricted cash at beginning of period

3.0

94.7

132.5

—

230.2
Cash and cash equivalents and restricted cash at end of period

$
0.1

$
126.8

$
164.5

$
—

$
291.4

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

In addition to historical information, this Quarterly Report on Form 10–Q contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “may,” “will,” “forecast,” “estimate,” “project,” “intend,” “plan,” “expect,” “should,” “believe” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Similarly, certain statements made herein and elsewhere regarding our recent acquisitions are also forward-looking statements, including statements regarding the expected benefits of the acquisition on our future business, operations and financial performance and our ability to successfully integrate the recently acquired businesses. These forward-looking statements are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including those discussed in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the following:

●

risks relating to motion picture production and performance;

●

our lack of control over distributors of films;

●

intense competition in the geographic areas in which we operate;

●

increased use of alternative film delivery methods or other forms of entertainment;

●

shrinking exclusive theatrical release windows;

●

AMC Stubs^® A-List may not meet anticipated revenue projections which could result in a negative impact upon operating results;

●

general and international economic, political, social and financial market conditions and other risks including the effects of the exit of the United Kingdom from the European Union;

●

risks and uncertainties relating to our significant indebtedness;

●

limitations on the availability of capital may prevent us from deploying strategic ~~initiatives and continue our share repurchase program;~~

initiatives;

●

certain covenants in the agreements that govern our indebtedness may limit our ability to take advantage of certain business opportunities;

●

our ability to achieve expected synergies, benefits and performance from our ~~recent~~ strategic theatre acquisitions and strategic initiatives;

●

our ability to refinance our indebtedness on terms favorable to us;

●

optimizing our theatre circuit through new construction and the transformation of our existing theatres may be subject to delay and unanticipated costs;

●

failures, unavailability or security breaches of our information systems;

●

risks relating to impairment losses, including with respect to goodwill and other intangibles, and theatre and other closure charges;

●

our ability to utilize net operating loss carryforwards to reduce our future tax liability or valuation allowances taken with respect to deferred tax assets;

●

review by antitrust authorities in connection with acquisition opportunities;

●

risks relating to unexpected costs or unknown liabilities relating to recently completed acquisitions;

●

risks relating to the incurrence of legal liability, including costs associated with recently filed securities class action lawsuits;

●

dependence on key personnel for current and future performance and our ability to attract and retain senior executives and other key personnel, including in connection with any future acquisitions;

●

risks of poor financial results may prevent us from deploying strategic initiatives;

●

operating a business in international markets AMC is unfamiliar with, including acceptance by movie-goers of AMC initiatives that are new to those markets;

●

increased costs in order to comply or resulting from failure to comply with governmental regulation, including the General Data Protection Regulation (“GDPR”) and ~~the impact of governmental investigations concerning potentially anticompetitive conduct, including film clearances~~pending future domestic privacy laws and ~~partnering with other major exhibitors in joint ventures;~~regulations; and

●

we may not generate sufficient cash flows or have sufficient restricted payment capacity under our Senior Secured Credit Facility or the indentures governing our debt securities to pay our intended dividends on our Class A and Class B common stock.

terms established prior to the opening of the picture. In certain circumstances and less frequently, our rental fees are based on a mutually agreed settlement upon the conclusion of the picture. Under an aggregate terms formula, we pay the distributor a specified percentage of box office gross or pay based on a scale of percentages tied to different amounts of box office gross. The settlement process allows for negotiation based upon how a film actually performs.

~~During the 2017 calendar year, films licensed from our seven largest distributors based on revenues accounted for approximately 88% of our U.S. admissions revenues.~~ ~~In Europe, approximately 77% of our box office revenue came from films attributed to our six largest distributors.~~ Our revenues attributable to individual distributors may vary significantly from year to year depending upon the commercial success of each distributor’s films in any given year.

Our revenues are dependent upon the timing and popularity of film releases by distributors. The most marketable films have historically been released during the summer and the calendar year-end holiday seasons. Our results of operations may vary significantly from quarter to quarter and from year to year based on the timing onand popularity of film releases.

AMC Movie Screens

During the nine months ended September 30, ~~2018,~~2019, we opened five new theatres with a total of 4638 screens, acquired ~~four theatres with 39~~64 screens, permanently closed ~~177~~181 screens, temporarily closed ~~466~~352 screens to install consumer experience upgrades and reopened ~~360~~285 screens ~~to implement our strategy~~ to install consumer experience upgrades.

As of September 30, ~~2018,~~2019, we had ~~5,400~~5,336 3D enabled screens, including ~~212~~219 IMAX^®, and ~~106~~114 Premium Large Format (“PLF”) screens; approximately 49% of our screens were 3D enabled screens, including IMAX^® 3D enabled screens, and approximately 2% of our screens were IMAX^® 3D enabled screens. The following table identifies the upgrades to our theatre circuit during the periods indicated:


	Number of	Number of
	Screens As of	Screens As of

			Number of	Number of
			Screens As of	Screens As of
Format	September 30, 2018	December 31, 2017	September 30, 2019	December 31, 2018
Digital	10,971	11,169	10,945	11,091
3D enabled	5,400	5,471	5,336	5,411
IMAX® (3D enabled)	212	209	219	216
Dolby CinemaTM at AMC	117	89	143	127
Other PLF (3D enabled)	106	99	114	112
Dine-in theatres	441	430	379	437
Premium seating	3,102	2,631	3,603	3,279

~~IMAX~~®. ~~IMAX~~® ~~is one of the world’s leading entertainment technology companies, specializing in motion picture technologies and presentations. IMAX~~® offers a unique end-to-end cinematic solution combining proprietary software, theater architecture and equipment to create the highest-quality, most immersive motion picture experience for which the IMAX® ~~brand has become known globally. Top filmmakers and studios utilize IMAX~~® ~~theaters to connect with audiences in innovative ways, and as such, IMAX~~®~~’s theater network is among the most important and successful theatrical distribution platforms for major event films around the world.~~

~~As of September 30, 2018, AMC is the largest IMAX~~® ~~exhibitor in the U.S. with a 51% market share, and each of our IMAX~~® ~~local installations is protected by geographic exclusivity. As of September 30, 2018, our IMAX~~® ~~screen count is 97% greater than our closest competitor. We believe that we have had considerable success with our IMAX~~® ~~partnership.~~

~~Dolby Cinema™ at AMC.~~ In May 2015, we partnered with Dolby Laboratories, Inc. to unveil a premium cinema offering for movie-goers that combined state-of-the-art image and sound technologies with inspired theatre design and comfort. Dolby Cinema™ at AMC includes Dolby Vision™ laser projection and object oriented Dolby Atmos® ~~audio technology, as well as AMC’s plush power reclining seats with seat transducers that vibrate with the action on screen.~~

As of September 30, 2018, we have 117 fully operational Dolby Cinema™ at AMC screens in the U.S. In August 2016, we announced the acceleration of our Dolby Cinema™ at AMC deployment. We expect to have 129 Dolby Cinema™ at AMC screens operational by the end of 2018.

~~Prime at AMC.~~ We believe there is considerable opportunity to add a private label PLF format in many of our locations, with superior sight and sound technology and enhanced seating as contrasted with our traditional auditoriums. ~~This proprietary PLF auditorium offers an enhanced theatrical experience for movie-goers beyond our current core theatres, at a lower price premium when higher prices for~~ ~~IMAX~~® ~~and/or Dolby Cinema™ at AMC might not be feasible. Therefore, it may be especially relevant in smaller or more price sensitive markets.~~

~~Technical innovation has allowed us to enhance the consumer experience through premium formats such as 3D, IMAX~~®, and other large screen formats. When combined with our major markets’ customer base, the operating flexibility of digital technology enhances our programming flexibility. This enables us to achieve higher capacity utilization and ticket prices for premium formats, as well as provide incremental revenue from the exhibition of alternative content. Within each of our major markets, we are able to charge a premium for these services relative to our smaller markets. We intend to continue to broaden our content offerings and enhance the customer experience in operating IMAX® ~~screens and through the installation of additional Dolby Cinema™ at AMC screens, our PLF screen concepts, and the presentation of attractive alternative content.~~

Guest Amenities

We continually upgrade the quality of our theatre circuit through substantial renovations featuring our seating concepts, acquisitions, new builds (including expansions), expansion of food and beverage offerings (including dine-in theatres), and by disposing of older screens through closures and sales. We believe we are an industry leader in the development and operation of theatres. Typically, our theatres have 12 or more screens and offer amenities to enhance the movie-going experience, such as stadium seating providing unobstructed viewing, digital sound and premium seat design.

Recliner seating is the key feature of theatre ~~renovations. We believe that maximizing comfort and convenience for our customers will be increasingly necessary to maintain and improve our relevance.~~renovations, which drive a 35% increase in attendance at these locations in their first year post renovation. These renovations, in conjunction with capital contributions from our landlords, involve stripping theatres to their basic structure in order to replace finishes throughout, upgrade the sight and sound experience, install modernized points of sale and ~~most importantly,~~ replace traditional theatre seats with plush, electric recliners that allow customers to deploy a leg rest and fully recline at the push of a button. The renovation process typically involves losing up to two-thirds of a given auditorium’s seating capacity. For an industry historically focused on quantity, this reduction in seating capacity could be viewed as counter-intuitive and harmful to revenues. However, the quality improvement in the customer experience is driving a 47% increase in attendance on average at these locations in their first-year post renovation. Our customers have responded favorably to the significant personal space gains from ample row depths, ability to recline or stretch their legs, extra-wide pillowed chaise and oversized armrests. The reseated theatres attract more midweek audiences than normal theatres and tend to draw more adults who pay higher ticket prices than teens or young children. We typically do not change ticket prices in the first year after construction, however, in subsequent years we typically increase our ticket prices at our reseated theatres by amounts well in excess of price adjustments for our non-renovated theatres.recliners.

As of September 30, ~~2018,~~2019, we now feature recliner seating in approximately ~~323~~378 theatres, including Dine-in-Theatres, totaling approximately ~~3,102~~3,603 screens. By the end of ~~2018,~~2019, we expect to convert an additional ~~198~~202 screens to recliner seating.

Rebalancing of the new supply-demand relationship created by recliner seating presents us two further opportunities to improve customer convenience and maximize operating results: open-source internet ticketing and reserved seating.

Open-source internet ticketing makes our AMC seats (over 1.1 million) in all our U.S. theatres and auditoriums, for all our showtimes ~~widely~~as available as possible, on as many websites as possible. ~~This is a significant departure from the years prior to 2012, when tickets to any one of our theatres were only available on one website.~~ Our tickets are currently on sale over the internet, directly or through mobile apps, at our own website and app, ~~Fandango, Movietickets.com, Flixster,~~ and Atom Tickets. We believe increased online access is important because it captures customers’ purchase intent more immediately and directly than if we wait for their arrival at the theatre box office to make a purchase. Carefully monitoring internet pre-sales also lets us adjust capacity in real time, moving movies that are poised to over perform to larger capacity auditoriums or adding additional auditoriums, thereby maximizing yield.other third-party ticketing vendors.

Food and beverage sales are our second largest source of revenue after box office admissions. Food and beverage items traditionally include popcorn, soft drinks, candy and hot dogs. Different varieties of food and beverage items are offered at our theatres based on preferences in the particular geographic region. Our traditional food and beverage strategy emphasizes prominent and appealing food and beverage offerings designed for rapid service and efficiency, including a customer friendly self-serve experience. We design our theatres to have more food and beverage capacity to make it easier to serve larger numbers of customers. Strategic placement of large food and beverage operations within theatres increases their visibility, aids in reducing the length of lines, allows flexibility to introduce new concepts and improves traffic flow around the food and beverage stands.

~~To address recent consumer trends, we are expanding our~~

Our expanded menu ofincludes enhanced food and beverage products to include made-to-order drinks and meals, customized coffee, healthy snacks, premium beers, wine and mixed drinks, flatbread pizzas, more varieties of hot dogs, four flavors of popcorn and other menu items. We plan to invest across a spectrum of enhanced food and beverage formats, ranging from simple, less capital-intensive food and beverage design improvements to the development of new dine-in theatre options. The costs of these conversions in some cases are partially covered by investments from the theatre landlord. We currently operate 3026 Dine-In Theatres that deliver ~~chef-inspired menus~~meals with seat-side or delivery ~~service to luxury recliners with tables. Our recent Dine-In Theatre concepts are designed to capitalize on the latest food service trend, the fast casual eating experience.~~service.

~~Coca Cola Freestyle~~® ~~puts customers in charge with over 100 drink flavor options in a technologically advanced compact footprint. Our operational excellence and history~~50

AMC Stubs^®

AMC Stubs^® is a customer loyalty program for our U.S. markets which allows members to earn rewards, receive discounts and participate in exclusive members-only offerings and services. It features both a traditional paid tier called AMC Stubs Premiere^TMand a ~~new~~ non-paid tier called AMC Stubs Insider^TM. Both programs reward loyal guests for their patronage of AMC Theatres. ~~The~~

On June 26, 2018, we launched AMC Stubs ~~Insider~~TM tier rewards guests for simply coming to the movies and benefits include free refills on certain food items, discount ticket offers, a birthday gift and 20 reward points earned for every dollar spent. For a $15 annual membership fee, AMC Stubs PremiereTM members enjoy express service with specially marked shorter lines at the box office and concession stand, free size upgrades on certain food and beverage items, discount ticket offers, a birthday gift, discounted online ticketing fees and 100 points for every dollar spent. Some of the rewards earned are redeemable on future purchases at AMC locations.

~~On June 20, 2018, we announced the launch of AMC Stubs~~^® A-List, a new ~~VIP~~ tier of our AMC Stubs^® loyalty ~~program for $19.95 per month.~~program. This program ~~will offer~~offers guests admission to the ~~very best of~~movies at AMC up to three times per week including multiple movies per day and repeat visits to already seen ~~movies.~~movies for $19.95 to $23.95 per month depending upon geographic market. AMC Stubs^® A-List also includes premium offerings including IMAX^®, Dolby Cinema™ at AMC, RealD Holdings Inc., Prime and BigD. AMC Stubs^® A-List members can book tickets on-line in advance and select specific seats at AMC Theatres with reserved seating.

As of September 30, ~~2018,~~2019, we had ~~16,585,000~~approximately 21,596,000 member households in the AMC Stubs^® program. AMC Stubs^® members represented approximately ~~40%~~46% of AMC U.S. markets attendance during the three months ended September 30, ~~2018,~~2019, driving an average ~~153%~~2.0x higher total gross revenue versus non-members. ~~We believe movie-goers want to be recognized and rewarded for attending our theatres and as a result, our new AMC Stubs~~® ~~program is designed to strengthen guest loyalty, attract new guests and drive additional return visits.~~ Our much larger database of identified movie-goers also provides us with additional insight into our customers’ movie preferences, and this enables us to have both a larger and a more targeted marketing ~~effort to support our Hollywood studio partners.~~effort.

The portion of the admissions and food and beverage revenues attributed to the rewards is deferred as a reduction of admissions and food and beverage revenues and is allocated between admissions and food and beverage revenues based on expected member redemptions.

Upon redemption, deferred rewards are recognized as revenues along with associated cost of goods. Prior to January 1, 2018, rewards for expired memberships were forfeited based upon specified periods of inactivity of the membership and recognized as admissions or food and beverage revenues. As of January 1, 2018, we changed our method for recognizing forfeited rewards from the remote method to the proportional method, where weWe estimate point breakage in assigning value to the points at the time of sale based on historical trends. The program’s annual

membership fee is allocated to the material rights for discounted or free products and services and is initially deferred, net of estimated refunds, and recognized as the rights are redeemed based on estimated utilization, over the one-year membership period in admissions, food and beverage, and other revenues. A portion of the revenues related to a material right are deferred as a virtual rewards performance obligation using the relative standalone selling price method and are recognized as the rights are redeemed or expire.

~~The following tables reflect AMC Stubs~~® ~~activity during the three and nine months ended September 30, 2018:~~

AMC Stubs® Revenue for

Three Months Ended September 30, 2018


Deferred





Food and


Other Theatre

Membership

Deferred

Admissions

Beverage

Ticketing

Revenues
(In millions)

Fees

Rewards

Revenues

Revenues

Revenues

(Membership Fees)
Balance, June 30, 2018

$
18.5

$
27.4

Membership fees received

5.4

—

$
—

$
—

$
—

$
—
Rewards accumulated, net of expirations:

Admissions

—

7.1

(7.1)

—

—

—
Food and beverage

—

15.6

—

(15.6)

—

—
Rewards redeemed:

Admissions

—

(7.1)

7.1

—

—

—
Food and beverage

—

(13.6)

—

13.6

—

—
Amortization of deferred revenue

(7.7)

—

0.9

1.8

0.9

4.1
For the period ended or balance as of September 30, 2018

$
16.2

$
29.4

$
0.9

$
(0.2)

$
0.9

$
4.1

AMC Stubs® Revenue for

Nine Months Ended September 30, 2018


Deferred





Food and


Other Theatre

Membership

Deferred

Admissions

Beverage

Ticketing

Revenues
(In millions)

Fees

Rewards

Revenues

Revenues

Revenues

(Membership Fees)
Balance, December 31, 2017

$
15.8

$
26.4

Cumulative effect of ASC 606

—

(3.3)

Membership fees received

23.1

—

$
—

$
—

$
—

$
—
Rewards accumulated, net of expirations:

Admissions

—

22.6

(22.6)

—

—

—
Food and beverage

—

42.7

—

(42.7)

—

—
Rewards redeemed:

Admissions

—

(21.1)

21.1

—

—

—
Food and beverage

—

(37.9)

—

37.9

—

—
Amortization of deferred revenue

(22.7)

—

2.7

5.4

2.7

12.0
For the period ended or balance as of September 30, 2018

$
16.2

$
29.4

$
1.2

$
0.6

$
2.7

$
12.0

~~The following tables reflect AMC Stubs~~® ~~activity during the three and nine months ended September 30, 2017:~~

AMC Stubs® Revenue for

Three Months Ended September 30, 2017


Deferred





Food and


Other Theatre

Membership

Deferred

Admissions

Beverage

Ticketing

Revenues
(In millions)

Fees

Rewards

Revenues

Revenues

Revenues

(Membership Fees)
Balance, June 30, 2017

$
16.5

$
24.5

Membership fees received

5.4

—

$
—

$
—

$
—

$
—
Rewards accumulated, net of expirations:

Admissions

—

6.7

(6.7)

—

—

—
Food and beverage

—

11.4

—

(11.4)

—

—
Rewards redeemed:

Admissions

—

(7.0)

7.0

—

—

—
Food and beverage

—

(10.2)

—

10.2

—

—
Amortization of deferred revenue

(6.5)

—

0.8

1.5

0.7

3.4
For the period ended or balance as of September 30, 2017

$
15.4

$
25.4

$
1.1

$
0.3

$
0.7

$
3.4

AMC Stubs® Revenue for

Nine Months Ended September 30, 2017


Deferred





Food and


Other Theatre

Membership

Deferred

Admissions

Beverage

Ticketing

Revenues
(In millions)

Fees

Rewards

Revenues

Revenues

Revenues

(Membership Fees)
Balance, December 31, 2016

$
12.5

$
23.3

Membership fees received

21.6

—

$
—

$
—

$
—

$
—
Rewards accumulated, net of expirations:

Admissions

—

20.2

(20.2)

—

—

—
Food and beverage

—

32.2

—

(32.2)

—

—
Rewards redeemed:

Admissions

—

(20.1)

20.1

—

—

—
Food and beverage

—

(30.2)

—

30.2

—

—
Amortization of deferred revenue

(18.7)

—

2.2

4.4

2.2

9.8
For the period ended or balance as of September 30, 2017

$
15.4

$
25.4

$
2.1

$
2.4

$
2.2

$
9.8

~~Significant Events~~

Critical Accounting Policies ~~– Income Taxes~~and Estimates

In the fourth quarter of calendar 2017, we recorded the impact of the change in the U.S. enacted federal income tax rate from 35% to 21% which reduced our deferred tax assets. During the fourth quarter and in connection with the preparation of our 2017 financial statements, we also determined that realization of our deferred tax assets in the U.S. tax jurisdictions was not more likely than not, primarily as a result of cumulative net losses recorded for three years and we recorded a full valuation allowance for our deferred tax assets in U.S. tax jurisdictions. As a result of the change in enacted tax rate and recording a full valuation allowance for our deferred tax assets in U.S. tax jurisdictions, we recorded a charge to income tax provision of approximately $310.0 million in the fourth quarter of 2017. See Note 8–Income Taxes in the Notes to Consolidated Financial Statements ~~in Item 1 of Part I of this Form 10-Q for further information~~.

~~Critical Accounting Policies – Goodwill~~

Goodwill. We evaluate the goodwill recorded at our two reporting units (Domestic Theatres and International Theatres) for impairment annually as of the beginning of the fourth fiscal quarter or more frequently as specific events or circumstances dictate. ~~A decline in~~Prior to calendar 2019, we evaluated our common stock price and the resulting impact on market capitalization is one of several qualitative factors we consider when making this evaluation. Based on declines in the trading price of our Class A common stock in 2017, we performed an interimrecorded goodwill for impairment ~~test as of~~

September 30, 2017. We performed a qualitative assessment as of December 31, 2017, March 31, 2018, June 30, 2018, and September 30, 2018. We considered the potential for changes in the inputs utilized in our prior quantitative analyses as of September 30, 2017 and our actual cashflows from September 30, 2017 through September 30, 2018 which were consistent with our projections of cashflows for ourat three reporting units (Domestic Theatres, Odeon Theatres and ~~concluded there were no qualitative factors that would indicate it is more likely than not that the fair~~Nordic Theatres). Our market capitalization has been below carrying value since May 24, 2019.

The following table sets forth the historical closing prices per share of our Class A common stock for the calendar periods indicated:


	Closing

			Closing
Date		Price Per Share		Price Per Share
March 31, 2017	$	31.45
June 30, 2017		22.75	$	22.75
September 29, 2017		14.70
September 30, 2017				14.70
December 31, 2017		15.10		15.10
March 31, 2018		14.05		14.05
June 30, 2018		15.90		15.90
September 30,2018		20.50
November 6, 2018		18.42
September 30, 2018				20.50
December 31, 2018				12.28
January 31, 2019				14.65
February 28, 2019				14.03
March 31, 2019				14.85
April 30, 2019				15.16
May 31, 2019				11.98
June 30, 2019				9.33
July 31, 2019				11.83
August 31, 2019				11.11
September 30, 2019				10.70
November 6, 2019				9.69

Based on sustained declines during 2019 in our market capitalization, we performed a step 1 quantitative goodwill impairment test as of September 30, 2019. The impairment test for goodwill involves estimating the fair value of the reporting unit and comparing that value to its carrying value. If the ~~market price~~estimated fair value of the reporting unit is less than its carrying value, the difference is recorded as a goodwill impairment charge, not to exceed the total amount of goodwill allocated to that reporting unit.

We determined the fair value of our ~~common~~Domestic Theatres and International Theatres reporting units by using an enterprise valuation methodology and an equally weighted combination of the income approach, which utilizes discounted cash flows, and the market approach which utilizes market comparable multiples of cash flows. We believe that a market participant acquisition premium for a highly leveraged company is more reasonably measured on an enterprise value basis. There was considerable management judgment with respect to cash flow estimates and appropriate multiples and discount rates to be used in estimating fair value, which are classified as Level 3 in the fair value hierarchy. The income approach provides an estimate of fair value by measuring estimated annual cash flows over a discrete projection period and applying a present value discount rate to the cash flows. The present value of the cash flows is then added to the present value equivalent of the residual value of the business to arrive at an estimated fair value of the reporting unit. The residual value represents the present value of the projected cash flows beyond the discrete projection period. The discount rates were determined using a rate of return deemed appropriate for the risk of achieving the projected cash flows. The market approach used cash flow multiples based on a comparison of growth and profitability of the reporting units and publicly traded peer companies and a 20% enterprise control premium based on analysis of comparable transactions.

The following is a calculation of our market equity capitalization as of September 30, 2019:


(In millions, except share data)	As of September 30, 2019
Total outstanding shares		103,849,861
Share price	$	10.70
Market equity capitalization	$	1,111.2

The following is a comparison of our estimated enterprise fair value to our market enterprise value indicating an implied premium to market of 13.1%:


(In millions)	As of September 30, 2019
Estimated enterprise fair value	$	6,651.5

Market equity capitalization	$	1,111.2
Estimated fair value corporate borrowings and finance lease obligations		4,769.9
Market enterprise value	$	5,881.1

Implied premium to market		13.1%

We believe a significant reason for the difference in our current market enterprise value as compared to our estimated enterprise fair value is due to a market participant acquisition premium. We believe a market participant acquisition premium is applicable and has been historically realized in our industry. In the event of an acquisition of control of our enterprise by another market participant, this premium for control would likely be realized in the form of increased revenue opportunities, lower costs, better working capital terms and lower cost of capital. In addition, following our adoption of ASC 842, there are certain data providers in the analyst community that have characterized our operating lease liabilities as indebtedness, which has the impact of increasing our leverage as reported by these data providers. We believe inconsistencies in the reported data concerning operating leases from these data providers has caused market confusion which has negatively impacted our stock ~~declines from current levels, or if other events or circumstances change that would more likely than~~price.

Key rates used in the income and market approach were as follows:


	September 30, 2019
	Domestic	International
Description	Theatres	Theatres
Income approach:
Weighted average cost of capital/discount rate	9.0%	11.0%
Long-term growth rate	2.0%	2.0%
Market approach:
Control premium	20%	20%
Selected cash flow multiple	6.5 x	9.74 x

The enterprise fair value of the Domestic Theatres and International Theatres reporting units exceeded their enterprise carrying values by approximately 9.9% and 11.8%, respectively. Accordingly, there was no goodwill impairment recorded as of September 30, 2019. Our Domestic Theatres reporting unit has a negative equity value carrying amount.

Prior to completing the goodwill impairment test, we tested the recoverability of long-lived intangible assets in our Domestic Theatres and our International Theatres, and concluded these assets were not ~~reduce~~impaired as of September 30, 2019.

While the enterprise fair value of our reporting units ~~below~~exceed the enterprise carrying values at the present time, the performance of the reporting units may require continued improvement in future periods to maintain their ~~respective~~ carrying ~~value, all or a portion~~values. Declines in the operating performance of our ~~goodwill may be impaired~~Domestic and International Theatres, declines in ~~future periods.~~the trading price of our Class A common stock, small changes in certain key input assumptions, and/or other events or circumstances could occur and could have a significant impact on estimated fair value. Examples of ~~such~~ adverse events or circumstances that could change include (i) an adverse change in macroeconomic ~~conditions;~~conditions; (ii) increased cost factors that have a negative effect on our earnings and cash ~~flows;~~flows; (iii) negative or overall declining financial performance compared with our actual and projected results of relevant prior ~~periods;~~periods; and (iv) a further sustained decrease in our share price. A future impairment could result for a portion of the goodwill, long-lived assets or intangible assets. Any impairment charges that we may take in the future could be material to our results of operations and financial condition. ~~Our closing price per share of our common stock is in excess of our $12.12 carrying value per share as of September 30, 2018.~~

~~NCM.~~ In March 2018, we recorded in the line item, Equity in loss of non-consolidated entities, a lower of carrying value or fair value impairment charge of $16.0 million, to reduce the carrying value of our held-for-sale interests in NCM common units and NCM, Inc. common shares to LevelLeases. We adopted ASC Topic 842 effective January 1, ~~fair value as of March 31, 2018. The impairment charge reflects recording our held-for-sale units~~2019 and ~~shares at the publicly quoted per share price on March 31, 2018 of $5.19.~~

On June 18, 2018, the Company entered into two Unit Purchase Agreements (the “Agreements”) with each of Regal Cinemas, Inc. (“Regal”) and Cinemark USA, Inc. (“Cinemark”) pursuant to which Regal and Cinemark each separately agreed to purchase 10,738,740 common units of NCM at a sales price of $7.30 per unit and aggregate consideration of approximately $156.8 million (the “Sales”). The Sales closed on July 5, 2018. Following the closing of the Sales, the Company no longer owns any shares of common stock NCM, Inc. or NCM. NCM consented to the Sales and waived its rights under the memorandum of understanding that provided the Company would not reduce its combined ownership of NCM and NCM, Inc. below 4.5%. We recorded a gain on sale of $28.9 million during the three months ended September 30, 2018.

~~Screenvision Merger.~~ On May 30, 2018 Screenvision entered into an Agreement and Plan of Merger under which a change of control in Screenvision occurred upon consummation of the transactions contemplated therein. We received distributions and merger consideration of $45.9 million on July 2, 2018 upon consummation of the merger and retain a 21.2% common membership interest in Screenvision on a fully diluted basis. We reduced the carrying value of our investment in Screenvision to $0 and recorded equity in earnings for the excess distribution of $30.1 million during the three months ended September 30, 2018.

~~Sale and Leaseback Transaction:~~ On June 18, 2018, we completed the sale and leaseback of the real estate assets associated with one theatre for proceeds, net of closing costs, of $50.1 million. The gain on the sale of approximately $27.4 million has been deferred and will be amortized over the remaining lease term.

~~Fifth Amendment to Credit Agreement:~~ On August 14, 2018, we entered into the Fifth Amendment to Credit Agreement with Citicorp North America, Inc, as administrative agent and the other lenders party thereto, amending the credit Agreement dated as of April 30, 2013. The Fifth Amendment made certain changes to certain covenants and related definitions. These amendments to the Senior Secured Credit Agreement were executed in order to facilitate an internal reorganization due to recent tax changes and to make modifications which clarified certain ambiguities in the Senior Secured Credit Agreement.

~~The cash flows for the term loans due 2022 and 2023 were not changed~~ as a result of the August 14, 2018 modification and the Borrowing Capacity under the Revolving Credit Agreement was not changed. As a result, we accounted for the Fifth Amendment as a modification. We expensed $0.3 million of third party costs during the three and nine months ended September 30, 2018 and capitalized $1.5 million debt issuance costs for amounts paid to lenders.

~~Senior Unsecured Convertible Notes due 2024:~~ ~~On September 14, 2018, we issued $600.0 million aggregate principal amount of~~ our 2.95% Senior Unsecured Convertible Notes due 2024. The Convertible Notes due 2024 mature on September 15, 2024, subject to earlier conversion by the holders thereof, repurchase by AMC at the option of the holders or redemption by AMC upon the occurrence of certain contingencies,lease accounting policy has been modified as discussed ~~below. Upon maturity,~~in Note 2—Leases in the ~~$600.0 million principal amount of the Convertible~~ Notes due 2024 will be payable in cash. We will pay interest in cash on the Convertible Notes due 2024 at 2.95% per annum, semi-annually in arrears on September 15th and March 15th, commencing on March 15, 2019. We used the net proceeds from the sale of the Convertible Notes due 2024 to repurchase and retire 24,057,143 shares of Class B common stock held by Wanda for $17.50 per share or approximately $421.0 million, associated legal fees of $1.9 million, and to pay a special dividend of $1.55 per share of Class A common stock and Class B common stock, or approximately $160.5 million on September 28, 2018 to shareholders of record on September 25, 2018. See Note 6 – Corporate Borrowings for additional information on the terms of the Convertible Notes due 2024.

~~We bifurcated the conversion feature from the principal balance of the Convertible Notes due 2024 as a derivative liability because (1) a conversion feature is not clearly and closely related~~ to the ~~debt instrument~~Condensed Consolidated Financial Statements under Item 1. Lessees are required to recognize a right-of-use asset and ~~the reset~~a lease liability for virtually all of ~~the conversion price discussed in the following paragraph causes the conversion feature to not be considered indexed to our equity, (2) the conversion feature standing alone meets~~their leases (other than leases that meet the definition of a ~~derivative, and (3) the Convertible Notes due 2024 are not remeasured at fair value each reporting period with changes in fair value recorded in the consolidated statement of operations.~~short-term lease). The ~~derivative~~ liability ~~of $90.4 million~~ is ~~offset by a discount~~equal to the principal and is amortized to interest expense resulting in an effective rate of 5.98% over the term of the Convertible Notes due 2024. We also recorded debt issuance costs of approximately $12.5 million related to the issuance of the Convertible Notes due 2024 and will amortize those costs to interest expense under the effective interest method over the term of the Convertible Notes due 2024. We recorded interest expense for the period from September 14, 2018 to September 30, 2018 of $1.5 million. The derivative liability is remeasured at fair value each reporting period with changes in fair value recorded in the consolidated statement of operations as other expense or income. See Note 9 – Fair Value Measurements for a discussion of the valuation methodology. For the three months ended September 30, 2018, this resulted in a charge of $54.1 million. The if-convertedpresent value of ~~the Convertible Notes due 2024 exceeded the principal balance by approximately $49.1 million as of September 30, 2018~~lease payments. The asset is based on the ~~closing price per share~~liability, subject to certain adjustments, such as for lease incentives. For financial presentation purposes, a dual model was retained, requiring leases to be classified as either operating or finance leases. Operating leases result in straight-line expense (similar to operating leases under the prior accounting standard) while finance leases result in a front-loaded expense pattern (similar to capital leases under the prior accounting standard). We used our incremental borrowing rate to calculate the present value of our ~~common stock of $20.50 per share.~~

~~The Convertible Notes due 2024 are generally not convertible to equity in~~future operating lease payments, which was determined using a portfolio approach based on the first year after issuance. Upon conversion by a holder thereof, we shall deliver, at our election, either cash, shares of our Class A common stock or a combination of cash and shares of our Class A common stock at a conversion rate of 52.7704 per $1,000 principal amount of the Convertible Notes due 2024 (which represents an initial conversion price of $18.95), in each case subject to customary anti-dilution adjustments. As of September 30, 2018, the $600.0 million principal balance of the Convertible Notes due 2024 would be convertible into 31,662,269 shares of Class A common stock. In addition to typical anti-dilution adjustments, in the event that the then-applicable conversion price is greater than 120% of the average of the volume-weighted average price of our Class A common stock for the ten days prior to the second anniversary of issuance, the conversion price for the Convertible Notes due 2024 is subject to a reset provision that would adjust the conversion price downward to such Reset Conversion Price. However, this conversion price reset provision is subject to a conversion price floor such that the shares of our Class A common stock issuable upon conversion would not exceed 30% of our then outstanding fully-diluted share capital after giving effect to the conversion. In addition, a trigger of the reset provision would result in up to 5,666,000 shares of our Class B common stock held by Wanda becoming subject to forfeiture and retirement by AMC at no additional cost pursuant to the stock

repurchase agreement between us and Wanda discussed in Note 7 – Stockholders’ Equity. Additionally, the conversion rate will be adjusted if any cash dividend or distribution is made to all or substantially all holders of our common stock (other than the special dividend referenced above and a regular, quarterly cash dividend that does not exceed $0.20 per share until the second anniversary of issuance and $0.10 per share thereafter). Any Convertible Notes due 2024 that are converted in connection with a Make-Whole Fundamental Change (as defined in the indenture governing the Convertible Notes due 2024) are, under certain circumstances, entitled to an increase in the conversion rate.

We have the option to redeem the Convertible Notes due 2024 for cash on or after the fifth anniversary of issuance at par if the price for our Class A common stock is equal to or greater than 150% of the then applicable conversion price for 20 or more trading days out of a consecutive 30 day trading period (including the final three trading days), at which time the holders have the option to convert. We also have the option to redeem the Convertible Notes due 2024, between the second and third anniversary of issuance, if the reset provision described above is triggered at a redemption price in cash that would result in the noteholders realizing a 15% IRR from the date of issuance regardless of when any particular noteholder acquired its Convertible Notes due 2024. We also bifurcated this redemption feature from the principal balance of the Convertible Notes due 2024 and considered it as a part of the overall fair value of the derivative liability.

With certain exceptions, upon a change of control of AMC or if our Class A common stock is not listed for trading on The New York Stock Exchange, The NASDAQ Global Select Market or The NASDAQ Global Market, the holders of the Convertible Notes due 2024 may requireinterest that we ~~repurchase in cash all or part of the principal~~would have to pay to borrow an amount ~~of the Convertible Notes due 2024 at a purchase price~~ equal to the principal amount plus accrued and unpaid interest up to, but excluding, the date of repurchase. The Indenture includes restrictive covenants that, subject to specified exceptions and parameters, limit the ability of us to incur additional debt and limit the ability of us to incur liens with respect to our senior subordinated notes or any debt incurred to refinance our senior subordinated notes. The Indenture also includes customary events of default, which may result in the acceleration of the maturity of the Convertible Notes due 2024 under the Indenture.

~~The Convertible Notes due 2024 are general unsecured senior obligations of AMC and are fully and unconditionally guaranteed~~lease payments on a ~~joint and several senior unsecured~~collateralized basis ~~by all of our existing and future domestic restricted subsidiaries that guarantee its other indebtedness.~~over a similar term.

~~Special Dividend:~~ On September 14, 2018, our Board of Directors declared a special cash dividend in the amount of $1.55 per share of Class A and Class B common stock, payable on September 28, 2018 to stockholders of record on September 25, 2018.

Dividends. The following is a summary of dividends and dividend equivalents declared to stockholders:


			Amount per		Total Amount
			Share of		Declared
Declaration Date	Record Date	Date Paid	Common Stock		(In millions)
August 2, 2019	September 9, 2019	September 23, 2019	$	0.20	$	21.3
May 3, 2019	June 10, 2019	June 24, 2019		0.20		21.3
February 15, 2019	March 11, 2019	March 25, 2019		0.20		21.3
November 1, 2018	December 10, 2018	December 26, 2018		0.20		21.2
September 14, 2018	September 25, 2018	September 28, 2018		1.55		162.9
July 24, 2018	September 10, 2018	September 24, 2018		0.20		25.8
May 3, 2018	June 11, 2018	June 25, 2018		0.20		26.0
February 28, 2018	March 12, 2018	March 26, 2018		0.20		26.0

Amount per

Total Amount

Share of

Declared
Declaration Date

Record Date

Date Paid

Common Stock

(In millions)
February 28, 2018

March 12, 2018

March 26, 2018

$
0.20

$
26.0
May 3, 2018

June 11, 2018

June 25, 2018

0.20

26.0
July 24, 2018

September 10, 2018

September 24, 2018

0.20

25.8
September 14, 2018

September 25, 2018

September 28, 2018

1.55

162.9

During the nine months ended September 30, ~~2018~~2019 and September 30, ~~2017,~~2018, we paid dividends and dividend equivalents of ~~$237.4~~$63.4 million and ~~$78.7~~$237.4 million, respectively. As of September 30, ~~2018,~~2019, we accrued ~~$3.7~~$3.9 million for the remaining unpaid dividends.

On ~~November 1, 2018,~~October 24, 2019, we declared a cash dividend in the amount of $0.20 per share ofon our Class A and Class B common stock, payable on December ~~26, 2018~~16, 2019 to stockholders of record on December ~~10, 2018.~~2, 2019.

Stock Repurchases. On August 3, 2017, we announced that our Board of Directors had approved a $100.0 million share repurchase program to repurchase our Class A common stock over a two-year period.

Repurchases may be made at management's discretion from time to time through open-market transactions including block purchases, through privately negotiated transactions, or otherwise over the next two years in accordance with all applicable securities laws and regulations. The extent to which AMC repurchases its shares, and the timing of

such repurchases, will depend upon a variety of factors, including liquidity, capital needs of the business, market conditions, regulatory requirements, and other corporate considerations, as determined by AMC’s management team. Repurchases may be made under a Rule 10b5-1 plan, which would permit common stock to be repurchased when our management might otherwise be precluded from doing so under insider trading laws. The repurchase program does not obligate us to repurchase any minimum dollar amount or number of shares and may be suspended for periods or discontinued at any time. This program expired on August 2, 2019. During the ~~nine months ended September 30, 2018,~~program, we repurchased ~~500,000~~3,695,856 shares for approximately $55.7 million and at an average price of ~~Class A common stock at a cost of $8.2 million. As of September 30, 2018, we had $44.3 million remaining available for repurchases under this plan.~~$14.87 per share.

AMC Shares Repurchased from ~~Wanda:~~ Wanda. On September 14, 2018, we issued $600.0 million of Convertible Notes due 2024. Using proceeds from the Convertible Notes, we repurchased 24,057,143 shares from Wanda at a price of $17.50 per share or $421.0 million and associated legal fees of ~~$1.9~~$2.6 million. As of September 30, ~~2018,~~2019, Wanda owns ~~50.01%~~49.85% of AMC through its 51,769,784 shares of Class B common stock. With the 3 to 1 voting rights of Class B common shares, Wanda retains voting control of AMC.

~~Nordic Acquisition.~~ On March 28, 2017, we completed the acquisition of Nordic Cinema Group. As such, three months of Nordic financial results are included in the Management’s Discussion and Analysis for the three months ended September 30, 2017, while six months and four days of Nordic financial results are included for the nine months ended September 30, 2017 and nine months of Nordic financial results are included for the nine months ended September 30, 2018.

~~(1)~~

Equity in (earnings) loss of non-consolidated entities includes a lower of cost or fair value impairment of our held-for-sale investment in NCM of $16.0 million for the nine months ended September 30, 2018. The nine months ended September 30, 2017 included an other-than-temporary impairment loss of $204.5 million, respectively, on our investment in NCM.

Segment Operating Results

The following table sets forth our revenues, operating costs and expenses by reportable segment.


	U.S. Markets				International Markets				Consolidated
	Three Months Ended				Three Months Ended				Three Months Ended
	September 30,				September 30,				September 30,

													U.S. Markets				International Markets				Consolidated
													Three Months Ended				Three Months Ended				Three Months Ended
													September 30,				September 30,				September 30,
(In millions)	2018		2017		2018		2017		2018		2017		2019		2018		2019		2018		2019		2018
Revenues
Admissions	$	539.0	$	531.7	$	212.4	$	221.8	$	751.4	$	753.5	$	578.1	$	539.0	$	219.2	$	212.4	$	797.3	$	751.4
Food and beverage		301.4		278.3		83.4		83.1		384.8		361.4		327.0		301.4		93.0		83.4		420.0		384.8
Other theatre		55.2		35.7		30.0		28.1		85.2		63.8		65.6		55.2		33.9		30.0		99.5		85.2
Total revenues		895.6		845.7		325.8		333.0		1,221.4		1,178.7		970.7		895.6		346.1		325.8		1,316.8		1,221.4
Operating Costs and Expenses
Film exhibition costs		289.0		269.2		89.8		95.6		378.8		364.8		321.7		289.0		95.1		89.8		416.8		378.8
Food and beverage costs		43.9		41.2		19.7		19.5		63.6		60.7		46.5		43.9		20.7		19.7		67.2		63.6
Operating expense		283.5		272.9		117.0		110.3		400.5		383.2		303.7		283.5		115.3		117.0		419.0		400.5
Rent		152.1		148.2		51.6		52.5		203.7		200.7		174.9		152.1		63.8		51.6		238.7		203.7
General and administrative expense:
Merger, acquisition and transaction costs		9.0		3.7		9.1		1.9		18.1		5.6
Merger, acquisition and other costs														2.3		9.0		2.4		9.1		4.7		18.1
Other		31.7		16.8		16.7		15.8		48.4		32.6		22.1		31.7		15.4		16.7		37.5		48.4
Depreciation and amortization		94.2		98.9		36.0		36.3		130.2		135.2		84.3		94.2		27.8		36.0		112.1		130.2
Operating costs and expenses		903.4		850.9		339.9		331.9		1,243.3		1,182.8		955.5		903.4		340.5		339.9		1,296.0		1,243.3
Operating income (loss)		(7.8)		(5.2)		(14.1)		1.1		(21.9)		(4.1)		15.2		(7.8)		5.6		(14.1)		20.8		(21.9)
Other expense (income):
Other (income) expense		54.6		(0.3)		(0.5)		(0.1)		54.1		(0.4)
Other expense (income)														(1.6)		54.6		0.3		(0.5)		(1.3)		54.1
Interest expense:
Corporate borrowings		63.5		60.3		0.8		0.5		64.3		60.8		72.4		63.5		0.8		0.8		73.2		64.3
Capital and financing lease obligations		4.3		5.0		5.1		5.6		9.4		10.6		0.5		4.3		1.3		5.1		1.8		9.4
Non-cash NCM exhibitor service agreement		10.3		—		—		—		10.3		—		10.1		10.3		—		—		10.1		10.3
Equity in (earnings) loss of non-consolidated entities		(67.4)		2.7		(2.6)		(0.9)		(70.0)		1.8
Investment (income) expense		(0.7)		(17.0)		—		0.4		(0.7)		(16.6)
Equity in earnings of non-consolidated entities														(7.2)		(67.4)		(0.3)		(2.6)		(7.5)		(70.0)
Investment income														(0.4)		(0.7)		(0.1)		—		(0.5)		(0.7)
Total other expense		64.6		50.7		2.8		5.5		67.4		56.2		73.8		64.6		2.0		2.8		75.8		67.4
Loss before income taxes		(72.4)		(55.9)		(16.9)		(4.4)		(89.3)		(60.3)
Earnings (loss) before income taxes														(58.6)		(72.4)		3.6		(16.9)		(55.0)		(89.3)
Income tax provision (benefit)		12.1		(18.9)		(1.0)		1.3		11.1		(17.6)		(0.4)		12.1		0.2		(1.0)		(0.2)		11.1
Net loss	$	(84.5)	$	(37.0)	$	(15.9)	$	(5.7)	$	(100.4)	$	(42.7)
Net earnings (loss)													$	(58.2)	$	(84.5)	$	3.4	$	(15.9)	$	(54.8)	$	(100.4)


	U.S. Markets		International Markets		Consolidated
	Three Months Ended		Three Months Ended		Three Months Ended
	September 30,		September 30,		September 30,
	2019	2018	2019	2018	2019	2018
Segment Operating Data:
Screen additions	—	—	1	6	1	6
Screen acquisitions	—	8	—	—	—	8
Screen dispositions	70	30	7	13	77	43
Construction openings (closures), net	6	22	(21)	(10)	(15)	12
Average screens (1)	7,996	7,992	2,666	2,634	10,662	10,626
Number of screens operated	8,043	8,080	2,902	2,891	10,945	10,971
Number of theatres operated	634	639	366	363	1,000	1,002
Screens per theatre	12.7	12.6	7.9	8.0	10.9	10.9
Attendance (in thousands) (1)	61,172	58,935	25,928	23,727	87,100	82,662

U.S. Markets

International Markets

Consolidated

Three Months Ended

Three Months Ended

Three Months Ended

September 30,

September 30,

September 30,

2018

2017

2018

2017

2018

2017
Segment Operating Data:

Screen additions

—

21

6

1

6

22
Screen acquisitions

8

15

—

—

8

15
Screen dispositions

30

16

13

5

43

21
Construction openings (closures), net

22

(30)

(10)

(23)

12

(53)
Average screens (1)

7,992

8,028

2,634

2,679

10,626

10,707
Number of screens operated

8,080

8,139

2,891

2,907

10,971

11,046
Number of theatres operated

639

645

363

361

1,002

1,006
Screens per theatre

12.6

12.6

8.0

8.1

10.9

11.0
Attendance (in thousands) (1)

58,935

54,269

23,727

25,182

82,662

79,451

(1)

Includes consolidated theatres only and excludes screens offline due to construction.

6657

Table of Contents


	U.S. Markets				International Markets				Consolidated
	Nine Months Ended				Nine Months Ended				Nine Months Ended
	September 30,				September 30,				September 30,

													U.S. Markets				International Markets				Consolidated
													Nine Months Ended				Nine Months Ended				Nine Months Ended
													September 30,				September 30,				September 30,
(In millions)	2018		2017		2018		2017		2018		2017		2019		2018		2019		2018		2019		2018
Revenues
Admissions	$	1,837.9	$	1,716.3	$	684.8	$	616.1	$	2,522.7	$	2,332.4	$	1,774.1	$	1,837.9	$	650.2	$	684.8	$	2,424.3	$	2,522.7
Food and beverage		982.2		904.7		254.2		228.4		1,236.4		1,133.1		1,015.7		982.2		265.6		254.2		1,281.3		1,236.4
Other theatre		187.0		124.2		101.4		72.7		288.4		196.9		209.3		187.0		108.4		101.4		317.7		288.4
Total revenues		3,007.1		2,745.2		1,040.4		917.2		4,047.5		3,662.4		2,999.1		3,007.1		1,024.2		1,040.4		4,023.3		4,047.5
Operating Costs and Expenses
Film exhibition costs		996.6		904.7		280.1		259.5		1,276.7		1,164.2		989.2		996.6		275.4		280.1		1,264.6		1,276.7
Food and beverage costs		142.4		129.7		59.6		52.9		202.0		182.6		145.6		142.4		59.5		59.6		205.1		202.0
Operating expense		866.0		824.3		370.9		304.5		1,236.9		1,128.8		910.2		866.0		349.0		370.9		1,259.2		1,236.9
Rent		430.8		445.6		162.3		145.3		593.1		590.9		531.1		430.8		195.5		162.3		726.6		593.1
General and administrative expense:
Merger, acquisition and transaction costs		15.2		54.3		11.9		2.9		27.1		57.2
Merger, acquisition and other costs														5.8		15.2		5.4		11.9		11.2		27.1
Other		84.7		67.8		50.9		45.2		135.6		113.0		74.4		84.7		52.5		50.9		126.9		135.6
Depreciation and amortization		285.6		294.3		112.8		99.6		398.4		393.9		252.2		285.6		84.9		112.8		337.1		398.4
Operating costs and expenses		2,821.3		2,720.7		1,048.5		909.9		3,869.8		3,630.6		2,908.5		2,821.3		1,022.2		1,048.5		3,930.7		3,869.8
Operating income (loss)		185.8		24.5		(8.1)		7.3		177.7		31.8		90.6		185.8		2.0		(8.1)		92.6		177.7
Other expense (income):
Other (income) expense		56.2		(2.1)		1.3		0.2		57.5		(1.9)
Other expense														4.6		56.2		0.5		1.3		5.1		57.5
Interest expense:
Corporate borrowings		185.5		170.2		2.7		1.5		188.2		171.7		216.5		185.5		2.2		2.7		218.7		188.2
Capital and financing lease obligations		13.2		15.3		16.3		16.4		29.5		31.7		1.8		13.2		4.2		16.3		6.0		29.5
Non-cash NCM exhibitor service agreement		31.2		—		—		—		31.2		—		30.4		31.2		—		—		30.4		31.2
Equity in (earnings) loss of non-consolidated entities (1)		(71.0)		200.1		(3.0)		(1.0)		(74.0)		199.1
Investment (income) expense		(7.4)		(22.3)		—		0.7		(7.4)		(21.6)
Total other expense		207.7		361.2		17.3		17.8		225.0		379.0
Loss before income taxes		(21.9)		(336.7)		(25.4)		(10.5)		(47.3)		(347.2)
Equity in earnings of non-consolidated entities (1)														(23.2)		(71.0)		(1.0)		(3.0)		(24.2)		(74.0)
Investment income														(5.7)		(7.4)		(13.0)		—		(18.7)		(7.4)
Total other expense (income)														224.4		207.7		(7.1)		17.3		217.3		225.0
Earnings (loss) before income taxes														(133.8)		(21.9)		9.1		(25.4)		(124.7)		(47.3)
Income tax provision (benefit)		14.6		(138.0)		(1.4)		1.6		13.2		(136.4)		8.9		14.6		2.0		(1.4)		10.9		13.2
Net loss	$	(36.5)	$	(198.7)	$	(24.0)	$	(12.1)	$	(60.5)	$	(210.8)
Net earnings (loss)													$	(142.7)	$	(36.5)	$	7.1	$	(24.0)	$	(135.6)	$	(60.5)


	U.S. Markets		International Markets		Consolidated
	Nine Months Ended		Nine Months Ended		Nine Months Ended
	September 30,		September 30,		September 30,
	2019	2018	2019	2018	2019	2018
Segment Operating Data:
Screen additions	21	26	17	20	38	46
Screen acquisitions	64	31	—	8	64	39
Screen dispositions	121	155	60	22	181	177
Construction openings (closures), net	(35)	(46)	(32)	(60)	(67)	(106)
Average screens (1)	8,001	8,032	2,673	2,667	10,674	10,699
Number of screens operated	8,043	8,080	2,902	2,891	10,945	10,971
Number of theatres operated	634	639	366	363	1,000	1,002
Screens per theatre	12.7	12.6	7.9	8.0	10.9	10.9
Attendance (in thousands) (1)	188,051	190,542	75,829	74,296	263,880	264,838

U.S. Markets

International Markets

Consolidated

Nine Months Ended

Nine Months Ended

Nine Months Ended

September 30,

September 30,

September 30,

2018

2017

2018

2017

2018

2017
Segment Operating Data:

Screen additions

26

30

20

34

46

64
Screen acquisitions

31

37

8

683

39

720
Screen dispositions

155

218

22

39

177

257
Construction openings (closures), net

(46)

(3)

(60)

(36)

(106)

(39)
Average screens (1)

8,032

8,083

2,667

2,557

10,699

10,640
Number of screens operated

8,080

8,139

2,891

2,907

10,971

11,046
Number of theatres operated

639

645

363

361

1,002

1,006
Screens per theatre

12.6

12.6

8.0

8.1

10.9

11.0
Attendance (in thousands) (1)

190,542

179,041

74,296

75,400

264,838

254,441

(1)

Includes consolidated theatres only and excludes screens offline due to construction.

~~Table of Contents~~

Adjusted EBITDA

We present Adjusted EBITDA as a supplemental measure of our performance. We define Adjusted EBITDA as net earnings (loss) plus (i) income tax provision (benefit), (ii) interest expense and (iii) depreciation and amortization, as further adjusted to eliminate the impact of certain items that we do not consider indicative of our ongoing operating performance and to include attributable EBITDA from equity investments in theatre operations in international markets and any cash distributions of earnings from other equity method investees. These further adjustments are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we may

Table of Contents

incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

Adjusted EBITDA ~~decreased~~increased by ~~$5.0~~$14.1 million ~~or 3.4%~~ during the three months ended September 30, ~~2018~~2019 compared to the three months ended September 30, ~~2017.~~2018. Adjusted EBITDA in U.S. markets ~~decreased~~increased by ~~$2.6~~$11.3 million ~~or 2.4%~~primarily due to the increase in attendance, food and beverage per patron, and average ticket price, partially offset by the increased rent due to the new lease standard that reduced Adjusted EBITDA by approximately $12.8 million. Adjusted EBITDA in international markets increased $2.8 million primarily due to increases in ~~certain general~~attendance and ~~administrative: other expense, declines in cash distributions from non-consolidated entities,~~food and beverage per patron, partially offset by ~~increases in attendance and~~increased rent due to the new ~~revenue recognition standard.~~lease standard that reduced Adjusted EBITDA ~~in international markets decreased $2.4~~by approximately $9.9 million ~~or 6.0% primarily due to~~and a decrease in foreign currency translation ~~rates and declines~~rates. See Note 2—Leases in ~~attendance.~~the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Adjusted EBITDA ~~increased~~decreased by ~~$130.8~~$162.8 million ~~or 24.5%~~ during the nine months ended September 30, ~~2018~~2019 compared to the nine months ended September 30, 2017. Adjusted EBITDA in U.S. markets increased by $115.0 million or 27.3% primarily due to increases in attendance and decreases in rent expense related to a lease modification during the nine months ended September 30, 2018. Adjusted EBITDA in ~~international~~U.S. markets ~~increased $15.8~~decreased by $139.8 million ~~or 13.9%~~ primarily due to ~~increases~~the modification of a lease in ~~attendance from~~ the ~~Nordic acquisition on March 28, 2017~~prior year that reduced rent expense in 2018 by $35.0 million, increased rent due to the new lease standard that reduced Adjusted EBITDA by approximately $38.4 million, and ~~improvements~~the decrease in attendance. Adjusted EBITDA in international markets decreased $23.0 million primarily due to increased rent due to the new lease standard that reduced Adjusted EBITDA by approximately $29.7 million and a decrease in foreign currency translation ~~rates.~~rates, partially offset by an increase in attendance and food and beverage per patron. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

The following tables set forth our Adjusted EBITDA by reportable operating segment and our reconciliation of Adjusted EBITDA:


	Three Months Ended				Nine Months Ended
Adjusted EBITDA (In millions)	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
U.S. markets (1)	$	116.3	$	105.0	$	395.8	$	535.6
International markets		40.2		37.4		106.5		129.5
Total Adjusted EBITDA	$	156.5	$	142.4	$	502.3	$	665.1

Three Months Ended

Nine Months Ended
Adjusted EBITDA (In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
U.S. markets (1)

$
105.0

$
107.6

$
535.6

$
420.6
International markets

37.4

39.8

129.5

113.7
Total Adjusted EBITDA

$
142.4

$
147.4

$
665.1

$
534.3

(1)

Distributions from NCM are reported entirely within the U.S. markets segment.


	Three Months Ended				Nine Months Ended
(In millions)	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
Net loss	$	(54.8)	$	(100.4)	$	(135.6)	$	(60.5)
Plus:
Income tax provision (benefit)		(0.2)		11.1		10.9		13.2
Interest expense		85.1		84.0		255.1		248.9
Depreciation and amortization		112.1		130.2		337.1		398.4
Certain operating expenses (1)		5.3		6.6		10.1		16.2
Equity in earnings of non-consolidated entities (2)		(7.5)		(70.0)		(24.2)		(74.0)
Cash distributions from non-consolidated entities (3)		4.7		3.1		17.0		30.9
Attributable EBITDA (4)		0.9		2.1		3.8		3.7
Investment income		(0.5)		(0.7)		(18.7)		(7.4)
Other expense (income) (5)		(1.5)		54.1		4.6		57.7
Non-cash rent - purchase accounting (6)		6.1		—		19.5		—
General and administrative — unallocated:
Merger, acquisition and other costs (7)		4.7		18.1		11.2		27.1
Stock-based compensation expense (8)		2.1		4.2		11.5		10.9
Adjusted EBITDA	$	156.5	$	142.4	$	502.3	$	665.1

Three Months Ended

Nine Months Ended
(In millions)

September 30, 2018

September 30, 2017

September 30, 2018

September 30, 2017
Net earnings (loss)

$
(100.4)

$
(42.7)

$
(60.5)

$
(210.8)
Plus:

Income tax provision (benefit)

11.1

(17.6)

13.2

(136.4)
Interest expense

84.0

71.4

248.9

203.4
Depreciation and amortization

130.2

135.2

398.4

393.9
Certain operating expenses (1)

6.6

3.7

16.2

12.5
Equity in (earnings) loss of non-consolidated entities (2)

(70.0)

1.8

(74.0)

199.1
Cash distributions from non-consolidated entities (3)

3.1

6.5

30.9

33.1
Attributable EBITDA (4)

2.1

0.8

3.7

1.8
Investment (income) expense

(0.7)

(16.6)

(7.4)

(21.6)
Other expense (income) (5)

54.1

(0.6)

57.7

(1.8)
General and administrative — unallocated:

Merger, acquisition and transaction costs (6)

18.1

5.6

27.1

57.2
Stock-based compensation expense (7)

4.2

(0.1)

10.9

3.9
Adjusted EBITDA

$
142.4

$
147.4

$
665.1

$
534.3

~~Table of Contents~~

(1)

Table of Contents

included in operating expenses. We have excluded these items as they are non-cash in nature, include components of interest cost for the time value of money or are non-operating in nature.

(2)

~~During~~For the three and nine months ended September 30, 2019, we recorded $6.5 million and $21.1 million, respectively, in earnings from DCIP. For the three months ended September 30, 2018, we recorded equity in earnings related to our sale of all remaining NCM units of $28.9 million and a gain of $30.1 million related to the Screenvision merger. Equity in ~~loss~~earnings of non-consolidated entities also includes loss on the surrender (disposition) of a portion of our investment in NCM of $1.1 million during the nine months ended September 30, 2018. Equity in ~~(earnings) loss~~earnings of non-consolidated entities ~~includes a lower of carrying value or fair value impairment loss of the held-for sale portion of our investment in NCM of $16.0 million~~ for the nine months ended September 30, ~~2018. The nine months ended September 30, 2017 included an other-than-temporary~~2018 includes a lower of carrying value impairment ~~loss of $204.5 million, on our investment in NCM. The three months ended September 30, 2017 included a~~ loss on the ~~sale~~held-for-sale portion of NCM ~~shares~~ of ~~$21.0~~$16.0 million. The impairment charges reflect recording our held-for-sale units and other-than-temporary impaired shares at the publicly quoted per share price on March 31, 2018 of $5.19 and June 30, 2017 of $7.42.

(3)

IncludesU.S. non-theatre distributions from equitymethod investments and International ~~non-theatre~~ non-theatredistributions fromequitymethod investments to the extent received. We believe including cash distributionsis an appropriatereflection ofthe contribution of ~~the contribution of~~ these investments to our operations.

(4)

Attributable EBITDA includes the EBITDA from equity investments in theatre operators in certain international markets. See below for a reconciliation of our equity (earnings) loss of non-consolidated entities to attributable EBITDA. Because these equity investments are in theatre operators in regions where we hold a significant market share, we believe attributable EBITDA is more indicative of the performance of these equity investments and management uses this measure to monitor and evaluate these equity investments. We also provide services to these theatre operators including information technology systems, certain on-screen advertising services and our gift card and package ticket program. As these investments relate only to our Nordic acquisition, the second quarter of 2017 represents the first time we made this adjustment and does not impact prior historical presentations of Adjusted EBITDA.


	Three Months Ended				Nine Months Ended
(In millions)	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
Equity in earnings of non-consolidated entities	$	(7.5)	$	(70.0)	$	(24.2)	$	(74.0)
Less:
Equity in earnings of non-consolidated entities excluding International theatre JV's		(7.4)		(68.5)		(23.2)		(72.1)
Equity in earnings of International theatre JV's		0.1		1.5		1.0		1.9
Income tax provision		0.1		0.1		0.2		0.2
Investment income		(0.1)		(0.1)		(0.6)		(0.3)
Interest expense		—		—		0.1		—
Depreciation and amortization		0.5		0.6		2.8		1.9
Other expense		0.3		—		0.3		—
Attributable EBITDA	$	0.9	$	2.1	$	3.8	$	3.7

(5)

Other expense (income) for the three months ended September 30, 2019 includes income of $8.5 million due to the increase in fair value of our derivative asset for the Convertible Notes due 2024, expense of $5.7 million as a result of a decrease in the fair value of our derivative liability, and loss on Pound sterling forward contract of $0.7 million. Other expense for the nine months ended September 30, ~~2018~~2019 includes ~~financing losses~~$16.6 million of fees related to modifications of term loans income and ~~financing related foreign currency transaction losses.~~$1.7 million loss on GBP forward contract, partially offset by income of $14.9 million due to the decrease in fair value of our derivative liability for the Convertible Notes due 2024. During the three months ended September 30, 2018, we recorded expense of $54.1 million as a result of an increase in fair value of ~~our~~the derivative liability for the Convertible Notes due 2024.

Other expense (income) for the three and nine months ended September 30, 2018 includes financing losses and financing related foreign currency transaction losses.

(6)

Reflects amortization of certain intangible assets reclassified from depreciation and amortization to rent expense, due to the adoption of ASC 842.

(7)

Merger, acquisition and ~~transition~~other costs are excluded as they are non-operating in nature.

~~(7)~~

(8)

Stock-based compensation expense is non-cash ~~or non-recurring~~ expense included in general and administrative: ~~other~~

other.

Table of Contents

Adjusted EBITDA is a non-GAAP financial measure commonly used in our industry and should not be construed as an alternative to net earnings (loss) as an indicator of operating performance (as determined in accordance with U.S. GAAP). Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. We have included Adjusted EBITDA because we believe it provides management and investors with additional information to measure our performance and estimate our value.

Adjusted EBITDA has important limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. For example, Adjusted EBITDA:

●

does not reflect our capital expenditures, future requirements for capital expenditures or contractual commitments;

●

does not reflect changes in, or cash requirements for, our working capital needs;

●

does not reflect the significant interest expenses, or the cash requirements necessary to service interest or principal payments, on our debt;

●

excludes income tax payments that represent a reduction in cash available to us;

●

does not reflect any cash requirements for the assets being depreciated and amortized that may have to be replaced in the future; and

●

does not reflect the impact of divestitures that were required in connection with recently completed acquisitions.

~~International Segment Information~~

~~We acquired Nordic on March 28, 2017 and our results of operations include Nordic from the acquisition date forward.~~

Results of Operations—For the Three Months Ended September 30, ~~2018~~2019 and September 30, ~~2017~~2018

Condensed Consolidated Results of Operations

Revenues. Total revenues increased ~~3.6%~~7.8%, or ~~$42.7~~$95.4 million, during the three months ended September 30, ~~2018~~2019 compared to the three months ended September 30, ~~2017.~~2018. Admissions revenues ~~decreased 0.3%~~increased 6.1%, or ~~$2.1~~ $45.9 million during the three months ended September 30, ~~2018~~2019 compared to the three months ended September 30, 2017, primarily due to a 4.2% decrease in average ticket price, partially offset by a 4.0% increase in attendance. The decrease in average ticket price was primarily due to discounted pricing programs for our AMC Stubs members, increased attendance from our A-List loyalty program, and the decreased popularity and related decline in attendance for 3D and IMAX content, offset by increases in attendance for PLF premium content in U.S. Markets and price increases in our International Markets. The increase in attendance was primarily due to the popularity of films (for U.S. Markets) released in the quarter as compared to the same period a year ago, partially offset by a decline in attendance due to the lack of popular films compared to last year (for International Markets), increased competition in international markets and temporary screen closures for international theatre refurbishments.

Food and beverage revenues increased 6.5%, or $23.4 million, during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to the increase in attendance and a 2.3% increase in food and beverage revenues per patron. Food and beverage revenues per patron increased as a result of price increases in our International Markets.

Total other theatre revenues increased 33.5%, or $21.4 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to increases in ticketing fees and advertising including gross up for third party ticket fees of $3.9 million and increases from non-cash NCM ESA interest of $10.3 million, offset by a $3.8 million reduction in NCM ESA principal amortization in our U.S. Markets. Other revenues in our International Markets increased primarily due to increased ticket fees. See Note 1–Basis of Presentation for a further discussion of the increases in other revenues related to ASC 606.

~~Table of Contents~~

~~Operating costs and expenses.~~ Operating costs and expenses increased 5.1%, or $60.5 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017. Film exhibition costs increased 3.8%, or $14.0 million, during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to the increase in film exhibition cost percentage. As a percentage of admissions revenues, film exhibition costs were 50.4% for the three months ended September 30, 2018 and 48.4% for the three months ended September 30, 2017. The increase in film exhibition costs percentage is primarily due to our A-list loyalty program in the U.S. Markets in the current year, where admissions revenues are fixed based on a monthly fee of $19.95, while the related film rental is variable and based on retail ticket prices.

Food and beverage costs increased 4.8%, or $2.9 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017. The increase in food and beverage costs was primarily due to the increase in food and beverage revenues, offset by a decline in food and beverage costs as a percentage of revenues. As a percentage of food and beverage revenues, food and beverage costs were 16.5% for the three months ended September 30, 2018 and 16.8% for the three months ended September 30, 2017. Food and beverage gross profit per patron increased 2.7% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.

As a percentage of revenues, operating expense was 32.8% for the three months ended September 30, 2018 and 32.5% for the three months ended September 30, 2017. Rent expense increased 1.5%, or $3.0 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017.

~~Merger, acquisition and transaction costs.~~ Merger, acquisition and transaction costs were $18.1 million during the three months ended September 30, 2018 compared to $5.6 million during the three months ended September 30, 2017, primarily due to the write-off of $8.0 million of deferred costs related to an Odeon proposed public offering and $6.3 million of expense relating to an arbitration ruling on a pre-acquisition date rent dispute for Odeon.

~~Other.~~ Other general and administrative expense increased $15.8 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, due to increased fees for a legal settlement, higher bonus expense related to improvements in operating performance and increases in stock-based compensation expense.

~~Depreciation and amortization.~~ Depreciation and amortization decreased $5.0 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to the prior year impairment charges and adjustments to the estimated fair value of property, net acquired in the Carmike acquisition, partially offset by capital expenditures of $374.9 million during the nine months ended September 30, 2018 and $628.8 million during the year ended December 31, 2017.

~~Other Expense (Income):~~

~~Other expense.~~ Other expense increased $54.5 million during the three months ended September 30, 2018 and is primarily due to a $54.1 million charge for the derivative liability related to the embedded conversion feature for the Convertible Notes due 2024. See Note 6 – Corporate Borrowings for additional information on the terms of the Convertible Notes due 2024.

~~Interest expense.~~ Interest expense increased $12.6 million to $84.0 million for the three months ended September 30, 2018 compared to $71.4 million for the three months ended September 30, 2017 primarily due to a non-cash NCM ESA expense of $10.3 million recorded due to adoption of ASC 606 – Revenue Recognition, that required us to reflect an interest component for our long-term performance obligation. Additionally, on September 14, 2018, we issued $600.0 million of our 2.95% Convertible Notes due 2024.

~~Equity in (earnings) losses of non-consolidated entities.~~ Equity in earnings of non-consolidated entities were $70.0 million for the three months ended September 30, 2018 compared to equity losses of $1.8 million for the three months ended September 30, 2017. During the three months ended September 30, 2018, we recorded equity in earnings of $28.9 million related to the sale of all of our remaining interest in NCM and $30.1 million related to the Screenvision merger. During the three months ended September 30, 2017, we incurred a loss on sales of NCM shares of $21.0 million, partially offset by an increase in earnings from NCM of $6.7 million. See Note 5 – Investments of the Notes to the

~~Table of Contents~~

~~Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.~~

~~Investment income.~~ Investment income was $0.7 million for the three months ended September 30, 2018 compared to investment income of $16.6 million for the three months ended September 30, 2017. Investment income for the three months ended September 30, 2017 includes a $17.0 million gain on the sale of our investment in Open Road.

~~Income tax provision (benefit).~~ The income tax provision was $11.1 million for the three months ended September 30, 2018 and income tax benefit was $17.6 million for the three months ended September 30, 2017. See Note 8–Income Taxes of the Notes to the Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

~~Net loss.~~ Net loss was $100.4 million and $42.7 million during the three months ended September 30, 2018 and September 30, 2017, respectively. Net loss during the three months ended September 30, 2018 compared to the three months ended September 30, 2017 were negatively impacted by the $54.1 million charge for the derivative liability related to the embedded conversion feature for the Convertible Notes due 2024, higher income tax provision, increases in general and administrative: other, and merger and acquisition costs, decreases in investment income, and higher interest expense, partially offset by improvements in equity in earnings and gross profit.

~~Theatrical Exhibition–U.S. Markets~~

~~Revenues.~~ Total revenues increased 5.9% or $49.9 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017. Admissions revenues increased 1.4%, or $7.3 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to an 8.6% increase in attendance, offset by a decline in average ticket price of 6.6%. The increase in attendance was due to the popularity of film product compared to the prior year. The decrease in average ticket price was primarily due to discounted pricing for our AMC Stubs members, increased attendance from our A-list loyalty program, and decreased popularity and related decrease in attendance for 3D and IMAX content, offset by increased attendance for PLF premium content.

Food and beverage revenues increased 8.3%, or $23.1 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to the increase in attendance, offset by a 0.4% decrease in food and beverage per patron. Food and beverage revenues per patron decreased primarily due to attendance from A-list and AMC Stubs members producing a lower food and beverage revenue per person rate.

Total other theatre revenues increased 54.6%, or $19.5 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to increases in ticket fees and higher advertising revenues including gross up for third party ticket fees of $3.8 million and increases from non-cash NCM ESA interest of $10.3 million, offset by a $3.8 million reduction in NCM ESA principal amortization. See Note 1–Basis of Presentation for a further discussion of increases in other revenues related to ASC 606.

~~Operating costs and expenses.~~ Operating costs and expenses increased 6.2%, or $52.6 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017. Film exhibition costs increased 7.4%, or $19.8 million, during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to the increase in film exhibition costs percentage and the increase in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 53.6% and 50.6% for the three months ended September 30, 2018 and September 30, 2017, respectively. The increase in film exhibition cost percentage is primarily due to our A-list loyalty program where admissions revenues are fixed based on a monthly fee of $19.95 per member, while the related film rental is variable and based on the retail ticket price.

Food and beverage costs increased 6.6%, or $2.7 million, during the three months ended September 30, 2018 compared to the three months ended September 30, 2017. As a percentage of food and beverage revenues, food and beverage costs were 14.6% for the three months ended September 30, 2018 and 14.8% for the three months ended September 30, 2017. Food and beverage gross profit per patron was $4.37 and unchanged from the prior year and is calculated as food and beverage revenues less food and beverage costs divided by attendance.

As a percentage of revenues, operating expense was 31.7% for the three months ended September 30, 2018 and 32.3% for the three months ended September 30, 2017. Rent expense increased 2.6%, or $3.9 million during the three

~~Table of Contents~~

~~months ended September 30, 2018 compared to the three months ended September 30, 2017.~~

~~General and Administrative Expense:~~

~~Merger, acquisition and transaction costs.~~ Merger, acquisition and transaction costs were $9.0 million during the three months ended September 30, 2018 compared to $3.7 million during the three months ended September 30, 2017 and increased primarily due to the write-off of $8.0 million of deferred costs related to an Odeon proposed public offering.

~~Other.~~ Other general and administrative expense increased $14.9 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to increased fees for legal settlements, higher bonus expense related to improvements in operating performance and increases in stock-based compensation expense.

~~Depreciation and amortization.~~ Depreciation and amortization decreased $4.7 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to the prior year impairment charges and adjustments to the estimated fair value of property, net acquired in the Carmike acquisition, partially offset by depreciation on capital expenditures of $264.9 million during the nine months ended September 30, 2018, and $543.7 million during the year ended December 31, 2017.

~~Other Expense (Income):~~

~~Other expense.~~ Other expense of $54.6 million during the three months ended September 30, 2018 is primarily due to a $54.1 million charge for the derivative liability related to the embedded conversion feature for the Convertible Notes due 2024. See Note 6 – Corporate Borrowings for additional information on the terms of the Convertible Notes due 2024.

~~Interest expense.~~ Interest expense increased $12.8 million to $78.1 million for the three months ended September 30, 2018 compared to $65.3 million for the three months ended September 30, 2017 primarily due to a non-cash NCM ESA expense of $10.3 million recorded due to adoption of ASC 606 – Revenue Recognition, that required us to reflect an interest component for our long-term performance obligation. Additionally, on September 14, 2018, we issued $600.0 million of our 2.95% Convertible Notes due 2024.

~~Equity in (earnings) losses of non-consolidated entities.~~ Equity in earnings of non-consolidated entities were $(67.4) million for the three months ended September 30, 2018 compared to equity in losses of $2.7 million for the three months ended September 30, 2017. Equity in earnings for the three months ended September 30, 2018 includes a $28.9 million gain on the sale of NCM common units and a $30.1 million gain on the Screenvision merger. During the three months ended September 30, 2017, we incurred a loss on sales of NCM shares of $21.0 million, partially offset by an increase in earnings from NCM of $6.7 million. See Note 5 – Investments of the Notes to the Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

~~Investment income.~~ Investment income was $0.7 million for the three months ended September 30, 2018 compared to investment income of $17.0 million for the three months ended September 30, 2017. Investment income for the three months ended September 30, 2017 included a $17.0 million gain on the sale of our investment in Open Road Releasing, LLC (“Open Road”).

~~Income tax (benefit) provision.~~ The income tax provision was $12.1 million for the three months ended September 30, 2018 and income tax benefit was $18.9 million for the three months ended September 30, 2017. See Note 8–Income Taxes of the Notes to the Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

~~Net loss.~~ Net loss was $84.5 million and $37.0 million during the three months ended September 30, 2018 and September 30, 2017, respectively. Net loss during the three months ended September 30, 2018 compared to the three months ended September 30, 2017 was negatively impacted by the $54.1 million charge for the derivative liability related to the Convertible Notes due 2024, a higher provision for income taxes, declines in investment income, increases in general and administrative: other, and merger, acquisition and transaction costs, higher rent expense, higher interest expense, partially offset by higher equity in earnings from non-consolidated entities, higher gross profit from operations and lower depreciation and amortization.

~~Table of Contents~~

~~Theatrical Exhibition - International Markets~~

~~Revenues.~~ Total revenues decreased 2.2% or $7.2 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017. Admissions revenues decreased 4.2% or $9.4 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to a 5.8% decline in attendance, partially offset by a 1.6% increase in average ticket price. Attendance declined primarily due to the lack of popular films compared to last year, increased competition and temporary screen closures for our renovation initiatives. Average ticket price increased due to price increases, partially offset by deteriorations in foreign currency translation rates.

Food and beverage revenues increased 0.4% or $0.3 million, during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to a 6.5% increase in food and beverage per patron, partially offset by the overall decrease in attendance. Food and beverage per patron increased due to price increases and was offset by deteriorations in foreign currency translation rates.

Total other theatre revenues increased 6.8% or $1.9 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017, primarily due to increased ticket fees.

~~Operating costs and expenses.~~ Operating costs and expenses increased 2.4% or $7.9 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017. Film exhibition costs decreased 6.1% or $5.8 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017. The decrease in film exhibition cost is due to the decrease in admissions revenue and the decrease in film exhibition cost as a percentage of admissions revenues. As a percentage of admissions revenues, film exhibition costs were 42.3% for the three months ended September 30, 2018 and 43.1% for the three months ended September 30, 2017.

Food and beverage costs increased 1.0% or $0.2 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017. The increase in food and beverage costs was primarily due to the increase in food and beverage cost as a percent of revenues. As a percentage of food and beverage revenues, food and beverage costs were 23.6% for the three months ended September 30, 2018 and 23.5% for the three months ended September 30, 2017.

As a percentage of revenues, operating expense was 35.9% for the three months ended September 30, 2018 and 33.1% during the three months ended September 30, 2017. Rent expense decreased 1.7% or $0.9 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017 due primarily to deteriorations in foreign currency translation rates.

~~General and Administrative Expense:~~

~~Merger, acquisition and transaction costs.~~ Merger, acquisition and transaction costs were $9.1 million during the three months ended September 30, 2018 compared to $1.9 million during the three months ended September 30, 2017, primarily due to $6.3 million of expense related to an arbitration ruling on a pre-acquisition date rent dispute for Odeon.

~~Other.~~ ~~Other general and administrative expense increased 5.7% or $0.9 million, during the three months ended September 30, 2018 compared to the three months ended September 30, 2017.~~

~~Depreciation and amortization.~~ Depreciation and amortization decreased 0.8% or $0.3 million during the three months ended September 30, 2018 compared to the three months ended September 30, 2017 primarily due to deteriorations in foreign currency translation rates offset by depreciation on capital expenditures of $110.0 million during the nine months ended September 30, 2018, and $83.1 million during the year ended December 31, 2017.

~~Interest expense.~~ ~~Interest expense increased 3.2% or $0.2 million for the three months ended September 30, 2018 compared to the three months ended September 30, 2017.~~

~~Investment expense.~~ ~~Investment expense declined $0.4 million during the three months ended September 30,~~

~~Table of Contents~~

~~2018.~~

~~Income tax provision (benefit).~~ ~~The income tax benefit is $(1.0) million for the three months ended September 30, 2018 as compared to income tax provision of $1.3 million for the three months ended September 30, 2017.~~ ~~See Note 8–Income Taxes of the Notes to the Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.~~

~~Net loss.~~ ~~Net loss increased $10.2 million during~~ the three months ended September 30, 2018, primarily due to ~~increases in merger, acquisition and transaction costs, declines in attendance offset by higher equity in earnings from non-consolidated entities and lower income tax expense.~~

~~Results of Operations—For the Nine Months Ended September 30, 2018 and September 30, 2017~~

~~Consolidated Results of Operations~~

~~Revenues.~~ Total revenues increased 10.5% or $385.1 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017. Admissions revenues increased 8.2%, or $190.3 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily due to a ~~4.1%~~5.4% increase in attendance and a ~~3.9%~~0.7% increase in average ticket price. The increase in attendance was primarily due to the popularity of films ~~(for~~and strategic pricing initiatives in the U.S. ~~Markets) released as compared to the same period a year ago~~markets and the ~~acquisition~~popularity of ~~Nordic on March 28, 2017 (for International Markets), partially offset by a lack of popular film product, temporary screen closures for theatre refurbishments and increased competition~~films in International ~~Markets.~~markets The increase in average ticket price was primarily due to ~~strategic pricing initiatives put~~increases in ~~place over~~ the ~~last year, improvements in attendance and~~ popularity of PLF, IMAX and ~~other PLF~~3D premium content ~~and improvements~~partially offset by declines in foreign currency translation rates.

Food and beverage revenues increased 9.1%, or ~~$103.3~~$35.2 million, during the ~~nine~~three months ended September 30, 2019 compared to the three months ended September 30, 2018, ~~compared to the nine months ended September 30, 2017,~~ primarily due to ~~the increase in attendance and~~ a ~~4.8%~~3.6% increase in food and beverage revenues per ~~patron.~~patron and the increase in attendance. Food and beverage revenues per patron increased as a result of strategic price increases, our food and beverage initiatives including theatre renovations, and our Feature Fare menu, ~~that was introduced in 2017 and is available in 349 of our U.S. theatres, offering our guests a broader selection of items to choose from, price increases and improvements~~partially offset by declines in foreign currency translation rates.

Total other theatre revenues increased ~~46.5%~~16.8%, or ~~$91.5~~$14.3 million, during the ~~nine~~three months ended September 30, 2019 compared to the three months ended September 30, 2018, ~~compared to the nine months ended September 30, 2017,~~ primarily due to ~~increases~~the increase in ~~advertising revenues,~~ ticket fees, screen advertising and income from gift cards and package tickets ~~including gross up for third party ticket fees of $17.0 million and increases from non-cash NCM ESA interest of $31.3 million,~~partially offset by ~~a $11.5 million reduction~~declines in NCM ESA principal amortization. Other revenues also increased due to the acquisition of Nordic. See Note 1–Basis of Presentation for a further discussion of the increases in other revenues related to ASC 606.foreign currency translation rates.

Operating costs and expenses. Operating costs and expenses increased ~~6.6%~~4.2%, or ~~$239.4~~$52.7 million, during the ~~nine~~three months ended September 30, ~~2018~~2019 compared to the ~~nine~~three months ended September 30, ~~2017.~~2018. Film exhibition costs increased ~~9.7%~~10.0%, or ~~$112.5~~$38.0 million, during the ~~nine~~three months ended September 30, ~~2018~~2019 compared to the ~~nine~~three months ended September 30, ~~2017,~~2018, primarily due to the increase in admissions revenues. As a percentage of admissions revenues, film exhibition costs were ~~50.6%~~52.3% for the ~~nine~~three months ended September 30, ~~2018~~2019 and ~~49.9%~~50.4% for the ~~nine~~three months ended September 30, ~~2017.~~2018. The increase in film exhibition cost percentage is primarily due to the concentration of box office revenues in higher grossing films in the current year which typically results in higher film exhibition costs.

Food and beverage costs increased ~~10.6%~~5.7%, or ~~$19.4~~$3.6 million, during the ~~nine~~three months ended September 30, ~~2018~~ 2019

Table of Contents

compared to the ~~nine~~three months ended September 30, ~~2017.~~2018. The increase in food and beverage costs was primarily due to the increase in food and beverage revenues. As a percentage of food and beverage revenues, food and beverage costs were ~~16.3%~~16.0% for the ~~nine~~three months ended September 30, ~~2018~~2019 and ~~16.1%~~16.5% for the ~~nine~~three months ended September 30, ~~2017.~~2018. Food and beverage gross profit per patron increased ~~4.6%~~4.2% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.

As a percentage of revenues, operating expense was ~~30.6%~~31.8% for the ~~nine~~three months ended September 30, 2019 and 32.8% for the three months ended September 30, 2018. Rent expense increased 17.2%, or $35.0 million, during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to the adoption of ASC 842 for lease accounting where approximately $20.9 million of principal and ~~30.8% for~~interest payments were recorded as rent expense during the ~~nine~~three months ended September 30, ~~2017. Rent~~2019 related to previously capitalized build-to-suit financing lease obligations, the elimination of $1.8 million of deferred gain amortization for sale leaseback transactions that previously reduced rent expense ~~increased 0.4%, or $2.2~~and $6.1 million of non-cash expense from purchase accounting recorded as rent expense, which was previously recorded as depreciation and amortization expense. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

General and Administrative Expense:

Merger, acquisition and other costs. Merger, acquisition and other costs were $4.7 million during the ~~nine~~three months ended September 30, ~~2018~~2019 compared to $18.1 million during the ~~nine~~three months ended September 30, ~~2017, primarily due to the Nordic~~

~~Table of Contents~~

~~acquisition and improvements in translation rates, partially offset by the modification of a theatre lease in the U.S. markets which reduced rent expense by $35.0 million.~~

~~Merger, acquisition and transaction costs.~~ ~~Merger, acquisition and transaction costs were $27.1 million during the nine months ended September 30,~~ 2018, ~~compared to $57.2 million during the nine months ended September 30, 2017,~~ primarily due to expenses incurred in connection with the ~~Carmike, Odeon and~~ Nordic ~~acquisitions~~acquisition in the prior year. ~~The current year includes~~

Other. Other general and administrative expense decreased $10.9 million during the ~~write-off~~three months ended September 30, 2019 compared to the three months ended September 30, 2018 primarily due to a reduction in legal expenses of ~~$8.0~~$4.4 million, a $2.6 million decrease in bonus expense due to declines in number of participants and expected performance, $2.0 million of ~~deferred costs~~declines in stock-based compensation expense due to forfeitures and expected performance and declines in foreign currency translation rates.

Depreciation and amortization. Depreciation and amortization decreased $18.1 million during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to the adoption of ASC 842 where the financing lease building and related depreciation were eliminated. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Other Expense (Income):

Other expense (income). Other income of $1.3 million during the three months ended September 30, 2019 is primarily due to an increase in fair value of our derivative asset for the contingent call option related to the Class B common stock purchase and cancellation agreement of $8.5 million offset by an ~~Odeon proposed public offering and $6.3~~increase of $5.7 million in fair value of our derivative liability for the embedded conversion feature in our Convertible Notes due 2024 which resulted in a net gain of $2.8 million (See Note 6—Corporate Borrowings in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information). During the three months ended September 30, 2018, other expense included $54.1 million of expense related to ~~an arbitration ruling on a pre-acquisition date rent dispute~~our derivative liability for ~~Odeon. The merger, acquisition and transaction costs are a corporate function primarily recorded~~the embedded conversion feature in our Convertible Notes due 2024. See Note 1—Basis of Presentation in the ~~U.S. markets operating segment.~~Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information about the components of other expense (income).

In conjunction with the Carmike acquisition and the DOJ final judgment, we returned 1,807,220 additional NCM common units (valued at $22.6 million) in exchange for a waiver of exclusivity by NCM which resulted in $22.6 million of expense during the nine months ending September 30, 2017.

~~Other.~~ ~~Other general and administrative~~Interest expense. Interest expense increased ~~$22.6~~$1.1 million ~~during~~to $85.1 million for the ~~nine~~three months ended September 30, ~~2018~~2019 compared to $84.0 million during the ~~nine~~three months ended September 30, ~~2017,~~2018. The increase is primarily due to the ~~acquisition~~issuance of Nordic, increases in foreign currency translation rates, increases in legal settlement fees, increases in bonus expense related to improved performance and increases in stock-based compensation expense.

~~Depreciation and amortization.~~ ~~Depreciation and amortization increased $4.5~~our 2.95% $600.0 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily due to the acquisition of Nordic and improvements in foreign currency translation rates.

~~Other Expense (Income):~~

~~Other expense.~~ Other expense of $57.5 million during the nine months ended September 30, 2018 is primarily due to a $54.1 million charge for the derivative liability related to the embedded conversion feature for the Convertible Notes due ~~2024.~~

~~Interest expense.~~ ~~Interest expense increased $45.5 million~~2024 on September 14, 2018 and our Senior Secured Credit Facility-Term Loan due 2026, partially offset by the recording to ~~$248.9 million for the nine months ended September 30, 2018 compared to $203.4 million the nine months ended September 30, 2017 primarily due to a non-cash NCM ESA~~rent expense of ~~$31.2~~$6.9 million ~~recorded due to~~of financing lease obligation interest as a result of the adoption of ASC ~~606 – Revenue Recognition, that required us~~842. See Note 2—Leases in the Notes to ~~reflect an interest component~~the Condensed Consolidated Financial Statements under Item 1 for ~~our long-term performance obligation. On March 17, 2017, we issued $475.0 million~~the impact of ~~our 6.125% Notes due 2027 and £250.0 million ($313.4 million) of our 6.375% Sterling Notes due 2024. On September 14, 2018, we issued $600.0 million of our 2.95% Convertible Notes due 2024.~~ASC 842.

Equity in ~~(earnings) losses~~earnings of non-consolidated entities. Equity in earnings of non-consolidated entities ~~increased $237.1 million to $(74.0)~~were $7.5 million for the ~~nine~~three months ended September 30, ~~2018~~2019 compared to ~~equity losses of $199.1~~ $70.0 million for the nine months ended September 30, 2017. Equity in earnings for the nine months ended September 30, 2018 includes a $2.3 million gain on the sale of NCM common shares, partially offset by a $16.0 million lower of carrying value or fair value impairment loss on 9,492,820 NCM units and 1,000,000 NCM, Inc. common shares held-for-sale, a $1.1 million loss on the return of 915,150 NCM units as a part of the annual common unit adjustment under the NCM ESA and a $28.9 million gain on the sale of all of our remaining interest in NCM. Equity in earnings includes a $30.1 million gain related to the Screenvision merger during the ninethree months ended September 30, 2018. During the ~~nine~~three months ended September 30, ~~2017,~~2018, we recorded equity in earnings of $28.9 million related to the ~~loss~~sale of our then remaining interest in NCM and $30.1 million related to the Screenvision merger.

Investment income. Investment income was ~~primarily due~~$0.5 million for the three months ended September 30, 2019

Table of Contents

compared to ~~an other-than-temporary impairment loss on NCM of $204.5~~$0.7 million ~~loss on sales of NCM shares of $22.2~~for the three months ended September 30, 2018.

Income tax provision (benefit). The income tax benefit was ($0.2) million for the three months ended September 30, 2019 and ~~a recognition of previously suspended losses on our investment in Open Road of $8.9~~$11.1 million infor the ~~prior year.~~three months ended September 30, 2018. See Note ~~5 – Investments of~~8—Income Taxes in the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

~~Investment income.~~ ~~Investment income~~Net loss. Net loss was ~~$7.4~~$54.8 million ~~for~~and $100.4 million during the ~~nine~~three months ended September 30, 2019 and September 30, 2018, respectively. Net loss during the three months ended September 30, 2019 compared to the three months ended September 30, 2018 ~~compared~~was positively impacted by higher admissions and food and beverage revenue and higher other theatre revenue, decreased other expense related to ~~investment~~our derivative asset and liability, decreases in depreciation and amortization expense, lower general and administrative expenses, lower income ~~of $21.6~~tax expense and a decline in foreign currency translation rates and partially offset by lower equity in earnings and higher interest expense, rent expense and operating expenses.

Theatrical Exhibition–U.S. Markets

Revenues. Total revenues increased 8.4%, or $75.1 million, ~~for~~during the ~~nine~~three months ended September 30, ~~2017. Investment income includes payments received related~~2019 compared to the ~~NCM tax receivable agreement of $5.4~~ three months ended September 30, 2018. Admissions revenues increased 7.3%, or $39.1 million ~~and $5.5 million for~~during the ~~nine~~three months ended September 30, 2019 compared to the three months ended September 30, 2018, and September 30, 2017, respectively. Investment income for the nine months ended September 30, 2018 includes a $1.5 million gain on the sale of a joint venture managed theatre. Investment income for the nine months ended September 30, 2017 includes a $17.0 million gain on the sale of Open Road.

~~Table of Contents~~

~~Income tax (benefit) provision.~~ The income tax provision was $13.2 million for the nine months ended September 30, 2018 and income tax benefit was $136.4 million for the nine months ended September 30, 2017. See Note 8–Income Taxes of the Notes to the Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

~~Net loss.~~ Net loss was $(60.5) million and $(210.8) million during the nine months ended September 30, 2018 and September 30, 2017, respectively. Net loss during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017 were positively impacted by improvements in equity in earnings of non-consolidated entities related to the prior year impairment charge of $204.5 million for our investment in NCM, higher revenues, lower merger, acquisition and transaction costs, a $35.0 million rent reduction due to a lease modification, offset by the $54.1 million charge for the derivative liability related to the embedded conversion feature for the Convertible Notes due 2024, increases in depreciation and amortization expense, decreases in investment income, increases in interest expense, income tax provision and general and administrative expense (other).

~~Theatrical Exhibition–U.S. Markets~~

~~Revenues.~~ Total revenues increased 9.5% or $261.9 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017. Admissions revenues increased 7.1%, or $121.6 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily due to a ~~6.4%~~3.8% increase in attendance and a ~~0.6%~~3.3% increase in average ticket price. The increase in attendance was primarily due to the popularity of ~~film product during the current year as compared to the prior year.~~films and strategic pricing initiatives. The increase in average ticket price was primarily due to ~~increased~~increases in the popularity ~~and related increase in attendance for~~of PLF, IMAX and ~~other PLF~~3D premium ~~content and strategic price initiatives put in place over the last year.~~content.

Food and beverage revenues increased ~~8.6%~~8.5%, or ~~$77.5~~$25.6 million, during the ~~nine~~three months ended September 30, 2019 compared to the three months ended September 30, 2018, ~~compared to the nine months ended September 30, 2017,~~ primarily due to ~~the increase in attendance, and an~~a 4.5% increase in food and beverage revenues per patron ~~of 2.0%.~~and the increase in attendance. Food and beverage revenues per patron increased as a result of strategic price increases, our food and beverage initiatives including theatre renovations, and our Feature Fare ~~menu that was introduced in 2017 and is available in 349 of our U.S. theatres, offering our guests a broader selection of items to choose from and price increases.~~ menu.

Total other theatre revenues increased ~~50.6%~~18.8%, or ~~$62.8~~$10.4 million, during the ~~nine~~three months ended September 30, 2019 compared to the three months ended September 30, 2018, ~~compared to the nine months ended September 30, 2017,~~ primarily due to ~~ticket fees and advertising revenues including gross up for third party~~an increase in ticket fees of ~~$17.0~~$10.0 million and increases from non-cash NCM ESA interest of $31.3 million, offset by $11.5 million reduction in NCM ESA principal amortization. See Note 1–Basis of Presentation for a further discussion of increases in other revenues related to ASC 606.or 52.1%.

Operating costs and expenses. Operating costs and expenses increased ~~3.7%~~5.8%, or ~~$100.6~~$52.1 million, during the ~~nine~~three months ended September 30, ~~2018~~2019 compared to the ~~nine~~three months ended September 30, ~~2017.~~2018. Film exhibition costs increased ~~10.2%~~11.3%, or ~~$91.9~~$32.7 million, during the ~~nine~~three months ended September 30, ~~2018~~2019 compared to the ~~nine~~three months ended September 30, ~~2017,~~2018, primarily due to the increase in admissions revenues. As a percentage of admissions revenues, film exhibition costs were ~~54.2% and 52.7%~~55.6% for the ~~nine~~three months ended September 30, ~~2018~~2019 and 53.6% for the three months ended September 30, ~~2017, respectively.~~2018. The increase in film exhibition cost percentage is primarily due to the concentration of box office revenues in higher grossing films in the current year which typically results in higher film ~~terms.~~exhibition costs.

Food and beverage costs increased ~~9.8%~~5.9%, or ~~$12.7~~$2.6 million, during the ~~nine~~three months ended September 30, ~~2018~~2019 compared to the ~~nine~~three months ended September 30, 2017. As a percentage of food and beverage revenues, food and beverage costs were 14.5% for the nine months ended September 30, 2018 and 14.3% for the nine months ended September 30, 2017. The increase in food and beverage costs as a percentage of food and beverage revenues was primarily due to higher cost items in the new Feature Fare menu. Food and beverage gross profit per patron increased 1.8% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.

As a percentage of revenues, operating expense was 28.8% for the nine months ended September 30, 2018 and 30.0% for the nine months ended September 30, 2017. Rent expense decreased 3.3%, or $14.8 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily from the modification of a theatre lease which reduced rent expense by $35.0 million and partially offset by higher snow removal costs in the current year.

~~Table of Contents~~

~~General and Administrative Expense:~~

~~Merger, acquisition and transaction costs.~~ Merger, acquisition and transaction costs were $15.2 million during the nine months ended September 30, 2018 compared to $54.3 million during the nine months ended September 30, 2017, primarily due to expenses incurred in connection with the Carmike, Odeon and Nordic acquisitions in the prior year. The current year includes the write-off of $8.0 million of deferred charges related to an Odeon proposed public offering. The merger, acquisition and transaction costs are a corporate function primarily recorded in the U.S. markets operating segment.

~~Other.~~ Other general and administrative expense increased $16.9 million, during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily due to increases in legal settlement fees, bonus expense due to improved operating performance and stock-based compensation expense.

~~Depreciation and amortization.~~ Depreciation and amortization decreased $8.7 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily due to the prior year impairment charges and adjustments to the estimated fair value of property, net acquired in the Carmike acquisition, partially offset by depreciation on capital expenditures of $264.9 million during the nine months ended September 30, 2018 and $543.7 million during the year ended December 31, 2017.

~~Other Expense (Income):~~

~~Other expense.~~ Other expense of $56.2 million during the nine months ended September 30, 2018 is primarily due to a $54.1 million charge for the derivative liability related to the embedded conversion feature for the Convertible Notes due 2024. See Note 6 – Corporate Borrowings for additional information on the terms of the Convertible Notes due 2024.

~~Interest expense.~~ Interest expense increased $44.4 million to $229.9 million for the nine months ended September 30, 2018 compared to $185.5 million the nine months ended September 30, 2017 primarily due to a non-cash NCM ESA expense of $31.2 million recorded due to adoption of ASC 606 – Revenue Recognition, that required us to reflect an interest component for our long-term performance obligation. On March 17, 2017, we issued $475.0 million of our 6.125% Notes due 2027 and £250.0 million ($313.4 million) of our 6.375% Sterling Notes due 2024. On September 14, 2018, we issued $600.0 million of our 2.95% Convertible Notes due 2024.

~~Equity in (earnings) losses of non-consolidated entities.~~ Equity in earnings of non-consolidated entities increased $271.1 million to $(71.0) million for the nine months ended September 30, 2018 compared to equity in losses of $200.1 million for the nine months ended September 30, 2017. Equity in earnings for the nine months ended September 30, 2018 increased due to a $28.9 million gain on the sale of NCM common shares, a $30.1 million gain on the Screenvision merger, partially offset by a $16.0 million lower of carrying value or fair value impairment loss on 9,492,820 NCM units and 1,000,000 NCM, Inc. common shares held-for-sale (sold as of September 30, 2018) and a $1.1 million loss on the return of 915,150 NCM units as a part of the annual common unit adjustment under the NCM ESA. During the nine months ended September 30, 2017, the loss was primarily due to an other-than-temporary impairment loss on NCM of $204.5 million, a loss on sale of NCM shares of $22.2 million, and recognition of previously suspended losses on Open Road of $8.9 million. See Note 5 – Investments of the Notes to the Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

~~Investment income.~~ Investment income was $7.4 million for the nine months ended September 30, 2018 compared to investment income of $22.3 million for the nine months ended September 30, 2017. Investment income includes payments received related to the NCM tax receivable agreement of $5.4 million and $5.5 million for the nine months ended September 30, 2018 and September 30, 2017, respectively. Investment income for the nine months ended September 30, 2018 includes a $1.5 million gain on the sale of a joint venture managed theatre. Investment income for the nine months ended September 30, 2017 includes a $17.0 million gain on the sale of our investment in Open Road.

~~Income tax (benefit) provision.~~ The income tax provision was $14.6 million for the nine months ended September 30, 2018 and income tax benefit was $138.0 million for the nine months ended September 30, 2017. See Note 8–Income Taxes of the Notes to the Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

~~Table of Contents~~

~~Net loss.~~ Net losses were $36.5 million and $198.7 million during the nine months ended September 30, 2018 and September 30, 2017, respectively. Net loss during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017 were positively impacted by improvement in equity in earnings of non-consolidated entities due to the prior year $204.5 million impairment of our investment in NCM, higher revenues, lower merger, acquisition and transaction costs, a $35.0 million rent reduction due to a lease modification that reduced rent expense, lower depreciation and amortization, partially offset by the $54.1 million charge for the derivative liability, increased interest expense, income tax provision and general and administrative expense (other).

~~Theatrical Exhibition - International Markets~~

~~Revenues.~~ Total revenues increased 13.4% or $123.2 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017. Admissions revenues increased 11.2% or $68.7 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily due to a 11.4% increase in average ticket price, partially offset by a 1.5% decrease in attendance. The increase in average ticket price is due to improvements in foreign currency translation rates and increased ticket prices for Odeon. Attendance decreased primarily due to declines at Odeon due to the lack of popular films as compared to the prior year, increased competition and temporary screen closures for theatre refurbishments, partially offset by the acquisition of Nordic on March 28, 2017.

Food and beverage revenues increased 11.3% or $25.8 million, during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily due to food and beverage per patron increase of 13.9%. Food and beverage per patron increased primarily due to improvements in foreign currency translation rates and price increases.

Total other theatre revenues increased 39.5% or $28.7 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily due to the acquisition of Nordic, increases in ticket fees and gift card and package ticket income and improvements in foreign currency translation rates.

~~Operating costs and expenses.~~ Operating costs and expenses increased $138.6 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017. Film exhibition costs increased $20.6 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017, primarily due to the increase in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 40.9% for the nine months ended September 30, 2018 and 42.1% for the nine months ended September 30, 2017.

~~Food and beverage costs increased $6.7 million during the nine months ended September 30, 2018 compared to the nine months ended September 30, 2017.~~2018. The increase in food and beverage costs was primarily due to the increase in food and beverage revenues. As a percentage of food and beverage revenues, food and beverage costs were ~~23.4%~~14.2% for the ~~nine~~three months ended September 30, ~~2018~~2019 and ~~23.2%~~14.6% for the ~~nine~~three months ended September 30, ~~2017.~~2018. Food and beverage gross profit per patron increased 4.9% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.

As a percentage of revenues, operating expense was ~~35.6%~~31.3% for the ~~nine~~three months ended September 30, 2019 and 31.7% for the three months ended September 30, 2018. Rent expense increased 15.0%, or $22.8 million, during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to the adoption of ASC 842 for lease accounting where approximately $11.0 million of principal and ~~33.2%~~interest payments were recorded as rent expense during the ~~nine~~three months ended September 30, ~~2017. Rent~~2019 related to build-to-suit financing lease obligations, the elimination of $1.8 million of deferred gain amortization for sale leaseback transactions that previously reduced rent expense ~~increased $17.0~~and $4.6 million of non-cash expense from purchase accounting recorded as rent expense, which was previously recorded as depreciation and amortization expense. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Table of Contents

General and Administrative Expense:

Merger, acquisition and other costs. Merger, acquisition and other costs were $2.3 million during the ~~nine~~three months ended September 30, ~~2018~~2019 compared to $9.0 million during the ~~nine~~three months ended September 30, ~~2017 due primarily to the acquisition of Nordic on March 28, 2017 and improvements in foreign currency translation rates.~~

~~General and Administrative Expense:~~

~~Merger, acquisition and transaction costs.~~ ~~Merger, acquisition and transaction costs were $11.9 million during the nine months ended September 30,~~ 2018, ~~compared to $2.9 million during the nine months ended September 30, 2017,~~ primarily due to expenses incurred in connection with the ~~Odeon and~~ Nordic ~~acquisitions. We recorded expense during~~acquisition in the ~~current year of $6.3 million related to an arbitration ruling related to a pre-acquisition date rent dispute.~~prior year.

Other. Other general and administrative expense ~~increased $5.7~~decreased $9.6 million during the ~~nine~~three months ended September 30, 2019 compared to the three months ended September 30, 2018, ~~compared~~primarily due to a reduction in legal expenses of $4.4 million, a $2.6 million decrease in bonus expense due to declines in number of participants and expected performance and $1.8 million of declines in stock-based compensation expense due to forfeitures and expected performance.

Depreciation and amortization. Depreciation and amortization decreased $9.9 million during the ~~nine~~three months ended September 30, ~~2017 primarily due~~2019 compared to the ~~Nordic acquisition and stock-based compensation.~~

~~Table of Contents~~

~~Depreciation and amortization.~~ ~~Depreciation and amortization increased $13.2 million during the nine~~three months ended September 30, 2018, ~~compared~~primarily due to the ~~nine~~adoption of ASC 842 where the financing lease building and related depreciation were eliminated. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Other Expense (Income):

Other expense (income). Other income of $1.6 million during the three months ended September 30, ~~2017~~2019 is primarily due to ~~the acquisition~~an increase in fair value of ~~Nordic on March 28, 2017 and improvements in foreign currency translation rates.~~

~~Interest expense.~~ ~~Interest expense increased $1.1 million~~our derivative asset for the ~~nine~~contingent call option related to the Class B common stock purchase and cancellation agreement of $8.5 million offset by an increase of $5.7 million in fair value of our derivative liability for the embedded conversion feature in our Convertible Notes due 2024 which resulted in a net gain of $2.8 million (See Note 6—Corporate Borrowings in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information). During the three months ended September 30, 2018, ~~compared~~other expense included $54.1 million of expense related to our derivative liability for the embedded conversion feature in our Convertible Notes due 2024. See Note 1—Basis of Presentation in the Notes to the ~~nine~~Condensed Consolidated Financial Statements under Item 1 for additional information about the components of other expense (income).

Interest expense. Interest expense increased $4.9 million to $83.0 million for the three months ended September 30, ~~2017,~~2019 compared to $78.1 million during the three months ended September 30, 2018. The increase is primarily due to ~~improvements~~the issuance of our 2.95% $600.0 million Convertible Notes due 2024 on September 14, 2018 and our Senior Secured Credit Facility-Term Loan due 2026, partially offset by the recording to rent expense of $3.3 million of financing lease obligation interest as a result of the adoption of ASC 842. See Note 2—Leases in ~~foreign currency translation rates.~~the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Equity in earnings of non-consolidated entities. Equity in earnings of non-consolidated entities were $7.2 million for the three months ended September 30, 2019 compared to $67.4 million for the three months ended September 30, 2018. During the three months ended September 30, 2018, we recorded equity in earnings of $28.9 million related to the sale of our then remaining interest in NCM and $30.1 million related to the Screenvision merger.

Investment income. Investment income was $0.4 million for the three months ended September 30, 2019 compared to $0.7 million for the three months ended September 30, 2018.

Income tax provision (benefit). The income tax benefit was ~~$(1.4)~~($0.4) million for the ~~nine~~three months ended September 30, ~~2018 as compared to~~2019 and the income tax provision ~~of $1.6~~was $12.1 million for the ~~nine~~three months ended September 30, ~~2017.~~ 2018. See Note 8–8—Income Taxes ofin the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

Net loss. Net loss was $58.2 million and $84.5 million during the three months ended September 30, 2019 and September 30, 2018, respectively. Net loss during the three months ended September 30, 2019 compared to the three months ended September 30, 2018 was positively impacted by higher admissions and food and beverage revenue and higher other theatre revenue, decreased other expense related to our derivative asset and liability, decreases in depreciation and amortization expense, lower general and administrative expenses, lower income tax expense and partially offset by lower equity in earnings and higher interest expense, rent expense and operating expenses.

Table of Contents

Theatrical Exhibition - International Markets

Revenues. Total revenues increased ~~$11.9~~6.2%, or $20.3 million, during the three months ended September 30, 2019 compared to the three months ended September 30, 2018. Admissions revenues increased 3.2%, or $6.8 million during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to a 9.3% increase in attendance, partially offset by a 5.6% decrease in average ticket price including decreases related to foreign currency translation. The increase in attendance was primarily due to the popularity of films.

Food and beverage revenues increased 11.5%, or $9.6 million, during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due the increase in attendance and a 2.1% increase in food and beverage revenues per patron, partially offset by declines in foreign currency translation rates.

Total other theatre revenues increased 13.0%, or $3.9 million, during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to the increase in ticket fees, screen advertising and income from gift cards and package tickets partially offset by declines in foreign currency translation rates.

Operating costs and expenses. Operating costs and expenses increased 0.2%, or $0.6 million, during the three months ended September 30, 2019 compared to the three months ended September 30, 2018. Film exhibition costs increased 5.9%, or $5.3 million, during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to the increase in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 43.4% for the three months ended September 30, 2019 and 42.3% for the three months ended September 30, 2018. The increase in film exhibition cost percentage is primarily due to the concentration of box office revenues in higher grossing films in the current year which typically results in higher film exhibition costs.

Food and beverage costs increased 5.1%, or $1.0 million, during the three months ended September 30, 2019 compared to the three months ended September 30, 2018. The increase in food and beverage costs was primarily due to the increase in food and beverage revenues. As a percentage of food and beverage revenues, food and beverage costs were 22.3% for the three months ended September 30, 2019 and 23.6% for the three months ended September 30, 2018. Food and beverage gross profit per patron increased 3.9% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.

As a percentage of revenues, operating expense was 33.3% for the three months ended September 30, 2019 and 35.9% for the three months ended September 30, 2018. Rent expense increased 23.6%, or $12.2 million, during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to the adoption of ASC 842 for lease accounting where approximately $9.9 million of principal and interest payments were recorded as rent expense during the three months ended September 30, 2019 related to build-to-suit financing lease obligations and $1.5 million of non-cash expense from purchase accounting was recorded as rent expense, which was previously recorded as depreciation and amortization expense. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

General and Administrative Expense:

Merger, acquisition and other costs. Merger, acquisition and other costs were $2.4 million during the three months ended September 30, 2019 compared to $9.1 million during the three months ended September 30, 2018, primarily due to expenses incurred in connection with the Nordic acquisition in the prior year.

Other. Other general and administrative expense decreased $1.3 million or 7.8% during the three months ended September 30, 2019 compared to the three months ended September 30, 2018 primarily due to $0.2 million of declines in stock-based compensation expense due to forfeitures and expected performance and declines in foreign currency translation rates.

Depreciation and amortization. Depreciation and amortization decreased $8.2 million during the three months ended September 30, 2019 compared to the three months ended September 30, 2018, primarily due to the adoption of ASC 842 where the financing lease building and related depreciation were eliminated. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Table of Contents

Other Expense (Income):

Other expense (income). Other expense (income) was $0.3 million during the three months ended September 30, 2019 compared to ($0.5) million for the three months ended September 30, 2018. See Note 1—Basis of Presentation in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information about the components of other expense (income).

Interest expense. Interest expense decreased $3.8 million to $2.1 million for the three months ended September 30, 2019 compared to $5.9 million during the three months ended September 30, 2018. The decrease is primarily due to the recording to rent expense of $3.6 million of financing lease obligation interest as a result of the adoption of ASC 842. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Equity in earnings of non-consolidated entities. Equity in earnings of non-consolidated entities were $0.3 million for the three months ended September 30, 2019 compared to $2.6 million for the three months ended September 30, 2018. During the three months ended September 30, 2019, we recorded equity losses of $1.1 million related to Saudi Cinema Company LLC.

Income tax provision (benefit). The income tax provision was $0.2 million for the three months ended September 30, 2019 and the income tax benefit was $(1.0) million for the three months ended September 30, 2018. See Note 8—Income Taxes in the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

Net earnings (loss). Net earnings were $3.4 million during the three months ended September 30, 2019 and net loss was $15.9 million during the three months ended September 30, 2018. Net earnings (loss) during the three months ended September 30, 2019 compared to the three months ended September 30, 2018 was positively impacted by the increase in attendance, higher admissions and food and beverage revenue and higher other theatre revenue, decreases in depreciation and amortization expense, declines in interest expense, lower operating and general and administrative expenses and partially offset by higher rent expense, increased income tax expense, lower equity earnings of non-consolidated investees and decreases in foreign currency translation rates.

Results of Operations—For the Nine Months Ended September 30, 2019 and September 30, 2018

Condensed Consolidated Results of Operations

Revenues. Total revenues decreased 0.6%, or $24.2 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. Admissions revenues decreased 3.9%, or $98.4 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due a 3.5% decrease in average ticket price and a 0.4% decrease in attendance. The decrease in average ticket price was primarily due to strategic pricing initiatives put in place over the last year; decreases in the popularity of 3D premium content, and declines in foreign currency translation rates, partially offset by increases in attendance for PLF and IMAX premium content. The decrease in attendance was primarily due to the popularity of films (for U.S. markets and International markets) released in the first quarter as compared to the same period a year ago as well as temporary screen closures for theatre refurbishments.

Food and beverage revenues increased 3.6%, or $44.9 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to a 4.0% increase in food and beverage revenues per patron, partially offset by the decrease in attendance. Food and beverage revenues per patron increased as a result of strategic price increases, our food and beverage initiatives including theatre renovations, and our Feature Fare menu, partially offset by declines in foreign currency translation rates.

Total other theatre revenues increased 10.2%, or $29.3 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to increases in ticket fees, theatre rentals and income from gift cards and package tickets partially offset by declines in foreign currency translation rates.

Operating costs and expenses. Operating costs and expenses increased 1.6%, or $60.9 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. Film exhibition costs decreased 0.9%, or $12.1 million, during the nine months ended September 30, 2019 compared to the nine months

Table of Contents

ended September 30, 2018, primarily due to the decrease in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 52.2% for the nine months ended September 30, 2019 and 50.6% for the nine months ended September 30, 2018.

Food and beverage costs increased 1.5%, or $3.1 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. The increase in food and beverage costs was primarily due to the increase in food and beverage revenues. As a percentage of food and beverage revenues, food and beverage costs were 16.0% for the nine months ended September 30, 2019 and 16.3% for the nine months ended September 30, 2018. Food and beverage gross profit per patron increased 4.4% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.

As a percentage of revenues, operating expense was 31.3% for the nine months ended September 30, 2019 and 30.6% for the nine months ended September 30, 2018. Rent expense increased 22.5%, or $133.5 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to the adoption of ASC 842 for lease accounting where approximately $62.7 million of principal and interest payments were recorded as rent expense during the nine months ended September 30, 2019 related to build-to-suit financing lease obligations, prior year modification of a theatre lease which reduced rent by $35.0 million in 2018, and $19.5 million of non-cash expense from purchase accounting recorded as rent expense, which was previously recorded as depreciation and amortization expense, and the elimination of $5.4 million of deferred gain amortization for sale leaseback transactions that previously reduced rent expense. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

General and Administrative Expense:

Merger, acquisition and other costs. Merger, acquisition and other costs were $11.2 million during the nine months ended September 30, 2019 compared to $27.1 million during the nine months ended September 30, 2018, primarily due to expenses incurred in connection with the Nordic acquisition in the prior year.

Other. Other general and administrative expense decreased $8.7 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to a reduction in legal expenses of $5.4 million and a $2.9 million decrease in bonus expense due to declines in number of partipants and expected performance.

Depreciation and amortization. Depreciation and amortization decreased $61.3 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to the adoption of ASC 842 for lease accounting where the financing lease building and related depreciation were eliminated. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Other Expense (Income):

Other expense. Other expense of $5.1 million during the nine months ended September 30, 2019 is primarily due to $16.6 million of expense related to the repayment of indebtedness (See Note 6—Corporate Borrowings in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information), $2.5 million of foreign currency transaction losses and $0.8 million of non-operating net periodic benefit cost, partially offset by the increase in fair value of our derivative asset for the contingent call option related to the Class B common stock purchase and cancellation agreement of $0.5 million and a decrease in fair value of our derivative liability for the embedded conversion feature in our Convertible Notes due 2024 of $14.9 million. During the nine months ended September 30, 2018, other expense included $54.1 million of expense related to our derivative liability for the embedded conversion feature in our Convertible Notes due 2024. See Note 1—Basis of Presentation in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information about the components of other expense (income).

Interest expense. Interest expense increased $6.2 million to $255.1 million for the nine months ended September 30, 2019 compared to $248.9 million during the nine months ended September 30, 2018. The increase is primarily due to the issuance of our 2.95% $600.0 million Convertible Notes due 2024 on September 14, 2018 and our Senior Secured Credit Facility-Term Loan due 2026 (See Note 6—Corporate Borrowings in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information), partially offset by the recording to rent

Table of Contents

expense of $20.7 million of financing lease obligation interest as a result of the adoption of ASC 842. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Equity in earnings of non-consolidated entities. Equity in earnings of non-consolidated entities were $24.2 million for the nine months ended September 30, 2019 compared to $74.0 million for the nine months ended September 30, 2018. The earnings for the nine months ended September 30, 2018 includes equity in earnings of $28.9 million related to the sale of our then remaining interest in NCM, $30.1 million related to the Screenvision merger, and $2.3 million gain on the sale of NCM, Inc. common shares, partially offset by a $16.0 million lower of carrying value or fair value impairment loss on 9,492,820 NCM units and 1,000,000 NCM, Inc. common shares held-for-sale and a $1.1 million loss on the return of 915,150 NCM units as a part of the annual common unit adjustment under the NCM ESA.

Investment income. Investment income was $18.7 million for the nine months ended September 30, 2019 compared to $7.4 million for the nine months ended September 30, 2018. Investment income includes a gain on the sale of our Austria theatres of $12.9 million for the nine months ended September 30, 2019 and includes payments received related to the NCM tax receivable agreement of $4.0 million and $5.4 million for the nine months ended September 30, 2019 and September 30, 2018, respectively. Investment income for the nine months ended September 30, 2018 also includes a $1.5 million gain on the sale of a joint venture managed theatre.

Income tax provision. The income tax provision was $10.9 million and $13.2 million for the nine months ended September 30, 2019 and September 30, 2018, respectively. See Note 8—Income Taxes in the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

Net loss. Net loss was $135.6 million and $60.5 million during the nine months ended September 30, 2019 and September 30, 2018, respectively. Net loss during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 was impacted by lower attendance which negatively impacted admissions revenue, higher rent expense, operating expense and interest expense, decreased equity in earnings from non-consolidated entities, offset by increases in food and beverage revenues and other revenues, decreases in other expense related to our derivative liability, income tax provision, depreciation and amortization expense, general and administrative expenses increased ~~merger,~~investment income and a decline in foreign currency translation rates.

Theatrical Exhibition–U.S. Markets

Revenues. Total revenues decreased 0.3%, or $8.0 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. Admissions revenues decreased 3.5%, or $63.8 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to a 2.2% decrease in average ticket price and a 1.3% decrease in attendance. The decrease in average ticket price was primarily due to strategic pricing initiatives put in place over the last year; decreases in the popularity of 3D premium content, partially offset by increases in attendance for PLF and IMAX premium content. The decrease in attendance was primarily due to the popularity of films released in the first quarter as compared to the same period a year ago as well as temporary screen closures for theatre refurbishments.

Food and beverage revenues increased 3.4%, or $33.5 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to the increase in food and beverage revenues per patron of 4.8%, partially offset by the decrease in attendance. Food and beverage revenues per patron increased as a result of strategic price increases and our food and beverage initiatives including our Feature Fare menu and theatre renovations.

Total other theatre revenues increased 11.9%, or $22.3 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to increased ticket fees of $18.5 million or 25.1% and increase in theatre rentals.

Operating costs and expenses. Operating costs and expenses increased 3.1%, or $87.2 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. Film exhibition costs decreased 0.7%, or $7.4 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to the decrease in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 55.8% and 54.2% for the nine months ended September 30, 2019 and September 30, 2018, respectively.

Table of Contents

Food and beverage costs increased 2.2%, or $3.2 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily as the result of increases in food and beverage revenues. As a percentage of food and beverage revenues, food and beverage costs were 14.3% for the nine months ended September 30, 2019 and 14.5% for the nine months ended September 30, 2018. Food and beverage gross profit per patron increased 5.0% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.

As a percentage of revenues, operating expense was 30.3% for the nine months ended September 30, 2019 and 28.8% during the nine months ended September 30, 2018. Rent expense increased 23.3%, or $100.3 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 primarily due to a prior year modification of a theatre lease which reduced rent by $35.0 million in 2018 offset by the adoption of ASC 842 for lease accounting where approximately $33.0 million of principal and interest payments were recorded as rent expense during the nine months ended September 30, 2019 related to build-to-suit financing lease obligations, the elimination of $5.4 million of deferred gain amortization for sale leaseback transactions that previously reduced rent expense and $13.7 million of non-cash expense from purchase accounting recorded as rent expense, which was previously recorded as depreciation and amortization expense. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

General and Administrative Expense:

Merger, acquisition and ~~transaction~~other costs. Merger, acquisition and other costs were $5.8 million during the nine months ended September 30, 2019 compared to $15.2 million during the nine months ended September 30, 2018, primarily due to expenses incurred in connection with the Nordic acquisition in the prior year.

Other. Other general and ~~administrative:~~administrative expense decreased $10.3 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to a reduction in legal expenses of $5.4 million and a $2.9 million decrease in bonus expense due to declines in number of participants and expected performance.

Depreciation and amortization. Depreciation and amortization decreased $33.4 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to the adoption of ASC 842 for lease accounting where the financing lease buildings and related depreciation were eliminated. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Other Expense (Income):

Other expense. Other expense of $4.6 million during the nine months ended September 30, 2019 is primarily due to $16.6 million of expense related to the repayment of indebtedness (See Note 6—Corporate Borrowings in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information), $1.7 million of foreign currency transaction losses and $0.8 million of non-operating net periodic benefit cost, partially offset by the increase in fair value of our derivative asset for the contingent call option related to the Class B common stock purchase and cancellation agreement of $0.5 million and a decrease in fair value of our derivative liability for the embedded conversion feature in our Convertible Notes due 2024 of $14.9 million. During the nine months ended September 30, 2018, other expense included $54.1 million of expense related to our derivative liability for the embedded conversion feature in our Convertible Notes due 2024. See Note 1—Basis of Presentation in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information about the components of other expense (income).

Interest expense. Interest expense increased $18.8 million to $248.7 million for the nine months ended September 30, 2019 compared to $229.9 million the nine months ended September 30, 2018 primarily due to the interest expense related to our 2.95% $600.0 million Convertible Notes due 2024 issued on September 14, 2018 and our Senior Secured Credit Facility-Term Loan due 2026 (See Note 6—Corporate Borrowings in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information), partially offset by the recording to rent expense of $9.9 million of financing lease obligation interest as a result of the adoption of ASC 842. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Table of Contents

Equity in earnings of non-consolidated entities. Equity in earnings of non-consolidated entities were $23.2 million for the nine months ended September 30, 2019 compared to $71.0 million for the nine months ended September 30, 2018. Equity in earnings for the nine months ended September 30, 2018 includes equity in earnings of $28.9 million related to the sale of our then remaining interest in NCM, $30.1 million related to the Screenvision merger and a $2.3 million gain on the sale of NCM, Inc. common shares, partially offset by a $16.0 million lower of carrying value or fair value impairment loss on 9,492,820 NCM units and 1,000,000 NCM, Inc. common shares held-for-sale and a $1.1 million loss on the return of 915,150 NCM units as a part of the annual common unit adjustment under the NCM ESA.

Investment income. Investment income was $5.7 million for the nine months ended September 30, 2019 compared to $7.4 million for the nine months ended September 30, 2018. Investment income includes payments received related to the NCM tax receivable agreement of $4.0 million and $5.4 million for the nine months ended September 30, 2019 and September 30, 2018, respectively. Investment income for the nine months ended September 30, 2018 also includes a $1.5 million gain on the sale of a joint venture managed theatre.

Income tax provision. The income tax provision was $8.9 million and $14.6 million for the nine months ended September 30, 2019 and September 30, 2018, respectively. See Note 8—Income Taxes in the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

Net loss. Net loss was $142.7 million and $36.5 million during the nine months ended September 30, 2019 and September 30, 2018, respectively. Net loss during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 was impacted by lower attendance which negatively impacted admissions revenue, higher rent expense, operating expense and interest expense, decreased equity in earnings from non-consolidated entities, offset by increases in food and beverage revenues and other revenues, decreases in other expense related to our derivative liability, income tax provision, depreciation and amortization expense, general and administrative expenses and increased investment income.

Theatrical Exhibition - International Markets

Revenues. Total revenues decreased 1.6%, or $16.2 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. Admissions revenues decreased 5.1%, or $34.6 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to a decline in average ticket price of 7.0%, partially offset by ~~lower~~an increase in attendance of 2.1%. The decrease in average ticket price was primarily due to decreases in foreign currency translation rates. The increase in attendance was primarily due to the popularity of films released in the period as compared to the same period a year ago.

Food and beverage revenues increased 4.5%, or $11.4 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to the overall increase in food and beverage per patron of 2.3% including declines in foreign currency translation rates and the increase in attendance.

Total other theatre revenues increased $7.0 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to increases in ticket fees, theatre rentals and income from gift cards and package tickets, partially offset by a decline in foreign currency translation rates.

Operating costs and expenses. Operating costs and expenses decreased 2.5%, or $26.3 million, during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. Film exhibition costs decreased $4.7 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to the decrease in admissions revenues. As a percentage of admissions revenues, film exhibition costs were 42.4% for the nine months ended September 30, 2019 and 40.9% for the nine months ended September 30, 2018.

Food and beverage costs decreased $0.1 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018. The decrease in food and beverage costs was primarily due to the decrease in foreign currency translation rates. As a percentage of food and beverage revenues, food and beverage costs were 22.4% for the nine months ended September 30, 2019 and 23.4% for the nine months ended September 30, 2018. Food and beverage gross profit per patron increased 3.7% and is calculated as food and beverage revenues less food and beverage costs divided by attendance.

Table of Contents

As a percentage of revenues, operating expense was 34.1% for the nine months ended September 30, 2019 and 35.6% during the nine months ended September 30, 2018. Rent expense increased $33.2 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 primarily due to the adoption of ASC 842 for lease accounting where approximately $29.7 million of prior year principal and interest payments were recorded as rent expense during the nine months ended September 30, 2019 related to build-to-suit financing lease obligations and $5.8 million of non-cash rent expense - purchase accounting was recorded as rent expense, offset by a decline in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

General and Administrative Expense:

Merger, acquisition and other costs. Merger, acquisition and other costs decreased $6.5 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to expenses incurred in connection with the Nordic acquisition in the prior year.

Other. Other general and administrative expense increased $1.6 million during the nine months ended September 30, 2019, compared to the nine months ended September 30, 2018.

Depreciation and amortization. Depreciation and amortization decreased $27.9 million during the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018 primarily due to the adoption of ASC 842 for lease accounting where the financing lease buildings and depreciation were eliminated and a decline in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Other Expense:

Other expense. Other expense was $0.5 million during the nine months ended September 30, 2019 compared to $1.3 million for the nine months ended September 30, 2019. See Note 1—Basis of Presentation in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information about the components of other expense (income).

Interest expense. Interest expense decreased $12.6 million for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, primarily due to the adoption of ASC 842 for lease accounting which recorded build-to-suit finance lease obligation interest expense to rent and a decline in foreign currency translation rates. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1 for the impact of ASC 842.

Investment income. Investment income increased $13.0 million due to the gain on the sale of our Austria theatres.

Income tax provision (benefit). The income tax ~~expenses.~~provision was $2.0 million for the nine months ended September 30, 2019 and the income tax benefit was ($1.4) million for the nine months ended September 30, 2018. See Note 8—Income Taxes in the Notes to the Condensed Consolidated Financial Statements in Item 1 of Part I of this Form 10-Q for further information.

Net earnings (loss). Net earnings increased $31.1 million during the nine months ended September 30, 2019 as a result of higher attendance, increased investment income, lower depreciation and amortization, reduced operating expenses, lower general and administrative expense and lower interest expense, offset by a decline in foreign currency translation rates, higher rent expense and higher income tax provisions.

LIQUIDITY AND CAPITAL RESOURCES

Our consolidated revenues are primarily collected in cash, principally through box office admissions and food and beverage sales. We have an operating “float” which partially finances our operations, and which generally permits us to maintain a smaller amount of working capital capacity. This float exists because admissions revenues are received in cash, while exhibition costs (primarily film rentals) are ordinarily paid to distributors from 20 to 45 days following receipt of box office admissions revenues. Film distributors generally release the films which they anticipate will be the most successful during the summer and year-end holiday seasons. Consequently, we typically generate higher revenues

Table of Contents

during such periods.

We had working capital deficits (excluding restricted cash) as of September 30, ~~2018~~2019 and December 31, ~~2017~~2018 of ~~$(482.9 million)~~$1,208.7 million and ~~$(545.3 million),~~$557.5 million, respectively. Working capital included ~~$293.2~~$568.1 million and ~~$401.0~~$0 of operating lease liabilities as of September 30, 2019 and December 31, 2018, respectively. Working capital included $347.5 million and $414.8 million of deferred revenues as of September 30, ~~2018~~2019 and December 31, ~~2017,~~2018, respectively. We have the ability to borrow under our Revolving Credit Facility to meet obligations as they come due (subject to limitations on the incurrence of indebtedness in our various debt instruments). As of September 30, ~~2018,~~2019, we had ~~$211.1~~$211.7 million available for borrowing, net of letters of credit, under our Revolving Credit Facility. We also maintain a £100.0 million ($~~130.0~~123.0 million based on the foreign currency translation rate of ~~1.30~~1.2298 on September 30, ~~2018)~~2019) revolving credit facility at our Odeon subsidiary. As of September 30, ~~2018,~~2019, we had a$10.0 million drawn down on the revolving credit facility ~~by $6.6 million~~ and had issued ~~$19.2~~£17.0 million ($20.9 million) standby letters of credit in the ordinary course of business, leaving ~~£80.1~~£74.9 million ($~~104.2~~92.1 million) available for borrowing.

We believe that cash generated from operations, existing cash and cash equivalents, availability under our Revolving Credit Facility and Odeon’s ~~Revolving Credit Facility~~revolving credit facility will be sufficient to fund operations, planned capital expenditures ~~dividends~~ and ~~repurchases of our common stock~~dividends currently and for at least the next 12 months and enable us to maintain compliance with all financial debt covenants.

As of September 30, ~~2018,~~2019, we were in compliance with all financial debt covenants.

Cash Flows from Operating Activities

Cash flows provided by operating activities, as reflected in the ~~Consolidated Statements~~condensed consolidated statements of ~~Cash Flows,~~cash flows, were ~~$298.8~~$210.2 million and ~~$229.6~~$298.8 million during the nine months ended September 30, ~~2018~~2019 and September 30, ~~2017,~~2018, respectively. The ~~increase~~decrease in cash flows provided by operating activities was primarily due to ~~increased~~decreased attendance levels and average ticket prices which drove ~~higher~~lower operating results and ~~increases~~the adoption of ASC 842 which reclassified approximately $42.0 million of principal payments under build-to-suit finance lease obligations from net cash used in ~~landlord contributions.~~ financing activities to net cash used in operating activities during calendar 2019.

Cash Flows ~~used in~~from Investing Activities

Cash flows used in investing activities, as reflected in the ~~Consolidated Statements~~condensed consolidated statements of ~~Cash Flows,~~cash flows, were ~~$114.3~~$348.4 million and ~~$809.3~~$114.3 million during the nine months ended September 30, ~~2018~~2019 and September 30, ~~2017,~~2018, respectively. Cash outflows from investing activities include capital expenditures of $348.2 million and $374.9 million ~~and $467.7 million~~

~~Table of Contents~~

during the nine months ended September 30, ~~2018~~2019 and September 30, ~~2017,~~2018, respectively. Our capital expenditures primarily consisted of strategic growth initiatives and remodels, capital improvements to existing locations in our theatre circuit, and technology upgrades. During the nine months ended September 30, ~~2018,~~2019, cash ~~inflows from~~flows used in investing activities included the cash outflows of $11.8 million for the acquisition of assets related to 4 theatres in the U.S. markets, offset by proceeds from the disposition of long-term assets of $21.4 million. During the nine months ended September 30, 2018, net cash used in investing activities included proceeds from the Screenvision merger of $45.8 million, proceeds from sale leaseback transactions of $50.1 million, and proceeds from the disposition of NCM units of $162.5 million. During the nine months ended September 30, 2017, cash outflows from investing activities included the acquisition of Nordic, net of cash and restricted cash, of $577.6 million, proceeds from sale leaseback transactions of $128.4 million and proceeds from disposition of NCM units of $89.4 million. We expect that our ~~gross~~ cash outflows for capital expenditures, net of landlord contributions, will be approximately ~~$600.0 million to $640.0~~$415.0 million for ~~2018, before giving effect to expected landlord contributions of approximately $140.0 million to $150.0 million.~~ calendar 2019.

We fund the costs of constructing, maintaining and remodeling our theatres through existing cash balances, cash generated from operations, landlord contributions, or borrowed funds, as necessary. We generally lease our theatres pursuant to long-term non-cancelable operating leases which may require the developer, who owns the property, to reimburse us for the construction costs. We may decide to own the real estate assets of new or acquired theatres and, following construction or acquisition, sell and leaseback the real estate assets pursuant to long-term non-cancelable operating leases. See Commitments and Contingencies below for additional discussion of the potential cash ~~outflows and future sources of liquidity.~~outflows.

Cash Flows from Financing Activities

Cash flows ~~provided by (used in)~~used in financing activities, as reflected in the ~~Consolidated Statements~~condensed consolidated statements of ~~Cash Flows,~~cash flows, were ~~$(155.3)~~$72.9 million and ~~$621.0~~$155.3 million during the nine months ended September 30, ~~2018~~2019 and September 30, ~~2017,~~2018, respectively.

Table of Contents

During the nine months ended September 30, 2019, cash inflows from financing activities included the proceeds from the issuance of $1,990.0 million of Term Loans due 2026, offset by cash outflows for the repayment of the Term Loan due 2022 of $849.8 million, repayment of the Term Loan due 2023 of $488.7 million, repayments of the 6.0% Senior Secured Notes due 2023 of $230.0 million and payment of the 5.875% Senior Subordinated Notes due 2022 of $375.0 million. Call premiums paid related to the repayment of the 6.0% Senior Secured Notes due 2023 and the 5.875% Senior Subordinated Notes due 2022 were $15.9 million and debt financing costs paid were $11.7 million. See Note 6—Corporate Borrowings in the Notes to the Condensed Consolidated Financial Statements under Item 1 for additional information.

Principal payments under finance lease obligations declined to $8.5 million due primarily to the adoption of ASC 842 where principal payments of $42.0 million for build-to-suit finance lease obligations were reclassified as operating leases and the related cash flows were also classified as operating activities. See Note 2—Leases in the Notes to the Condensed Consolidated Financial Statements under Item 1. for the impact of ASC 842.

On February ~~28, 2018,~~15, 2019, our Board of Directors declared a cash dividend in the amount of $0.20 per share of Class A and Class B common stock, paid on March ~~26, 2018~~25, 2019 to stockholders of record on March ~~12, 2018.~~11, 2019. On May 3, ~~2018,~~2019, our Board of Directors declared a cash dividend in the amount of $0.20 per share of Class A and Class B common stock, paid on June ~~25, 2018~~24, 2019 to stockholders of record on June ~~11, 2018.~~10, 2019. On ~~July 24, 2018,~~August 2, 2019, our Board of Directors declared a cash dividend in the amount of $0.20 per share of Class A and Class B common stock, paid on September ~~24, 2018~~23, 2019 to stockholders of record on September 10, 2018. On September 14, 2018, our Board of Directors declared a cash dividend in the amount of $1.55 per share of Class A and Class B common stock, paid on September 28, 2018 to stockholders of record on September 25, 2018.9, 2019. We paid dividends and dividend equivalents of $63.4 million and $237.4 million during the nine months ended September 30, ~~2018~~2019 and ~~paid dividends and dividend equivalents of $78.7 million during the nine months ended~~ September 30, ~~2017.~~2018, respectively.

On ~~November 1, 2018, our~~October 24, 2019, the Board of Directors declared a cash dividend in the amount of $0.20 per share ofon our Class A and Class B common stock, ~~to be paid~~payable on December ~~26, 2018~~16, 2019 to stockholders of record on December ~~10, 2018.~~ 2, 2019.

We made tax payments for restricted stock units withholdings of ~~$1.7~~$1.3 million and ~~$6.5~~$1.7 million during the nine months ended September 30, ~~2018~~2019 and September 30, ~~2017,~~2018, respectively.

We paid $13.5 million for treasury stock purchased at the end of 2017 and settled during January of 2018. We paid $8.3 million for treasury stock purchased during the nine months ended September 30, 2018.

As of September 30, 2018, we had no borrowings outstanding under our Revolving Credit Facility and $13.9 million in outstanding standby letters of credit in the ordinary course of business and we had $6.6 million of borrowings outstanding under our Odeon revolving credit facility and $19.2 million in outstanding standby letters of credit in the ordinary course of business.

On March 17, 2017, we issued $475.0 million aggregate principal amount of our 6.125% Senior Subordinated Notes due 2027 in a private offering and £250.0 million ($327.8 million) additional aggregate principal amount of our Sterling Notes due 2024 at 106% plus accrued interest from November 8, 2016 in a private offering.

On March 28, 2017, we paid the Nordic SEK Term Loan of $144.4 million and the Nordic EUR Term Loan of $169.5 million aggregate principal amount in connection with the acquisition of Nordic using proceeds from our ~~Senior Subordinated Notes due 2027 and Sterling Notes due 2024.~~

~~Table of Contents~~

In February 2017, we completed an additional public offering of 20,330,874 shares of Class A common stock at a price of $31.50 per share ($640.4 million), resulting in net proceeds of $616.8 million after underwriters commission. We used a portion of the net proceeds to repay the aggregate principal amount of our Bridge Loan of $350.0 million.

~~On September 14, 2018, we issued $600.0 million aggregate principal amount of our 2.95% Senior Unsecured Convertible Notes due 2024.~~

On September 14, 2018, we used the net proceeds from the Convertible Notes due 2024 private offering to repurchase and retire 24,057,143 shares of Class B common stock held by Wanda for $422.9 million and to pay a special dividend on September 28, 2018 to shareholders of record on September 25, 2018 of $1.55 per share, or approximately $160.5 million.

Contractual Obligations, Commitments and Contingencies

We have commitments and contingencies for ~~capital and~~ financing leases, corporate borrowings, operating leases, capital related betterments and pension funding that were summarized in a table in our Annual Report on Form 10–K for the year ended December 31, ~~2017.~~2018. Since December 31, ~~2017,~~2018, there have been no material changes to the commitments and contingencies outside of ~~the Company outside~~ the ordinary course of business, except ~~as otherwise disclosed regarding~~entering into the ~~sale leaseback transaction (see Note 1 – Basis of Presentation for additional information regarding the sale leaseback transaction)~~amended and ~~the issuance of $600.0 million Convertible Notes due 2024, (see Note 6 – Corporate Borrowings for additional information on the terms of the Convertible Notes due 2024).~~restated Senior Secured Credit Agreement.

8273

Table of Contents

Item 3. Quantitative and Qualitative Disclosures about Market Risk

In the ordinary course of business, our financial results are exposed to fluctuations in interest rates and foreign currency exchange rates. In accordance with applicable guidance, we presented a sensitivity analysis showing the potential impact to net income of changes in interest rates and foreign currency exchange rates. For the nine months ended September 30, ~~2018,~~2019, our analysis utilized a hypothetical 100 basis-point increase or decrease to the average interest rate on our variable rate debt instruments to illustrate the potential impact to interest expense of changes in interest rates. For the nine months ended September 30, ~~2018,~~2019, our analysis utilized a hypothetical 100 basis-point increase or decrease to market interest rates on our fixed rate debt instruments to illustrate the potential impact to fair value of changes in interest rates.

Similarly, for the same period, our analysis used a uniform and hypothetical 10% strengthening of the U.S. dollar versus the average exchange rates of applicable currencies to depict the potential impact to net income of changes in foreign exchange rates. These market risk instruments and the potential impacts to the condensed consolidated statements of operations for the current year, have not materially fluctuated, individually or in the aggregate from the preceding year; thus, only current year information is presented below.

Market risk on ~~variable‑rate~~variable-rate financial instruments. At September 30, ~~2018,~~2019, we maintained a Senior Secured Credit Facility comprised of a $225.0 million revolving credit facility ~~$856.4~~and $2,000.0 million of ~~Senior Secured~~ Term ~~Loans~~Loan due ~~2022 and $492.5 million of Senior Secured Term Loans due 2023.~~2026. The Senior Secured Credit Facility provides for borrowings at a rate per annum equal to, at our option, either (i) an applicable margin plus ~~at our option, either~~ a base rate determined by reference to the highest of (a) 0.50% per annum plus the Federal Funds Effective Rate, or (b) the prime rate of Citi or (ii) the LIBOR + ~~2.25%~~3.0%. The rate in effect at September 30, ~~2018~~2019 for the outstanding ~~Senior Secured~~ Term ~~Loans~~Loan due ~~2022 and 2023~~2026 was ~~4.3844%~~5.23% per annum. Increases in market interest rates would cause interest expense to increase and earnings before income taxes to decrease. The change in interest expense and earnings before income taxes would be dependent upon the weighted average outstanding borrowings during the reporting period following an increase in market interest rates. At September 30, ~~2018,~~2019, we had ~~$6.6 million~~no variable-rate borrowings outstanding under our revolving credit ~~facilities~~facility and had an aggregate principal balance of ~~$1,348.9~~$1,990.0 million outstanding under the ~~Senior Secured~~ Term ~~Loans~~Loan due ~~2022 and 2023.~~2026. A 100-basis point change in market interest rates would have increased or decreased interest expense on the Senior Secured Credit Facility by ~~$10.1~~$14.9 million during the nine months ended September 30, ~~2018.~~2019.

Market risk on fixed-rate financial ~~instruments.~~ instruments. Included in long-term corporate borrowings at September 30 ~~2018~~2019 were principal amounts of $600.0 million of our Convertible Notes due 2024, ~~$230.0 million of our Senior Secured Notes due 2023,~~ $600.0 million of our Notes due 2025, ~~$375.0 million of our Notes due 2022,~~ $595.0 million of our Notes due 2026, $475.0 million of our Notes due 2027, and £500.0 million ($~~651.5~~614.9 million) of our Sterling Notes due 2024. A 100-basis point change in market interest rates would have caused an increase or (decrease) in the fair value of our fixed rate financial instruments of approximately ~~$190.1~~$136.0 million and ~~($178.0)~~$(128.0) million, respectively.

Foreign currency exchange rate risk. We are also exposed to market risk arising from changes in foreign currency exchange rates as a result of our ownership of Odeon and Nordic. Odeon’s revenues and operating expenses are transacted in British Pounds and Euros, and Nordic’s revenues and operating expenses are transacted primarily in Swedish Krona and Euros. U.S. GAAP requires that our subsidiaries use the currency of the primary economic environment in which they operate as their functional currency. If Odeon and Nordic operate in a highly inflationary economy, U.S. GAAP requires that the U.S. dollar be used as the functional currency for Odeon and Nordic. Currency fluctuations in the countries in which we operate result in us reporting exchange gains (losses) or foreign currency translation adjustments. Based upon our ownership in Odeon and Nordic as of September 30, ~~2018,~~2019, holding everything else constant, a hypothetical 10% ~~immediate, simultaneous, favorable change in all~~strengthening of the ~~foreign currency~~U.S. dollar versus the average exchange rates of applicable currencies to ~~which we are exposed,~~depict the potential impact to net income of changes in foreign exchange rates would ~~increase~~decrease the aggregate net ~~loss~~earnings of our International ~~markets reportable segment~~theatres for the nine months ended September 30, ~~2018~~2019 by approximately ~~$2.4~~$0.7 million.

Our foreign currency translation rates ~~increased~~decreased by approximately ~~6.0%~~6.3% for the nine months ended September 30, ~~2018 as~~2019 compared to the nine months ended September 30, ~~2017,~~2018, which did not significantly impact our consolidated net loss for the nine months ended September 30, ~~2018.~~2019.

8374

Table of Contents

Item 4. Controls and Procedures.

(a)

Evaluation of disclosure controls and procedures.

~~(a)Evaluation of disclosure controls and procedures.~~

The Company maintains a set of disclosure controls and procedures designed to ensure that material information required to be disclosed in its filings under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that material information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Company’s Chief Executive Officer and Chief Financial Officer have evaluated these disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10–Q and have determined that such disclosure controls and procedures were effective.

(b)

Changes in internal control.

~~(b)Changes in internal control.~~

As part of the adoption of ASC Topic ~~606,~~842, the Company implemented ~~changes to its control activities related to revenue recognition~~new internal controls to ensure ~~adequate evaluation of its~~we adequately evaluated our contracts and ~~proper assessment of the impact of~~properly assessed the new lease accounting ~~standard.~~standard’s impact on our consolidated financial statements. There were no other significant changes in the Company’s internal control over financial reporting due to the adoption of the new standard, and no other changes in its internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the quarter ended September 30, ~~2018,~~2019, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

8475

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

Reference is made to Note ~~14–~~12—Commitments and Contingencies of the Notes to the Company’s Condensed Consolidated Financial Statements contained in Part I of this quarterly report on Form 10–Q for information on certain litigation to which we are a party.

Item 1A. Risk Factors

Reference is made to Part I Item 1A. Risk Factors in our Annual Report on Form 10–K for the year ended December 31, ~~2017,~~2018, which sets forth information relating to important risks and uncertainties that could materially adversely affect our business, financial condition or operating results. There have been no material changes to the risk factors contained in our Annual Report on Form 10-K for the year ended December 31, ~~2017, except as set forth below.~~ 2018.

~~There may be future dilution of our Class A common stock, which could adversely affect the market price of shares of our Class A common stock.~~

In the future, we may issue additional shares of Class A common stock to raise cash to refinance indebtedness, for working capital, to finance strategic initiatives and future acquisitions or for other purposes. We may also acquire interests in other companies by using a combination of cash and shares of Class A common stock or just shares of Class A common stock. We may also issue securities convertible into, or exchangeable for, or that represent the right to receive, shares of Class A common stock. Any of these events may dilute the ownership interests of current stockholders, reduce our earnings per share or have an adverse effect on the price of our shares of Class A common stock. In addition, the conversion of some or all of our Convertible Notes due 2024, to the extent we deliver shares of Class A common stock upon conversion thereof, would dilute the ownership interests of current stockholders, reduce our earnings per share and potentially have an adverse effect on the price of our shares of Class A common stock.

~~Future sales of our Class A common stock in the public market could adversely affect the market price of our Class A common stock.~~

We cannot predict the effect, if any, that market sales of shares of our Class A common stock or the availability of shares of our Class A common stock for sale will have on the prevailing market price of our Class A common stock. Sales of a substantial number of shares of our Class A common stock in the public market, or the perception that these sales may occur, could reduce the market price of our shares of Class A common stock.

Wanda holds shares of our Class B common stock, all of which constitute "restricted securities" under the Securities Act. The shares of our Class B common stock automatically convert to Class A common stock (1) if transferred to a person other than certain permitted transferees or (2) upon Wanda and its permitted transferees holding less than 30% of all outstanding shares of our Class A and Class B common stock. Provided the holders comply with the applicable volume limits and other conditions prescribed in Rule 144 under the Securities Act, all of these restricted securities are currently freely tradeable. Pursuant to a registration rights agreement dated December 23, 2013, we have agreed to use our best efforts to effect registered offerings upon request from Wanda and to grant incidental or "piggyback" registration rights with respect to any registrable securities held by Wanda. The obligation to effect any demand for registration by Wanda will be subject to certain conditions, including limitations on the number of demand registrations and limitations on the minimum value of securities to be registered. We have also agreed to use our best efforts to grant certain incidental or "piggyback" registration rights with respect to securities issued to certain current and former officers. In connection with the sale of our Convertible Notes due 2024, we have agreed, subject to certain conditions, to use our reasonable efforts to effect registered offerings on behalf of holders of the Convertible Notes due 2024 with respect to the securities held by them and the shares of Class A common stock issuable upon conversion thereof. The exercise of such registration rights by Wanda, the holders of the Convertible Notes due 2024 and/or the current and former officers may substantially increase the number of shares of Class A common stock in the public market and could reduce the market price of shares of our Class A common stock.

~~Table of Contents~~

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(a)

None.

(b)

None.

(c)

Issuer Purchases of Equity Securities


	Purchases of Equity Securities
					Approximate Dollar
				Total Number of	Value of Shares that
				Shares Purchased as	May Yet Be
				Part of Publicly	Purchased Under the
	Total Number of	Average Price Paid		Announced Plans or	Plans or Program (a)
Period	Shares Purchased	Per Share		Programs (a)	(in millions)
July 1, 2019 through July 31, 2019	—	$	—	—	$	44.3
August 1, 2019 through August 31, 2019	—	$	—	—	$	44.3
September 1, 2019 through September 30, 2019	—	$	—	—	$	44.3
Total	—			—

Purchases of Equity Securities

Approximate Dollar

Total Number of

Value of Shares that

Shares Purchased as

May Yet Be

Part of Publicly

Purchased Under the

Total Number of

Average Price Paid

Announced Plans or

Plans or Program (a)
Period

Shares Purchased

Per Share

Programs (a)

(in millions)
July 1, 2018 through July 31, 2018

—

$
—

—

$
44.3
August 1, 2018 through August 31, 2018

—

$
—

—

$
44.3
September 1, 2018 through September 30, 2018 (b)

24,057,143

$
17.58

—

$
44.3
Total

24,057,143

—

(a)

As announced on August 3, 2017, our Board of Directors authorized a share repurchase program for an aggregate purchase of up to $100.0 million of our common stock, excluding transaction costs. As of September 30, ~~2018,~~2019, $44.3 million remained available for repurchase under this plan. A two-year time limit ~~has~~had been set for the completion of this program, ~~expiring~~which expired August 2, 2019.

~~(b)~~

As announced on September 14, 2018, our Board of Directors authorized repurchase of 24,057,143 shares from Wanda for approximately $421.0 million and associated legal fees of $1.9 million. This purchase was not part of our share repurchase program.

Item 3. Defaults Upon Senior Securities

None.

Item ~~4. Mine Safety Disclosures~~

~~Not applicable.~~

~~Item~~ 5. Other Information

None.

8676

Table of Contents

Item 6. Exhibits.

EXHIBIT INDEX


EXHIBIT NUMBER		DESCRIPTION
*3.1		~~Certificate of Retirement of 24,057,143 Shares of Class B Common Stock of AMC Entertainment Holdings, Inc., dated as of November 1, 2018.~~

~~4.1~~		Indenture by and among AMC Entertainment Holdings, Inc., the guarantors party thereto and U.S. Bank National Association, as trustee, dated as of September 14, 2018. (incorporated by reference from Exhibit 4.1 to AMCEH’s Current Report on Form 8-K (File No. 1-33892) filed on September 20, 2018)

*10.1		Fifth Amendment to Credit Agreement, dated as of August 14, 2018, by and among AMC Entertainment Holdings, Inc., as borrower, the other loan parties party thereto, the lenders party thereto and Citicorp North America, Inc., as administrative agent.

~~10.2~~		Investment Agreement by and between AMC Entertainment Holdings, Inc. and Silver Lake Alpine, L.P., dated as of September 14, 2018. (incorporated by reference from Exhibit 10.1 to AMCEH’s Current Report on Form 8-K (File No. 1-33892) filed on September 20, 2018)

~~10.3~~		Stock Repurchase and Cancellation Agreement by and between AMC Entertainment Holdings, Inc. and Wanda America Entertainment, Inc., dated as of September 14, 2018. (incorporated by reference from Exhibit 10.2 to AMCEH’s Current Report on Form 8-K (File No. 1-33892) filed on September 20, 2018)

~~10.4~~		Right of First Refusal Agreement by and among AMC Entertainment Holdings, Inc., Silver Lake Alpine, L.P. and Wanda America Entertainment, Inc., dated as of September 14, 2018. (incorporated by reference from Exhibit 10.3 to AMCEH’s Current Report on Form 8-K (File No. 1-33892) filed on September 20, 2018)

*10.5		~~AMC Entertainment Holdings, Inc. Non-Employee Director Compensation Program – Amended and Restated November 1, 2018, Effective January 1, 2019.~~

*31.1		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Acts of 2002.

*31.2		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Acts of 2002.

*32.1		Section 906 Certifications of Adam M. Aron (Chief Executive Officer) and Craig R. Ramsey (Chief Financial Officer) furnished in accordance with Securities Act Release 33-8212.

**101.INS		Inline XBRL Instance Document

**101.SCH		Inline XBRL Taxonomy Extension Schema Document

**101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document

**101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document

**101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document

**101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

**104		Cover Page Interactive Data File (formatted as inline XBRL and contained as Exhibit 101)

* Filed herewith

** Submitted electronically with this Report.

8777

Table of Contents

~~SIGNATURES~~

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	AMC ENTERTAINMENT HOLDINGS, INC.


Date: November ~~8, 2018~~7, 2019	/s/ ADAM M. ARON
	Adam M. Aron
	Chief Executive Officer, Director and President


Date: November ~~8, 2018~~7, 2019	/s/ CRAIG R. RAMSEY
	Craig R. Ramsey
	Executive Vice President and Chief Financial Officer

8878

		Page Number
	PART I—FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	3
	Condensed Consolidated Statements of Operations	3
	Condensed Consolidated Statements of Comprehensive Loss	4
	Condensed Consolidated Balance Sheets	5
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	54 48
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	83
~~Item 4.~~	~~Controls and Procedures~~	84
	~~PART II—OTHER INFORMATION~~	74
Item 1.4.	~~Legal Proceedings~~Controls and Procedures	85 75
	PART II—OTHER INFORMATION
Item ~~1A.~~1.	~~Risk Factors~~Legal Proceedings	85 76
Item 2.1A.	Risk Factors	76
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	86 76
Item 3.	Defaults Upon Senior Securities	86 76
Item 4.5.	~~Mine Safety Disclosures~~Other Information	86 76
Item 5.6.	~~Other Information~~Exhibits	86 77
~~Item 6.~~	~~Exhibits~~Signatures	87
78	~~Signatures~~	88


	Three Months Ended				Nine Months Ended
(in millions, except share and per share amounts)	September 30, 2018		September 30, 2017		September 30, 2018		September 30, 2017
	(unaudited)				(unaudited)
Revenues
Admissions	$	751.4	$	753.5	$	2,522.7	$	2,332.4
Food and beverage		384.8		361.4		1,236.4		1,133.1
Other theatre		85.2		63.8		288.4		196.9
Total revenues		1,221.4		1,178.7		4,047.5		3,662.4
Operating costs and expenses
Film exhibition costs		378.8		364.8		1,276.7		1,164.2
Food and beverage costs		63.6		60.7		202.0		182.6
Operating expense, excluding depreciation and amortization below		400.5		383.2		1,236.9		1,128.8
Rent		203.7		200.7		593.1		590.9
General and administrative:
Merger, acquisition and transaction costs		18.1		5.6		27.1		57.2
Other, excluding depreciation and amortization below		48.4		32.6		135.6		113.0
Depreciation and amortization		130.2		135.2		398.4		393.9
Operating costs and expenses		1,243.3		1,182.8		3,869.8		3,630.6
Operating income (loss)		(21.9)		(4.1)		177.7		31.8
Other expense (income):
Other expense (income)		54.1		(0.4)		57.5		(1.9)
Interest expense:
Corporate borrowings		64.3		60.8		188.2		171.7
Capital and financing lease obligations		9.4		10.6		29.5		31.7
Non-cash NCM exhibitor services agreement		10.3		—		31.2		—
Equity in (earnings) loss of non-consolidated entities		(70.0)		1.8		(74.0)		199.1
Investment income		(0.7)		(16.6)		(7.4)		(21.6)
Total other expense		67.4		56.2		225.0		379.0
Loss before income taxes		(89.3)		(60.3)		(47.3)		(347.2)
Income tax provision (benefit)		11.1		(17.6)		13.2		(136.4)
Net loss	$	(100.4)	$	(42.7)	$	(60.5)	$	(210.8)
Loss per share:
Basic	$	(0.82)	$	(0.33)	$	(0.48)	$	(1.65)
Diluted	$	(0.82)	$	(0.33)	$	(0.48)	$	(1.65)
Average shares outstanding:
Basic (in thousands)		123,126		131,077		126,386		127,902
Diluted (in thousands)		123,126		131,077		126,386		127,902


(In millions, except share data)	September 30, 2018		December 31, 2017
ASSETS
Current assets:
Cash and cash equivalents	$	333.3	$	310.0
Restricted cash		11.0		8.3
Receivables, net		155.2		271.5
Assets held for sale		—		80.0
Other current assets		187.0		202.6
Total current assets		686.5		872.4
Property, net		3,028.6		3,116.5
Intangible assets, net		359.3		380.5
Goodwill		4,820.8		4,931.7
Deferred tax asset, net		29.5		28.9
Other long-term assets		438.3		475.9
Total assets	$	9,363.0	$	9,805.9
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	395.1	$	569.6
Accrued expenses and other liabilities		387.1		351.1
Deferred revenues and income		293.2		401.0
Current maturities of corporate borrowings and capital and financing lease obligations		83.0		87.7
Total current liabilities		1,158.4		1,409.4
Corporate borrowings		4,840.3		4,220.1
Capital and financing lease obligations		516.7		578.9
Exhibitor services agreement		567.7		530.9
Deferred tax liability, net		44.3		49.6
Other long-term liabilities		980.7		903.8
Total liabilities		8,108.1		7,692.7
Commitments and contingencies
Class A common stock (temporary equity) ($.01 par value, 75,712 shares issued; 38,943 shares outstanding as of September 30, 2018 and 112,817 shares issued; 76,048 shares outstanding as of December 31, 2017)		0.4		0.8
Stockholders’ equity:
Class A common stock ($.01 par value, 524,173,073 shares authorized; 55,401,325 shares issued and 51,705,469 outstanding as of September 30, 2018; 55,010,160 shares issued and 51,814,304 outstanding as of December 31, 2017)		0.5		0.5
Class B common stock ($.01 par value, 75,826,927 shares authorized; 51,769,784 shares issued and outstanding as of September 30, 2018 and 75,826,927 shares authorized; 75,826,927 shares issued and outstanding as of December 31, 2017)		0.5		0.8
Additional paid-in capital		1,994.5		2,241.6
Treasury stock (3,732,625 shares as of September 30, 2018 and 3,232,625 shares as of December 31, 2017, at cost)		(56.4)		(48.2)
Accumulated other comprehensive income		26.0		125.6
Accumulated deficit		(710.6)		(207.9)
Total stockholders’ equity		1,254.5		2,112.4
Total liabilities and stockholders’ equity	$	9,363.0	$	9,805.9

Principal payments under capital and financing lease obligations		(53.5)		(54.1)
Cash used to pay for deferred financing costs		(14.3)		(29.8)
Cash used to pay dividends		(237.4)		(78.7)
Taxes paid for restricted unit withholdings		(1.7)		(6.5)
Retirement of Class B common stock		(422.9)		—
Purchase of treasury stock		(21.8)		(16.5)
Net cash provided by (used in) financing activities		(155.3)		621.0
Effect of exchange rate changes on cash and cash equivalents and restricted cash		(3.2)		19.9
Net increase (decrease) in cash and cash equivalents and restricted cash		26.0		61.2
Cash and cash equivalents and restricted cash at beginning of period		318.3		230.2
Cash and cash equivalents and restricted cash at end of period	$	344.3	$	291.4
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the period for:
Interest (including amounts capitalized of $0.4 million and $0.2 million)	$	175.1	$	161.5
Income taxes paid, net	$	9.9	$	9.6
Schedule of non-cash activities:
Investment in NCM (See Note 5-Investments)	$	(6.3)	$	235.2
Construction payables at period end	$	102.3	$	106.7


(In millions)	Balance at December 31, 2017 Without Adoption of ASC 606		Adjustments Due to ASC 606		Balance at January 1, 2018
Assets:
Other long-term assets	$	475.9	$	11.1	$	487.0
Current liabilities:
Deferred revenues and income		401.0		(10.0)		391.0
Long-term liabilities:
Exhibitor services agreement		530.9		52.9		583.8
Stockholders' equity:
Accumulated deficit		(207.9)		(31.8)		(239.7)


	Three Months Ended September 30, 2018
(In millions)	Without Adoption of ASC 606		Adjustments		As Reported
Revenues:
Admissions	$	751.7	$	(0.3)	$	751.4
Food and beverage		384.9		(0.1)		384.8
Other theatre		73.9		11.3		85.2
Total revenues		1,210.5		10.9		1,221.4
Operating costs and expenses:
Operating expense, excluding depreciation and amortization		395.2		5.3		400.5
Non-cash interest expense related to NCM exhibitor service agreement		—		10.3		10.3
Net loss		(95.7)		(4.7)		(100.4)


	Nine Months Ended September 30, 2018
(In millions)	Without Adoption of ASC 606		Adjustments		As Reported
Revenues:
Admissions	$	2,523.7	$	(1.0)	$	2,522.7
Food and beverage		1,236.7		(0.3)		1,236.4
Other theatre		252.3		36.1		288.4
Total revenues		4,012.7		34.8		4,047.5
Operating costs and expenses:
Operating expense, excluding depreciation and amortization		1,216.4		20.5		1,236.9
Non-cash interest expense related to NCM exhibitor service agreement		—		31.2		31.2
Net loss		(43.6)		(16.9)		(60.5)


	Deferred Revenues
	Related to Contracts
(In millions)	with Customers
Balance as of December 31, 2017	$	376.1
Cumulative effect of initially applying ASC 606		(10.0)
Cash received in advance (1)		285.6
Customer loyalty rewards accumulated, net of expirations:
Admission revenues (2)		21.8
Food and beverage (2)		39.1
Other theatre (2)		3.9
Reclassification to revenue as the result of performance obligations satisfied:
Admission revenues (3)		(304.0)
Food and beverage (3)		(61.5)
Other theatre (4)		(61.6)
Business combination - Nordic purchase price allocation (5)		(2.3)
Foreign currency translation adjustment		1.5
Balance as of September 30, 2018	$	288.6


	Exhibitor Services
(In millions)	Agreement
Balance as of December 31, 2017	$	530.9
Cumulative effect of initially applying ASC 606		52.9
Common Unit Adjustment – surrender of common units (1)		(5.2)
Reclassification of the beginning balance to other theatre revenue, as the result of performance obligations satisfied		(10.9)
Balance as of September 30, 2018	$	567.7


(In millions)	March 28, 2017		Changes		March 31, 2018
Cash	$	70.5	$	0.9	$	71.4
Restricted cash		—		5.9		5.9
Receivables		25.0		(11.6)		13.4
Other current assets		14.0		9.6		23.6
Property (1)		89.8		43.4		133.2
Intangible assets (1) (2)		—		22.1		22.1
Goodwill (3)		872.1		(79.2)		792.9
Deferred tax asset		5.5		(4.6)		0.9
Other long-term assets (6)		41.0		34.2		75.2
Accounts payable		(30.3)		0.1		(30.2)
Accrued expenses and other liabilities		(26.5)		(9.6)		(36.1)
Deferred revenues and income		(43.5)		2.3		(41.2)
Term Loan Facility (SEK)		(144.4)		—		(144.4)
Term Loan Facility (EUR)		(169.5)		—		(169.5)
Capital lease and financing lease obligations (1)(4)		(29.2)		19.2		(10.0)
Deferred tax liability		(5.2)		(13.5)		(18.7)
Other long-term liabilities (5)		(14.4)		(19.2)		(33.6)
Total estimated purchase price	$	654.9	$	—	$	654.9


	Weighted Average		Gross
(In millions)	Amortization Period		Carrying Amount
Acquired intangible assets:
Amortizable intangible assets:
Favorable leases		7.0 years	$	3.5
Favorable subleases		4.0 years		1.1
Screen advertising agreement		5.0 years		6.6
Trade name agreement		4.0 years		0.4
Total, amortizable		5.5 years	$	11.6
Unamortized intangible assets:
Trade names			$	10.5


	Actual Nine Months Ended		Pro Forma Nine Months Ended
(In millions)	September 30, 2018		September 30, 2017
Revenues	$	4,047.5	$	3,739.2
Operating income (loss)	$	177.7	$	38.4
Net earnings (loss)	$	(60.5)	$	(209.0)
Earnings (loss) per share:
Basic	$	(0.48)	$	(1.63)
Diluted	$	(0.48)	$	(1.63)


(In millions)	U.S. Markets		International Markets (1)		Total
Balance as of December 31, 2017	$	3,072.6	$	1,859.1	$	4,931.7
Adjustments to acquisition of Nordic		—		(6.4)		(6.4)
Currency translation adjustment		—		(104.5)		(104.5)
Balance as of September 30, 2018	$	3,072.6	$	1,748.2	$	4,820.8


	As of		As of
(In millions)	September 30, 2018		December 31, 2017
Due from NCM for on-screen advertising revenue	$	1.8	$	2.5
Due to NCM for Exhibitor Services Agreement		5.3		9.4
Promissory note payable to NCM		2.8		2.8


					Accumulated
			Exhibitor		Other				Equity in
	Investment in		Services		Comprehensive		Cash		(Earnings)		Advertising
(In millions)	NCM (1)		Agreement (2)		(Income)/Loss		Received (Paid)		Loss (3)		(Revenue)
Ending balance at December 31, 2017	$	161.1	$	(530.9)	$	(1.8)
ASC 606 revenue recognition change in amortization method		—		(52.9)		—
Surrender of common units for common unit adjustment		(6.3)		5.2		—	$	—	$	1.1		—
Receipt of excess cash distributions		(15.3)		—		—		15.3		—		—
Impairment loss - held for sale (4)		(14.4)		—		—		—		14.4		—
Expenses on sale of NCM common units		—		—		—		1.4		1.4		—
Sale of NCM common units		(128.3)		—		1.7		156.8		(30.2)		—
Equity in earnings		3.2		—		0.1		—		(3.3)		—
Amortization of ESA		—		10.9		—		—		—		(10.9)
For the period ended or balance as of September 30, 2018	$	—	$	(567.7)	$	—	$	173.5	$	(16.6)	$	(10.9)


	Common
	Membership Units		Common Shares
	Tranche 1	Tranche 2 (a)	NCM, Inc. (5)
Beginning balance at December 31, 2012	17,323,782	—	—
Additional units received in the quarter ended June 30, 2013	—	1,728,988	—
Additional units received in the quarter ended June 30, 2014	—	141,731	—
Additional units received in the quarter ended June 30, 2015	—	469,163	—
Additional units received in the quarter ended December 31, 2015	—	4,399,324	—
Units exchanged for NCM, Inc. shares in December 2015	—	(200,000)	200,000
Additional units received in the quarter ended March 31, 2017	—	18,787,315	—
Surrender of units for transferred theatres in March 2017	—	(2,850,453)	—
Surrender of units for exclusivity waiver in March 2017	—	(1,807,220)	—
Conversion of units to NCM, Inc. common shares in September 2017	—	(14,600,000)	14,600,000
Sale of NCM, Inc. common shares in September 2017	—	—	(14,800,000)
Conversion of units to NCM, Inc. common shares in October 2017	—	(1,000,000)	1,000,000
Surrender of units in the quarter ended March 31, 2018	—	(915,150)	—
Sale of NCM, Inc. common shares in June 2018	—	—	(1,000,000)
Sale of NCM common units in July 2018	(17,323,782)	(4,153,698)	—
Ending balance at September 30, 2018	—	—	—


			Cash		NCM Inc.
	Investment in		Received		Equity in
(In millions)	NCM Inc.		(Paid)		(Earnings) Loss
Ending balance December 31, 2017	$	6.8	$	—	$	—
Held-for-sale impairment loss (4)		(1.6)		—		1.6
Expenses from the sale of NCM Inc. common shares		—		(0.1)		0.1
Dividend received NCM, Inc. common shares		(0.3)		0.3		—
Sale of NCM Inc. common shares		(4.9)		7.2		(2.3)
Ending balance at September 30, 2018	$	—	$	7.4	$	(0.6)


	Carrying Value				Carrying Value
	at Issuance on		Charges to		as of
	September 14, 2018		Earnings		September 30, 2018
Principal balance	$	600.0	$	—	$	600.0
Discount		(90.4)		0.6		(89.8)
Debt issuance costs		(12.5)		0.1		(12.4)
Derivative liability		90.4		54.1		144.5
Carrying Value	$	587.5	$	54.8	$	642.3


			Amount per		Total Amount
			Share of		Declared
Declaration Date	Record Date	Date Paid	Common Stock		(In millions)
February 28, 2018	March 12, 2018	March 26, 2018	$	0.20	$	26.0
May 3, 2018	June 11, 2018	June 25, 2018		0.20		26.0
July 24, 2018	September 10, 2018	September 24, 2018		0.20		25.8
September 14, 2018	September 25, 2018	September 28, 2018		1.55		162.9


							Additional
					Amount		Expected to		Expected to		Expected to
	Three Months Ended		Nine Months Ended		Unrecognized		Recognize		Recognize		Recognize
Grant	September 30, 2018		September 30, 2018		September 30, 2018		2018		2019		2020
2018 Board of Directors	$	—	$	0.5	$	—	$	—	$	—	$	—
2018 RSU awards		1.0		2.4		7.8		1.0		3.4		3.4
2018 PSU awards		1.8		4.1		6.0		1.8		3.0		1.2
2017 RSU awards		0.5		1.3		2.4		0.5		1.9		—
2017 RSU NEO awards		0.3		1.0		1.7		0.3		1.4		—
2017 PSU awards (1)		—		—		—		—		—		—
2016 RSU awards		0.3		0.8		0.3		0.3		—		—
2016 RSU NEO awards		0.3		0.8		0.3		0.3		—		—
2016 PSU awards (1)		—		—		—		—		—		—
	$	4.2	$	10.9	$	18.5	$	4.2	$	9.7	$	4.6


		Weighted
		Average
	Shares of RSU	Grant Date
	and PSU	Fair Value
Beginning balance at January 1, 2018	1,083,841	$	28.61
Granted	1,313,152		15.65
Vested	(195,432)		28.46
Forfeited	(27,870)		20.49
Nonvested at September 30, 2018	2,173,691	$	20.90


												Accumulated
	Class A Voting			Class B Voting			Additional					Other		Accumulated		Total
	Common Stock			Common Stock			Paid-in		Treasury Stock			Comprehensive		Earnings		Stockholders’

																													Accumulated
																		Class A Voting			Class B Voting			Additional					Other		Accumulated		Total
																		Common Stock			Common Stock			Paid-in		Treasury Stock			Comprehensive		Earnings		Stockholders’
(In millions, except share and per share data)	Shares	Amount		Shares	Amount		Capital		Shares	Amount		Income (Loss)		(Deficit)		Equity		Shares	Amount		Shares	Amount		Capital		Shares	Amount		Income (Loss)		(Deficit)		Equity
Balances December 31, 2017	55,010,160	$	0.5	75,826,927	$	0.8	$	2,241.6	3,232,625	$	(48.2)	$	125.6	$	(207.9)	$	2,112.4	55,010,160	$	0.5	75,826,927	$	0.8	$	2,241.6	3,232,625	$	(48.2)	$	125.6	$	(207.9)	$	2,112.4
Cumulative effect adjustments for the adoption of new accounting principles (AS 606, ASU 2016-01 and ASU 2018-02)	—		—	—		—		—	—		—		4.4		(36.2)		(31.8)
Cumulative effect adjustments for the adoption of new accounting principles (ASU 606, ASU 2016-01 and ASU 2018-02)																		—		—	—		—		—	—		—		4.4		(36.2)		(31.8)
Net earnings	—		—	—		—		—	—		—		—		17.7		17.7	—		—	—		—		—	—		—		—		17.7		17.7
Other comprehensive income	—		—	—		—		—	—		—		10.5		—		10.5	—		—	—		—		—	—		—		10.7		—		10.7
Dividends declared:
Class A common stock, $0.20/share	—		—	—		—		—	—		—		—		(10.8)		(10.8)	—		—	—		—		—	—		—		—		(10.8)		(10.8)
Class B common stock, $0.20/share	—		—	—		—		—	—		—		—		(15.2)		(15.2)	—		—	—		—		—	—		—		—		(15.2)		(15.2)
Reversed dividend accrual for nonvested PSU's	—		—	—		—		—	—		—		—		0.7		0.7	—		—	—		—		—	—		—		—		0.7		0.7
RSUs surrendered to pay for payroll taxes	326,005		—	—		—		(1.8)	—		—		—		—		(1.8)	—		—	—		—		(1.8)	—		—		—		—		(1.8)
Reclassification from temporary equity	27,195		—	—		—		0.3	—		—		—		—		0.3	27,195		—	—		—		0.3	—		—		—		—		0.3
Stock-based compensation	28,055							2.8									2.8	354,060		—	—		—		2.8	—		—		—		—		2.8
Balances March 31, 2018	55,391,415	$	0.5	75,826,927	$	0.8	$	2,242.9	3,232,625	$	(48.2)	$	140.5	$	(251.7)	$	2,084.8	55,391,415	$	0.5	75,826,927	$	0.8	$	2,242.9	3,232,625	$	(48.2)	$	140.7	$	(251.7)	$	2,085.0
Net earnings	—		—	—		—		—	—		—		—		22.2		22.2	—		—	—		—		—	—		—		—		22.2		22.2
Other comprehensive loss	—		—	—		—		—	—		—		(107.0)		—		(107.0)	—		—	—		—		—	—		—		(107.2)		—		(107.2)
Dividends declared:
Class A common stock, $0.20/share	—		—	—		—		—	—		—		—		(10.8)		(10.8)	—		—	—		—		—	—		—		—		(10.8)		(10.8)
Class B common stock, $0.20/share	—		—	—		—		—	—		—		—		(15.2)		(15.2)	—		—	—		—		—	—		—		—		(15.2)		(15.2)
Reclassification from temporary equity	9,910		—	—		—		0.1	—		—		—		—		0.1	9,910		—	—		—		0.1	—		—		—		—		0.1
Stock-based compensation	—		—	—		—		4.0	—		—		—		—		4.0	—		—	—		—		4.0	—		—		—		—		4.0
Class A common stock repurchases	—		—	—		—		—	500,000		(8.2)		—		—		(8.2)	—		—	—		—		—	500,000		(8.2)		—		—		(8.2)
Balances June 30, 2018	55,401,325	$	0.5	75,826,927	$	0.8	$	2,247.0	3,732,625	$	(56.4)	$	33.5	$	(255.5)	$	1,969.9	55,401,325	$	0.5	75,826,927	$	0.8	$	2,247.0	3,732,625	$	(56.4)	$	33.5	$	(255.5)	$	1,969.9
Net loss	—		—	—		—		—	—		—		—		(100.4)		(100.4)	—		—	—		—		—	—		—		—		(100.4)		(100.4)
Other comprehensive loss	—		—	—		—		—	—		—		(7.5)		—		(7.5)	—		—	—		—		—	—		—		(7.5)		—		(7.5)
Dividends declared:
Class A common stock, $0.20/share																		—		—	—		—		—	—		—		—		(10.6)		(10.6)
Class B common stock, $0.20/share																		—		—	—		—		—	—		—		—		(15.3)		(15.3)
Special dividend declared:
Class A common stock, $1.55/share																		—		—	—		—		—	—		—		—		(82.7)		(82.7)
Class B common stock, $1.55/share																		—		—	—		—		—	—		—		—		(80.2)		(80.2)
Stock-based compensation																		—		—	—		—		4.2	—		—		—		—		4.2
Class B common stock repurchase and cancellation																		—		—	(24,057,143)		(0.3)		(256.7)	—		—		—		(165.9)		(422.9)
Balances September 30, 2018																		55,401,325	$	0.5	51,769,784	$	0.5	$	1,994.5	3,732,625	$	(56.4)	$	26.0	$	(710.6)	$	1,254.5


			Fair Value Measurements at September 30, 2019 Using
							Significant
	Total Carrying		Quoted prices in		Significant other		unobservable
	Value at		active market		observable inputs		inputs
(In millions)	September 30, 2019		(Level 1)		(Level 2)		(Level 3)
Other long-term assets:
Money market mutual funds	$	0.6	$	0.6	$	—	$	—
Derivative asset		56.2		—		—		56.2
Investments measured at net asset value (1)		11.1		—		—		—
Equity securities, available-for-sale:
Investment in NCM		1.6		1.6		—		—
Total assets at fair value	$	69.5	$	2.2	$	—	$	56.2

Corporate Borrowings:
Derivative liability	$	9.1	$	—	$	—	$	9.1
Total liabilities at fair value	$	9.1	$	—	$	—	$	9.1


			Fair Value Measurements at September 30, 2018 Using
							Significant
	Total Carrying		Quoted prices in		Significant other		unobservable
	Value at		active market		observable inputs		inputs
(In millions)	September 30, 2018		(Level 1)		(Level 2)		(Level 3)
Other long-term assets:
Money market mutual funds	$	0.5	$	0.5	$	—	$	—
Equity securities, available-for-sale:
Investments measured at net asset value (1)		10.8		—		—		—
Total assets at fair value	$	11.3	$	0.5	$	—	$	—

Other long-term liabilities:
Derivative liability	$	144.5	$	—	$	—	$	144.5
Total liabilities at fair value	$	144.5	$	—	$	—	$	144.5


					Unrealized Net		Unrealized Net
			Pension and		Gain from		Gain from Equity
	Foreign		Other		Marketable		Method Investees’
(In millions)	Currency		Benefits		Securities		Cash Flow Hedge		Total
Balance, December 31, 2017	$	129.9	$	(6.6)	$	0.6	$	1.7	$	125.6
Other comprehensive income (loss) before reclassifications		(101.6)		(1.4)		—		0.2		(102.8)
Amounts reclassified from accumulated other comprehensive income		1.0		—		—		(2.2)		(1.2)
Other comprehensive income (loss)		(100.6)		(1.4)		—		(2.0)		(104.0)
Adoption of ASU 2016-01 - reclassification to retained earnings		—		—		(0.6)		—		(0.6)
Adoption of ASU 2018-02 - reclassification to retained earnings		4.0		0.6		—		0.4		5.0
Balance, September 30, 2018	$	33.3	$	(7.4)	$	—	$	0.1	$	26.0


	Three Months Ended				Nine Months Ended
Revenues (In millions)	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
U.S. Markets	$	970.7	$	895.6	$	2,999.1	$	3,007.1
International Markets		346.1		325.8		1,024.2		1,040.4
Total revenues	$	1,316.8	$	1,221.4	$	4,023.3	$	4,047.5


	Three Months Ended				Nine Months Ended
Adjusted EBITDA (1) (In millions)	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
U.S. Markets (2)	$	116.3	$	105.0	$	395.8	$	535.6
International Markets		40.2		37.4		106.5		129.5
Total Adjusted EBITDA	$	156.5	$	142.4	$	502.3	$	665.1


	Three Months Ended				Nine Months Ended
Revenues (In millions)	September 30, 2018		September 30, 2017		September 30, 2018		September 30, 2017
U.S. markets	$	895.6	$	845.7	$	3,007.1	$	2,745.2
International markets		325.8		333.0		1,040.4		917.2
Total revenues	$	1,221.4	$	1,178.7	$	4,047.5	$	3,662.4


	Three Months Ended				Nine Months Ended
Adjusted EBITDA (1) (In millions)	September 30, 2018		September 30, 2017		September 30, 2018		September 30, 2017
U.S. markets (2)	$	105.0	$	107.6	$	535.6	$	420.6
International markets		37.4		39.8		129.5		113.7
Total Adjusted EBITDA	$	142.4	$	147.4	$	665.1	$	534.3


	As of		As of
Long-term assets, net (In millions)	September 30, 2019		December 31, 2018
United States	$	9,124.2	$	5,826.5
International		3,708.4		2,888.0
Total long-term assets (1)	$	12,832.6	$	8,714.5


	As of		As of
Long-term assets, net (In millions)	September 30, 2018		December 31, 2017
United States	$	5,775.9	$	5,866.8
International		2,900.6		3,066.7
Total long-term assets (1)	$	8,676.5	$	8,933.5